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ABSTRACT

THE APPLICATION OF FIRST PRINCIPLE MODELING IN COMBINATION WITH
EMPIRICAL DESIGN OF EXPERIMENTS AND REAL-TIME DATA
MANAGEMENT FOR THE AUTOMATED CONTROL OF PHARMACEUTICAL
UNIT OPERATIONS

By
Brian M. Zacour
May 2012
Dissertation supervised by Carl A. Anderson, Ph.D.
The U.S. Food and Drug Administration has accepted the guidelines put forth by
the International Conference on Harmonization (ICH-Q8) that allow for operational
flexibility within a validated design space. These Quality by Design initiatives have
allowed drug manufacturers to incorporate more rigorous scientific controls into their
production streams.
Fully automated control systems can incorporate information about a process back
into the system to adjust process variables to consistently hit product quality targets
(feedback control), or monitor variability in raw materials or intermediate products to
adjust downstream manufacturing operations (feedforward control).

These controls

enable increased process understanding, continuous process and product improvement,
iv

assurance of product quality, and the possibility of real-time release. Control systems
require significant planning and an initial investment, but the improved product quality
and manufacturing efficiency provide ample incentive for the expense.
The fluid bed granulation and drying unit operation was an excellent case study
for control systems implementation because it is a complex unit operation with dynamic
powder movement, high energy input, solid-liquid-gas interactions, and difficulty with
scale-up development. Traditionally, fluid bed control systems have either used first
principle calculations to control the internal process environment or purely empirical
methods that incorporate online process measurements with process models.

This

dissertation was predicated on the development of a novel hybrid control system that
combines the two traditional approaches.
The hybrid controls reduced the number of input factors for the creation of
efficient experimental designs, reduced the variability between batches, enabled control
of the drying process for a sensitive active pharmaceutical ingredient, rendered
preconditioned air systems unnecessary, and facilitated the collection of data for the
development of process models and the rigorous calculation of design spaces. Significant
variably in the inlet airstream was able to be mitigated using feedforward controls, while
process analytical technology provided immediate feedback about the process for strict
control of process inputs. Tolerance surfaces provided the ideal tool for determining
design spaces that assured the reduction of manufacturing risk among all future batches,
and the information gained using small scale experimentation was leveraged to provide
efficient scale-up, making these control systems feasible for consistent use.

v
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Chapter 1: Introduction

1.1 Statement of the Problem
Throughout its history, the pharmaceutical industry has relied upon traditional
batch manufacturing processes for the production of solid dosage forms.

In these

processes, raw materials are processed through several separate unit operations to create
the final product.

Unit operations for pharmaceutical tablets include particle size

enlargement (granulation), drying, particle size reduction (comminution), powder
blending, compaction, and coating among several others.

Most pharmaceutical

production lines are still predicated on these same systems.
Typically, each unit operation is considered independently, with the product of
each unit operation analyzed for quality by several measurements of material attributes
that are believed to indicate future product performance. Specifications are defined that
are believed to represent product quality. These specifications put limits on product
measurements, but the link between the specification limits and product performance is
not often explicitly defined. Inappropriately defined specifications have the potential to
allow unsatisfactory materials to be distributed to the public which could have severe
health consequences. Conversely, specifications that are too stringent put an unnecessary
economical burden on the manufacturing company, which is then shifted to the public via
increased medical costs. Therefore, it is crucial that the impact of process parameters are
related to meaningful measures of product performance, which allows specifications to
guarantee product quality.
1

Well developed controls of manufacturing unit operations are also necessary to
increase process understanding and limit batch failures. Without measurements on the
process or integrated control systems, batch failures require extensive investigations to
determine the root cause of failure. While major advancements have been achieved in
drug molecules, drug delivery systems, and drug targeting, very little innovation has
occurred in manufacturing development to improve efficiency and quality.
Other industries are well ahead of the pharmaceutical industry in terms of
manufacturing quality and efficiency.

A study published in 2007 reported that the

pharmaceutical industry operates at approximately 35,000 defect units per 1,000,000
produced,1 while the semiconductor industry and a number of chemical companies
achieve Six Sigma production (3.4 defects per 1,000,000 units). The United States Food
and Drug Administration (FDA) openly acknowledge this shortcoming and have recently
encouraged use of the guidelines put forth by the International Conference on
Harmonisation (ICH-Q8(R2))2 that allow for operational flexibility within a validated
design space.

This allows fully automated control systems that incorporate real-time

data management to be feasible. These systems offer the opportunity for continuous
improvement of the process and resulting drug product by allowing information gained
during manufacturing through online process measurements to inform the process to
ensure constant product quality (Feedback Control).3 Conversely, incoming variability
from raw materials, environmental factors, or intermediate products can be identified
using process analytical technology (PAT) and the downstream manufacturing
parameters can be adjusted accordingly to assure quality in the final product
(Feedforward Control).
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The FDA Quality by Design (QbD) initiatives are risk based, meaning a company
that rigorously defines the unit operations or product properties that most significantly
impact product quality and demonstrates sufficient scientific knowledge to control this
critical variability will be granted greater regulatory flexibility. The unit operations that
comprise batch manufacturing depend on a number of critical process, environmental,
and material parameters whose effects and interactions must be understood to establish
control.

Well executed design of experiments, online process measurements, data

management, and control software to create feedback and feedforward models that can
predict and control the critical quality attributes (CQAs) of the final product are required
to enable successful implementation of control systems. Rigorous statistical analyses are
needed to identify the significant factors and interaction terms and to determine
meaningful specifications or a design space that guarantees future product quality.
Control systems, especially those that can provide economic incentives for the
pharmaceutical company over time, are universally desirable. Consumers are afforded
low risk product at reduced costs, regulatory agencies can assess product safety and
efficacy using scientific methods, and pharmaceutical companies are able to produce
quality product efficiently, and may even achieve real-time release (RTR).

Initial

implementation can seem daunting and requires a substantial investment, but if developed
correctly, automated control systems provide a significant return on investment.
Automated control systems must be developed to meet the specific needs of a
given product or unit operation. Quantitative risk management is defined and optimized
for each system, independently. For this reason, this dissertation will consider two unit
operations, fluid bed processing and powder blending, and two different product
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formulations to demonstrate the unique development required for each system. Fluid bed
processing of pharmaceutical powders is typically more complicated than powder
blending and has more factors that can potentially affect product quality, so the
development of a control system for fluid bed processing requires more complicated
models and communication systems to mitigate the increased risk.

Conversely,

additional expenses devoted to the powder blending unit operation beyond those needed
to mitigate risk to the final product are wasted expenditures that a pharmaceutical
company can avoid.

The specific risks of the drug product must be considered

simultaneously, as well. This dissertation aims to provide a blueprint for identification
and management of critical factors in developing design spaces and automation systems
for pharmaceutical unit operations.
First principle calculations are a tool that can be used to increase development
efficiency while still providing the necessary control of the major mechanisms by which
unit operations effect product quality. They reduce the dimensions of DOE, account for
external fluctuations by adjusting process parameters in real time, and enable direct scaleup of first principle variables.

Fluid bed processing of pharmaceutical powders is

affected by the properties of the air used to fluidize the solid powders, so first principle
controls are particularly advantageous for this unit operation. Fluctuations in the inlet air
properties can be measured and used to inform process parameter adjustments to maintain
consistent product quality.

This can eliminate large systems that precondition inlet

airstreams, control laboratory environments, or narrow incoming variability.

These

advantages allow systems to be developed more efficiently while providing benefits to
product quality.
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Statistical design of experiments (DOE) is another tool that can be valuable in
terms of maximizing the value of the development process. Experimentation relies on
empirical models to quantify the relationship between important factors of the
manufacturing operation and final product characteristics, but designs that are created to
satisfy the needs of the system can provide valuable process understanding in an efficient
manner. Interactions between independent variables can have a substantial impact on the
response variables, and they must be identified through empirical modeling.

This

information can be used to create feedback control where specifications can be placed on
the response factors and maintained by adjusting the input variables.
The process understanding gained by online process monitoring through
spectroscopy and other methods is invaluable. Use of such systems lowers the risk of
batch failures and thereby eliminates the need for expensive investigations. They allow
the immediate identification and correction of deviations in product quality attributes.
Online measurements also allow for RTR in well developed systems, which reduces the
burden of end product testing and reduces the queue time for batches between unit
operations. This can lead to efficient supply chains and better control of inventory,
providing an economic incentive for pharmaceutical manufacturing companies. Further,
these economic benefits can also be extended to consumers through reduced medical
costs. The advantages offered by online PAT systems can be beneficial to both fluid bed
processing and powder blending.
Automation systems require the incorporation of myriad models, all of which
include error and uncertainty. Rigorous statistical analyses are needed to account for
these uncertainties to define meaningful boundaries, so a design space can assure product
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quality in future batches. These models must also be robust so that they may function for
extended periods of time and be easily transferred to different systems or larger scales,
and can be easily updated. Failure in scale-up, transfer, or update may cause the initial
investment to be lost, which would make these systems infeasible. Therefore, the process
understanding gained during initial development must be leveraged to provide maximum
value in future use.
To date, drug manufacturing has not improved at the same rate as comparable
industries, leaving a weakness that must be addressed to achieve satisfactory levels of
pharmaceutical quality and efficiency. This dissertation demonstrates how automated
control systems can be developed using efficient techniques to adjust process parameters
in real time to ensure product quality while providing scientific justification of a design
space to satisfy regulatory concerns.
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1.2 Hypothesis and Objectives
This dissertation is based on the central hypothesis that the integration of first
principle calculations with empirical modeling and real-time data management enables a
control system to provide a high standard of product quality with economic efficiency
that mitigates the risk identified for a specific formulation and manufacturing
combination.
Given the central hypothesis, the objectives of this dissertation were to:
1. Develop a fully automated, hybrid control system for the fluid bed drying of a
model drug formulation with stability considerations using efficient methods.
2. Develop a model for the prediction of downstream product properties from the
reduced variables that are the process factors of the hybrid controls, for the
creation of a design space that assures future product quality.
3. Utilize the hybrid control system to facilitate scale-up experimentation.
4. Extend the control system to include fluid bed wet granulation and drying and
demonstrate the development of a design space that incorporates both formulation
and process factors within a single design space model.
5. Develop an efficient and optimized blending control system using multiple NIR
sensors, efficient calibration techniques, and blending homogeneity algorithms.
The results of the objectives provide a blueprint for the development of automated
control systems that offer improved product quality with efficient experimental designs.
This dissertation provides a clear demonstration to the pharmaceutical industry that a
high degree of product quality is possible in an economically feasible system.
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1.3 Literature Survey
1.3.1 Fluid Bed Granulation and Drying
1.3.1.1 General Fluid Bed Properties
Fluid bed processing of pharmaceutical powders is an excellent case study for the
development of a fully automated control system because of its complexity and the
multiple phases typically utilized during processing.4,5 A single fluid bed unit operation
can take raw powders through blending, wet granulation, drying, and cooling. A fully
automated control system must be able to define the process at any point during the
progression, define meaningful end points of each phase before moving into the next
phase, and incorporate information from process measurements back into the process so
that the manufacturing parameters can be adjusted to control the process trajectory. This
requires a well developed communication system that can synchronize multiple process
measurements and organize data for analytical and process models. The models typically
require comprehensive experimental designs to be performed so that prediction results
maximize user confidence. Development of these systems require a substantial initial
investment, but the rewards in product quality and efficiency can lead to a significant
return on the investments due to removing batch failures, reduced inventory and storage,
and real-time release.
Fluid bed processing is also important because of the significant advantages that
can be realized when processing solid powder systems. Fluidization is the operation by
which solid particles are transformed into a fluid-like state through suspension in a gas or
liquid.6 For the manufacturing of solid dosage forms in the pharmaceutical industry,
8

fluidization is almost exclusively solid powders suspended in a flowing gas, which is
usually air. This dissertation considers this as the operating definition for fluidization.
Fluidized beds with gases and solids have unusual properties that are useful for
industrial applications. Fluidized beds appear as a boiling liquid-like material and exhibit
liquid-like behavior.

These properties include flow properties, nearly isothermal

conditions due to rapid mixing, a resistance to rapid temperature changes due to efficient
heat exchange which makes a large magnitude of heat transport possible.6 Many of these
advantages reduce the risk of hot spots or thermal gradients in high energy drying
processes while reducing the time needed to dry large batches of moist powders. These
properties allow processing at large scales.
At a certain minimum airflow velocity the frictional forces between the fluid and
solid particles counterbalance the weight of the particles, the vertical component of the
compressive force between adjacent particles disappears, and all particles are suspended
by the fluid. This is considered incipiently fluidized or at minimum fluidization. 6 The
minimum fluidization velocity for a system can be calculated if the material and
equipment have been adequately characterized,7 but it is typically much easier and more
practical to determine empirically.

With an increase in flow rate beyond minimum

fluidization, large instabilities within the bed are observed creating bubbling and the
channeling of gas. The volume of the bed does not expand much beyond its volume of
minimum fluidization, but agitation becomes more violent and the movement of solids
becomes more vigorous as the airflow rate is increased.
In gas/solid systems, gas bubbles coalesce and grow as they rise. Fine particles
flow smoothly down the wall around the rising gas voids, while coarse particles are
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pushed upward and rain down from the slug when the gas void finally disintegrates. The
range and magnitude of optimum operating conditions depends on particle characteristics
including size distribution, shape, and density, 8-10 as well as equipment properties
including geometry, bed depth, and distributor plate arrangement. 6 Careful planning and
design of the equipment and operating conditions for a given system of particulates is
crucial for robust processing at multiple scales.
Different regimes of fluidizations are displayed in Figure 1.1, which is reproduced
from Kunii and Levenspiel.7 Low airflow velocities increase the risk of losing the
fluidized bed during processing, while high airflow velocities increase the probability of
exceeding the terminal velocity of fine particles, causing entrainment in the filter bags.
The mixing or segregation tendencies of a given system are an equilibrium process that
depends on processing conditions. Fluidization velocities near the minimum for a given
particle size increase the probability of high density particles separating to the bottom of
the bed. However, in high velocities the mixing resulting from bubbling and circulation
dominate.11 This mixing is more efficient in larger systems. The range of possible
fluidization regimes highlights the importance of controlling the application using first
principle controls from the beginning of use.
Industrial applications for physical operations in batch processes in the
pharmaceutical industry, such as granulation and drying, are typically performed in the
bubbling or turbulent bed regimes.7,12 In the bubbling or turbulent regimes, temperature
is nearly constant throughout the bed due to efficient heat exchange, and a wide size
distribution of particles is possible for these applications. These advantages facilitate
scale-up. Conversely, a high pressure drop across the distributor plate is necessary to
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assure uniform gas flow and uniform fluidization of particles. This leads to large power
consumption.

This dissertation optimizes the fluidization within the bubbling bed

regime.7

Figure 1.1. A general flow regime diagram reproduced from Kunii and Levenspiel4 for
the whole range of gas-solid contacting, from percolating packed beds to lean pneumatic
transport of solids; letters C, A, B, and D refer to the Geldart classifications of solids.
The abscissa (dp*) is a dimensionless measure of particle diameter, while the ordinate (u*)
is a dimensionless measure of particle velocity.

1.3.1.2 Fluidization of Solid Powders
The particle size distribution of the solid system is a strong factor in determining
the fluidization velocities necessary for robust processing. Fine particles tend to clump
and agglomerate in the presence of adsorbed moisture, requiring higher airflow velocities
11

and increased particle entrainment/elutriation. Large, uniform particles fluidize poorly
with bumping, spouting, and slugging common.

Addition of fines to large particle

systems act as a lubricant, allowing for easier fluidization. Due to this lubrication, wide
particle size distributions increase the range of possible fluidization velocities, increasing
the robustness of the operation.6 Extensive work is required to characterize and optimize
a given system.
The bubbling bed occurs at fluidization velocities between the minimum
fluidization velocity and ten times the minimum velocity. The actual magnitude depends
on the powder properties and bed geometries, and strongly depends on the fraction of
particles less than 45 µm.7 When the minimum bubbling velocity is exceeded, the bed
height decreases slightly and bubbles become visible. The rising bubbles cause the
observed churning, mixing, and flow of solids, which provides the desired mixing and
contacting properties. Professor D. Geldart characterized particles into four groups based
on particle size and density that are very useful in determining fluidization behavior. 9,10
While most pharmaceutical or industrial applications contain particles from several or all
groups, Geldart B or A particles are the most common encountered and their
characteristics can be used to predict fluidization properties.
Geldart B particles are considered sand-like, with median particle sizes between
40-500 µm and densities between 1.4-4 g/mL. These particles fluidize well with vigorous
bubbling action and bubbles that grow large. Bubbles form as soon as the gas velocity
exceeds the minimum fluidization velocity. Bubbles grow and coalesce as they rise and
their size is independent of the particle size and roughly linearly related to the distance
from the distributor plate.
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Geldart A particles are considered aerotable, and have small particle sizes and low
densities. They fluidized smoothly at low velocities and display controlled bubbling at
higher velocities. The bed expands considerably before bubbling occurs with the fines
acting as a lubricant to the other particles. In Figure 1.1b, it can be seen that bubbling
beds can be operated stably over a wide range of conditions for Geldart A or B particles.
For all particle groups, when the fluidization velocity exceeds ten times the
minimum fluidization velocity, particles are projected into the freeboard above the bed,
and the amount of particles lost is significantly increased. To minimize loss of powder,
the working fluidization velocity should be maintained below the terminal velocity of the
smallest size particles in a significant fraction of the bed. 7 The terminal velocity of
particles is the velocity a particle falls through a fluid (free-fall velocity). It is inversely
proportional to particle size and can be expressed by:

1
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where u t* is the terminal velocity, d *p is a dimensionless particle size,7  s is the sphericity
of the particles, and sphericity must be between 0.5 and 1. This information can be used
to reduce the experimental space explored during process development and can be used
to guide scale-up efforts.
1.3.1.3 Mixing in a Fluidized Bed
The performance of the fluidized bed operation depends on the bubbling behavior.
Control and improvement of performance can only be attained after the gas/solid
contacting is understood.

The bubbling bed behaves like a bubbling liquid of low
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viscosity.13 Bubbles of similar sizes have similar shapes, small bubbles rise slowly
compared to large bubbles, a train of bubbles may coalesce to give larger bubbles, and
the rise velocities can be described by the same expressions. Unlike the liquid-gas
system, however, there is an interchange of gas between a rising bubble and the dense
(emulsion) phase in a fluidized bed.
Bubbling behavior, the movement of gas and solids, and the pressure distribution
of rising bubbles has been model by Davidson. 14 The pressure in the lower portion of a
rising bubble is lower than in higher portions, so gas enters the bubble from the bottom
and leaves from the top. Bubbles circulate three times the amount of gas processed by
the equivalent section of emulsion phase gas, giving rise to dynamic mixing. The flow of
gas through the emulsion phase far from any bubbles is essentially laminar.
Solids move out of the way as bubbles rise except for the small fraction (0.21.0%) caught inside bubbles. Solids, however, are caught in the wake of the rising
bubble and are drawn upward behind the bubble. They slowly leak from this wake and
fall back into the general bed, meaning there is a continuous interchange of solids
between the wake and emulsion regions. This leads to an increase in turbulent mixing.
The wake of a rising bubble is also used to explain why trailing bubbles are drawn
into the leading bubble and coalesce. The size of bubbles increases with gas velocity and
with distance from the distributor plate, but varies widely between systems due to
changes in geometry and particle properties. Smaller particles (Geldart A) tend to have
smaller maximum bubble sizes than larger particle system at comparable velocities.
There are many different methods to calculate an average bubble size for a given system
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using particle property estimates, initial bubble sizes, and distance from the distributor
plate.15
Early attempts at modeling the bubbling bed as a whole used the simple two phase
model. This expression assumed that once bubbling began all gas in excess of the
minimum fluidization velocity pass through the bed in bubbles. 15 Numerous examples
have shown that empirical results are more complex than the two phase model indicates.
The conceptual model developed by Kunii and Levenspiel15 for the bubbling bed was
aimed at estimating features or properties of the bed such as contacting regimes and
volume fraction of phases using only a few measurements or correlations. Some of the
general findings are presented below.
For typical Geldart B and A particle systems, the bubble gas is less than the
difference between the fluidization velocity and the minimum fluidization velocity. The
emulsion voidage increases with airflow velocity, and the emulsion phase is not stagnant.
Distinct flow patterns, called gulf streaming, occur. Figure 1.2, reproduced from Kunii
and Levenspiel,15 displays typical flow patterns in the emulsion phase of a bubbling bed.
The upflow emulsion regions should be rich in bubbles, and the downflow regions should
have few, if any, rising bubbles. This dynamic movement, combined with the vigorous
mixing from the rising bubbles, creates excellent circulation systems that increase the
probability of uniform processing of powders. It should be noted, however, that there is
an order of magnitude difference in mixing in the vertical and horizontal directions.
Vertical mixing is significantly more efficient, but the duration of normal batch
operations still allows for adequate horizontal distribution of materials.
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Horizontal

mixing is strongly affected by solids ejected into the free board (gas section above the
bubbling bed) and mixing in the wake of rising bubbles.
The gulf stream behavior is increased in larger systems because the surface area
of walls and equipment is decreased in relation to the bed volume. Walls and equipment
provide frictional resistance to flow. As a result, mixing characteristics may change with
changes in scale, with more efficient mixing present in larger systems. Internal structures
may be added to larger fluidization systems to increase the frictional resistance, slow
bubble rise velocities, and decrease bubble size to promote better gas solid contacting and
more efficient drying in a pharmaceutical operation. Scaling factors have been proposed
by Horio et al.16 and Fitzgerald and Crane,17,18 which have shown some success in simple
systems, but the authors agree that much more work is needed in the area of fluid bed
scale-up, scale-down, and hydrodynamic similarity for practical applications. 15

Figure 1.2. Reproduced from Kunii and Levenspiel.4 The movement of solids within the emulsion phase
of bubbling fluidized beds.

The choice of distributor plates at the bottom of the bed and placement of the
spray nozzle can significantly impact fluidization behavior and granulation properties. 19
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Contacting between gas and solids is most efficient directly above the distributor plate, so
this region significantly affects the efficiency of the overall process. Perforated plates
with a uniform distribution of circular openings are the most common plates because they
are the least expensive. The plate must provide a significant pressure drop to allow
uniform gas flow into the powder bed and to prevent channeling or gas jets. A large
pressure drop minimizes the effect that the distributor plate has on gas-solid contacting,
which is then dependent on the hydrodynamic properties of the bed itself.

This is

desirable and increases the probability of uniform processing. While larger pressure
drops benefit gas distribution, increased pumping power is required for increases in
pressure drop. To maximize contacting uniformity, the fraction of open area in the
distributor plate should be less than 10%.
Top spray systems that spray binder solution onto the top of the powder bed can
also promote uniform flow and improved mixing. Any spray or fluid movement against
the direction of bulk flow breaks up large bubbles and causes better distribution of
bubbles within the fluidized bed. Breaking of large bubbles also reduces the fraction of
solids that is ejected into the freeboard, thus reducing entrainment and elutriation. This
dissertation only considers a top spray granulation system.
1.3.1.4 Fluidized Bed Granulation and Drying
The energy requirement to do work in the fluid bed is provided by the heated
airstream. In pharmaceutical operations where the addition and removal of water to a
fluidized bed is the primary mechanism of action (the situation investigated in this
dissertation), the work can be accomplished via heat or mass transfer between the
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fluidized solids and the airstream. Therefore, the contacting of the gas and solid is
critical in determining the progress of the unit operation.
This dissertation considers the fluidized bed granulation and drying of
pharmaceutical powders using water as the solvent. Therefore, the heat and mass transfer
occurs between the solids and surrounding gas to provide the energy for the evaporation
of water. The bulk of mass transfer occurs in the emulsion phase of the fluidized bed
(outside of bubbles), while the bulk of the air that passes through the bed are in bubbles.
As a result, water must travel from particles to the emulsion gas, emulsion gas to cloud
gas surrounding bubbles, and finally to bubble gas before leaving the system.20 This is
especially true in fine particle systems where the fraction of gas passing through the bed
in bubbles increases. This leads to the conclusion that mass transfer in a given system is
governed by the type of particles being fluidized and the diffusion between emulsion gas
and bubble gas. These properties remain relatively constant for a given formulation,
except for changes due to inlet air humidity and airflow velocity. The major source of
control in terms of energy input comes from the heat transfer mechanism.
The heat transfer mechanism has virtually the same contacting properties as
described by the mass transfer mechanism, but the driving force (difference in
temperature between airstream and particles) is generally much larger and is easily
controlled. From the previous discussions it can be concluded that there is not efficient
mixing of gas in fine particle systems fluidized in the bubbling bed regime. This leads to
inefficient gas/solid contacting. There is efficient mixing of solid particles, however, and
the expense of air is low, so fluidized beds still provide advantageous properties for
pharmaceutical granulation and drying.
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In the drying phase, fluidized beds have large capacities at relatively low cost,
high thermal efficiency, and uniform temperature distribution.12 This is combined with
the cooling effect of evaporative drying to reduce the risk of temperature excursions
experienced by solid particles.21 The uniformity of temperature within a fluidized bed
exists both in the radial and axial direction, even in large systems. 22 An equilibrium is
reached very rapidly, so hot air that contacts cold solids reaches the temperature of the
solids before moving more than 2-3 cm into the bed.23
Each particle goes through two drying regimes during a drying process: the
constant rate and the falling rate drying periods.

The constant rate drying regime

removes the free moisture on the surface and in the pores of fluidized solids, and is
limited by heat transfer. Therefore, the moisture carrying capacity of the airstream limits
the drying rate, which varies proportionately with gas velocity and temperature, and
inversely with bed height. In this period, the approach to equilibrium is rapid for both
heat and mass transfer, so the bed and the leaving gas will remain close to the adiabatic
saturation temperature (web-bulb temperature) of the entering gas stream. 23
After the critical moisture content is reached, the drying rate begins to fall
because of diffusional effects. The remainder of the water is bound within the solid
particles and the diffusion of moisture to the surface is slow enough to control the overall
drying rate. The moisture loss is close to exponential with time. The critical moisture
content is reached when the moisture on the surface of solids is in equilibrium with the
gas bathing the particle. The vapor pressure at the surface of the solid particles drops
below the vapor pressure of the pure liquid at the drying conditions of the inlet gas
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stream. The critical moisture content is small for small particle systems and slower
overall drying rates.23
The high heat capacity of the fluidized bed and the rapid mixing of solids assure
that the temperature of solids is mostly independent of location in the bed and at any
instant the solids are all at the same stage of drying. This means there is very little
interaction between particles in the bed with respect to drying. The overall heating of
solids is determined by the heat capacity of the entering hot gas, not by the kinetics of the
process, and the time needed to heat a bed of dried solids is proportional to the static bed
height and inversely proportional to the gas velocity. The temperature of dried solids
changes exponentially with time, and the effect of evaporative cooling during the drying
phase keeps the temperature of solids low.23
These properties allow for strict temperature control and simple scale-up of the
temperature control system. A possible source of error in the temperature control is the
heat transfer between the bed and the walls of the equipment, which can be significantly
higher than for the gas (air) itself. 22 Heat loss to the surrounding environment is more
significant at smaller scales due to the increase in surface area per unit volume. The heat
loss in a commercial system is typically a few percent. The error term can be measured
simply by running a trial system at several temperatures and calculating the heat transfer
coefficient.
In the spray granulation phase, there is a combination of three sets of rate
processes: wetting and nucleation, consolidation and growth, and attrition and breakage. 5
Fluid bed granulation has properties that can be advantageous for all of these processes.
The efficient and complete solid mixing that takes place in the fluid bed distributes water
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or binder solution throughout the bed quickly, which leads to uniform wetting and
nucleation. The airstream removes large droplets of water that build up unevenly on a
few particles, and reduces the risk of forming large particles that must be milled later.
The efficiency with which nucleation and further coalescence occurs is dependent on the
wetting properties of the solid material, the water additional/removal rate, and the size of
the water droplets in the spray solution.
The mechanisms by which coalescence, attrition, and elutriation occur create a
process where small particles agglomerate with a higher probability than larger particles,
thereby narrowing the final particle size distribution achieved.4 The force of particle
collisions is proportional to the mass of the particles, so collisions between smaller
particles exhibit less force and increase the probability of coalescence in the presence of
moisture on the surface of the particles. Smaller particles also heat up faster than larger
particles, increasing the probability of evaporating binding solutions on small
agglomerates to create solid bridges. Conversely, collisions between larger particles have
a greater force, which increases the probability of breakage or attrition. Therefore,
precise and narrow particle size distributions are possible in well controlled systems.
Despite the advantages of fluidized beds, their use for industrial applications has
not been popular outside of simple drying processes. This is due to the complexity and
sensitivity of some systems which leads to problems with control, difficulty in scale-up,24,
25

and the lack of useful scientific models. 6 In addition, batch processes are not steady

state experiments, so the optimum fluidization parameters must be constantly varied as
the total mass and particle properties change. As a result, the use of fluidized beds have
traditionally been approached as an art, and due to the significant difference in behavior
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of large beds compared to small beds, extrapolation to a commercial scale has been
unreliable.

Development beginning with first principle theory is uncommon. This

dissertation attempts to address these shortcomings for the pharmaceutical scientist.
Two separate approaches have been attempted in previous studies to model or
control the fluid bed unit operation. The first approach uses first principle calculations
based on thermodynamic, heat, and mass balance equations to define and control the
environment inside the fluid bed chamber. The second approach is purely empirical and
uses online process measurements, spectroscopy, design of experiments (DOE), and
process modeling to control the unit operation.

Each method has benefits and

disadvantages, many of which are complementary, but they have never been used
together to their full extent in a single system.

This dissertation demonstrates the

development and implementation of a hybrid control system that uses both first principle
calculations and empirical data management to limit the drawbacks of each method to
manufacture pharmaceutical granules within tight specifications.

1.3.2. First Principle Control Systems for Fluid Bed Processing
First principle calculations have been used to model drying, aqueous film coating,
and fluid bed processes. However, they are not used frequently except for very simple
approximations. Examples of the controls for this approach are the simple temperature
difference method,26-28 complex thermodynamic environment controls,29-31 fluidization
regimes,4,7-10,15 computational fluid dynamics,32-36 and transport phenomena.37, 38 All of
these methods use material properties, fluid dynamics, and simple measurements of mass,
humidity, airflow, and heat at different points of the process to define the thermodynamic
condition of the bulk gas-solid suspension or surrounding environment.
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The approach taken in this dissertation utilizes the thermodynamic calculations
developed by Ebey and referred to as the environmental equivalency factor (EFF).29,31
These calculations were established in 1987 to define the aqueous film coating process.
The same evaporative drying mechanisms control spray granulation and drying in
aqueous fluid bed processing. The derivation of the EEF calculation for a specific fluid
bed system and the feedback/feedforward mechanism of control will be addressed in
significant detail in chapter 2.
First principle controls offer several advantages that are essential for robust and
efficient processing.

By definition the calculations are based on material and

environmental properties, so the calculations are universal for all systems. Separate
calibrations for new or adjusted formulations are unnecessary. Only the optimum set
points must be defined independently for new systems.

The equations are also

independent of scale or specific equipment, meaning all controls based in first principles
are directly scalable and transferable.

Scaling up processes from lab scales to full

manufacturing scales has traditionally been a major hurdle for pharmaceutical processes,
in particular, for fluid bed systems.24, 25 Therefore, eliminating any variables that need to
be adjusted between scales is a major advantage.
First principle calculations establish control by quantifying the scientific
mechanisms by which the process performs work. In the fluid bed example, the internal
environment, which controls the evaporative drying mechanism and the rate of water
addition or removal, can be defined to allow the final granule properties to be controlled
more precisely. Property fluctuations or failure during development can be explained
using scientific principles, leading to easier interpretation and greater process
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understanding. Complex interactions between processing parameters can be accounted
for by simply understanding their impact on simpler first principle mechanisms.
Mechanistic control offers improved performance in terms of inter-batch product
variability. Traditional cookbook and even empirical control systems do not account for
many sources of variability that have the possibility to impact final product properties.
Even if all process parameters remain constant, small fluctuations in the external
environment will affect the incoming airstream, thus altering the drying mechanism or
drying rate without additional controls. If the mechanism of action in a given system is
known and quantified, the impact that external variability has on the mechanisms can be
defined, and process parameters can be adjusted to ensure constant product quality.
The only alternative for achieving the highest degree of product control is to
implement systems that assure constant properties for all variables that may impact future
product quality (raw materials, air, etc.). While this is impractical, it is common within
the pharmaceutical industry to reduce environmental or raw material variability instead of
adjusting the process to account for the variability.

Preconditioning systems that

maintain constant air temperature and humidity within current good manufacturing
practice (cGMP) facilities are a standard practice.39

These systems are expensive,

especially for large, commercial facilities, and still do not remove all variability. Large
gradients with respect to temperature and humidity are common within large
manufacturing spaces, especially in the presence of a large work force. Additionally,
purchasing raw materials with reduced variability can be expensive or even impossible.
These are expenses that are unnecessary if the investment into a rigorous first principle
control system is made.
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The final and most substantial economic advantage offered by first principle
controls is variable reduction. The amount of development and experimentation can be
reduced exponentially by reducing the number of process variables investigated. This is
again achieved by quantifying the actual mechanisms of action. As an example, the EEF
calculation that will be used in this dissertation takes nine measurements – inlet air
temperature, inlet air humidity, heated air temperature, product temperature, outlet air
temperature, exhaust air temperature, exhaust air humidity, airflow velocity, and spray
rate – and calculates a single reduced variable. Of the nine measurements, four – inlet air
humidity, heated air temperature, airflow velocity, and spray rate - are factors that would
typically be altered independently in a purely empirical DOE. By reducing the number of
input factors to be explored in a DOE by three, the cost of development can be reduced
from 128 (27) experiments to 16 (24) experiments (1/8 costs). While a full factorial
design would not be practical for a system with 7 variables, it can be seen that the
benefits of a full factorial design can be realized when the number of variables is reduced
to 4 without compromising the degree of process understanding acquired.
There are several challenges to first principle controls, however. The calculations
in this dissertation assume an adiabatic system, which is not rigorously correct. There is
heat exchange from the equipment walls to the surrounding environment. Additionally,
first principle controls do not typically account for the effects of atomizing air, changes in
the droplet size of the spray, and changes in the kinetic energy of process air and water
vapor. Typically, these are minor factors, but can have more serious effects in sensitive
processes.
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The error term associated with the adiabatic assumption can be measured by
running trial systems, so the drying rate and heating effects on the solid can be controlled
precisely. A general heat exchange profile can be determined by running an empty
system at different airflow velocities and temperatures. More precise profiles can be
determined by using trial batches of a given formulation because the heat exchange
depends on the solid particles colliding against the inside wall of the equipment. This
measured error term can then be added to the feedback control system to adjust the
process parameters accordingly.
The droplet size of the spray rate has been shown to significantly affect the
granulation regime,5,25,40 which can impact the final particle size distribution and granule
porosity. These are often critical quality attributes (CQAs) of the granulation process, so
additional considerations may be necessary. The droplet size variable is often treated as a
nuisance variable and held constant. This works well to reduce variability between
batches of a given system, but is problematic for transfer and scale-up.25 It is very
difficult to match spray droplet sizes at different scales while keeping processing time
constant. This can only be accomplished by using multiple spray nozzles at different
locations.
While first principle calculations provide a quantitative and intuitive description
of the processing mechanisms, they provide no feedback on actual product properties in
real time. First principle control systems do not measure the moisture or chemical
concentrations in the product, nor do they provide estimates of particle size. Therefore,
the definitions of phase and batch end points are difficult to determine and are not
intuitive. Additionally, the first principle calculations describe the batch as a bulk system
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and provide no information on the spread of batch properties. There is also no access to
additional information such as material phase changes or chemical decomposition. This
information can be critical to optimizing a process, increasing process understanding, or
identifying a batch trending toward failure.
The measurements typical of a first principle control system (temperature,
humidity, etc.) often have slow response times when compared to online spectroscopic
methods.41 As a result, excursions from the process trajectory may be detected after a
finite time lag. This can have devastating consequences for a sensitive process. The risk
of batch failure may be substantially increased if information about the process lags even
30 seconds behind the process.
While the EEF calculations provide an excellent strategy for controlling the
drying mechanism and rate, which is the single most impactful mechanism in a physical
fluid bed operation with regards to the final product properties, additional calculations are
needed to understand and control airflow dynamics and mixing mechanisms. When
controlled, these properties limit the amount of solid entrainment/elutriation, narrow the
final particle size distribution, reduce the risk of uneven processing or temperature
excursions, and provide insight into potential problems in scale-up and transfer. Due to
the complexity of these phenomena, they are addressed through simulation using the
bubbling bed model,4 or through computational fluid dynamics. 32-36

Both methods

incorporate material and air properties into simplified expressions for complicated heat
and mass transfer models, hydrodynamic expressions, and kinetic theory. The results of
the simulation are then compared to empirical results, and the assumptions and input
properties are adjusted accordingly.

This information can provide knowledge about
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potential problems with dead spots in certain fluid bed geometries or distributor plate
designs, which is invaluable for initial process design, scale-up, and transfer applications.
Even in the most rigorous first principle control systems, some amount of
empirical modeling is necessary to define the optimum set points for the first principle
variables and to predict downstream product properties using critical material attributes
(CMAs) and critical process parameters (CPPs).

Expanding on these models and

including process analytical technology (PAT) 41 into the control system can reduce the
risk associated with the shortcomings of purely first principle systems.

Statistical

treatments of development data also quantify future uncertainty to reduce the risk of
future batch failures. This dissertation aims to demonstrate the feasibility of a hybrid
control system.

1.3.3 Empirical Control Systems for Fluid Bed Processing
The concept of complete empirical controls for fluid bed processors in the
pharmaceutical industry are more recent than the first principle controls and became
possible with the success of online spectroscopy, multivariate modeling, and complex
communication and data management systems. These systems began with traditional
DOE studies of fluid bed process factors,40,42-45 expanded to include online measurements
of product properties using spectroscopy,46-49 imaging systems,50,51 and other probes,52,53
to finally creating fully automated supervisory control and data acquisition (SCADA)
systems54,55 with limited complexity.
Empirical control systems are based on experimentation, observation, and
statistical modeling. Well designed experimental plans are needed to produce reliable
data for modeling.

These controls are completely defined through empirical data
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analysis. This usually requires a stochastic experimental approach to limit the number of
experiments and developmental costs.

Screening designs56 are used to identify

significant variables from a large pool of variables using a small number of experiments.
Selected variables from the screening design are then investigated in more
comprehensive designs such as factorial designs,57 response surface designs,58 mixture
designs,59 Bayesian designs,60, 61 or computer-aided designs62 to more adequately probe
the experimental space. The observed data is then related to the necessary response
factors using regression analysis,63 analysis of variance (ANOVA),63 analysis of
covariance (ANACOVA),64 or nonlinear methods.65 Augmentation of the second design
or a third design may be required to increase model performance in a local region of the
investigated space. Finally, response surface methodologies66 and estimates of model
uncertainty and future performance67 are often needed to describe the complex behavior
and interactions of the most significant variables with respect to product quality, and all
models must be validated with independent batches.2 The combination of these designs
creates a large amount of experimentation, but it is absolutely necessary because
empirical models are only as good as the variance space from which they are derived.
The advantages of empirical controls complement those of the first principle
controls.

Online sensors provide direct moisture,46,47 particle size,50,68 or other

measurements of the product in real time for immediate CQA information and the simple
and intuitive definition of phase end points. For single wavelength, diode array, or CCD
detector based instruments, which are commonly selected for online applications,
measurement and response times can be as short as milliseconds. Predictions can then be
generated for the acquired spectra from a previously calculated calibration in a matter of
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seconds.

This allows the process to be ended or adjusted accordingly prior to

significantly changing. The immediate feedback and control action provided by PAT is
crucial for robust processing and for reducing the risk of negative batch excursions.
It is also simple to define a phase or batch end point using a meaningful property
measurement of the product (e.g. moisture content). This simple and immediate feedback
reduces end point variability and improves product precision. Fluid bed drying processes
have an increased risk of overdrying when NIRS is not used to monitor moisture content
in real time. This can lead to unnecessary heating of the granules, which may impact
chemical or physical stability.21
The information contained in near infrared (NIR) or Raman spectra, common
online techniques, also includes chemical69 and physical phase information to give insight
into the water-solid interactions for improved process understanding.70-72 For example,
an active pharmaceutical ingredient’s (API) crystalline phase or percent purity can be
monitored in real time.

If an API is marketed as an anhydrous crystalline form,

conversion to a more stable hydrate may be thermodynamically favorable, which could
lead to severe deficiencies with regard to final product dissolution. 71,72,21 This increased
process understanding can provide insight into batch failures. The information can also
be used to create more robust processes using feedback control to limit the amount of
phase conversion during processing.
Online spectroscopic methods typically have small sample volumes in a single
measurement. Modern data management systems have very good computational power,
so large amounts of data are able to be analyzed with ease. As a result, online methods
are usually set to sample the system at high frequencies. This increases the overall
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sample size interrogated per unit time, and provides valuable information about process
trends, variability, and the breadth of material properties. First principle calculations
consider the system as a single unit, so the data afforded by online methods can be used
to calculate the precision of product CQAs, for better control of downstream
performance.
Finally, every robust control system requires some form of empirical modeling for
the optimization of CMAs and CPPs, identification of process interactions, the prediction
of downstream performance attributes, and the calculation of a final design space. Even
if all process set points can be described using first principle calculations, which is rare,
DOE is necessary to efficiently optimize the values for maximum performance and
identify interactions between parameters. Additionally, it is likely that empirical models
are necessary to quantify the relationship between a unit operation’s CPPs and
downstream/clinical product performance attributes, which are the only quality metrics
that are rigorously meaningful. Well constructed DOE and statistical treatments can
provide this information, enabling the identification of a meaningful design space that
allows for operational flexibility and corrective action, to assure final product
performance.

A manufacturing system that attempts to produce downstream CQAs

within specifications by maintaining constant CPPs is not a control system unless it can
be assured that there is no input variability that will impact performance, which is not
practically feasible.
Disadvantages of empirical controls essentially all relate to cost concerns. All
online methods require calibration building, and robust process models require large
experimental designs. Spectroscopic calibrations are formulation, equipment, and scale
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specific, so a new calibration must be created for each system or a rigorous transfer
technique73-75 must be applied. Multiple sensors are necessary in large systems because
of sampling concerns and batch uniformity questions, so it can be expensive to calibrate
each instrument independently. These costs can make development of purely empirical
controls economically infeasible.
Process DOE are large, especially when considering external environment factors.
Including any variable that could potentially affect the process creates unreasonably large
designs. Designs to investigate a large number of parameters can be cost prohibitive.
Adding to this problem, empirical process models are system dependent and not directly
scalable.

Therefore, the DOE must be repeated for new equipment, scale-up, or

formulation adjustments. These factors make the variable reduction capabilities of first
principle controls desirable.
A final disadvantage of the empirical approach deals with the sampling interface.
Online measurements must be integrated into the process. This can be accomplished by
submerging a probe into the process or monitoring the process through a viewing
window.

The windows can become obstructed by sample build-up, rendering the

measurement irrelevant, with possible product quality consequences. This requires a
number of sensors, so that the process can be managed without one or several
measurements. First principle calculations may also be used to continue a process along
the desired trajectory until a sampling interface can be cleared.
This dissertation aims to combine empirical controls with first principle controls
in a single hybrid system to eliminate some of the disadvantages and mitigate the risk
associated with each control methodology.
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The first principle calculations are

hypothesized to reduce the variability associated with processing mechanisms, while
reducing the experimental burden during development and scale-up.

The empirical

models are hypothesized to reduce the variability associated with end point criteria, while
providing immediate process feedback and increased process understanding. The hybrid
control system will provide the most efficient and rigorous automation system for
pharmaceutical batch manufacturing to date.

1.3.4 Automated Data Management and Control Systems
A control system is a set of devices, communication systems, and software
designed to regulate the manufacturing output of a product to consistently meet product
specifications. The purpose is to operate the manufacturing system so that the net return
is maximized in the presence of disturbances and uncertainties, rather than the often cited
advantage of controlling variables at their set points or to track dynamic set point
changes.76

This is accomplished by scientific design, statistical modeling, and by

exploiting available online measurements of the system to implement a control strategy,
which is a planned set of controls, derived from current product understanding that
assures process performance and product quality. 77
Prior to 2004, full control systems were difficult to implement in the
pharmaceutical industry due to regulatory constraints. Manufacturing processes were
approved based on a validated combination of process parameters and had to remain
fixed, so the process could not be adjusted to mitigate measured input disturbances.
However, the process analytical technology (PAT) 41 and quality by design (QbD)2
initiatives from the FDA (and recently, other regulatory agencies) allow operational
flexibility within a validated design space.
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These guidelines have made possible

automated control systems that incorporate information about a process back into the
system to adjust process variables to consistently hit product quality targets, or feedback
control.76 These systems offer continuous improvement of the process as additional
information is gained throughout production life, which provides companies
improvements in quality and efficiency, 1,78-80 and the possibility of real-time release.41
In the pharmaceutical industry a control strategy seeks to link the attributes of the
product that are important to the patient, to the controls in the manufacturing process that
are needed to deliver those attributes.81 This is the main tenet of the QbD initiative, and
the effort to describe how the manufacturing operations affect CQAs is a major
determinate in the amount of regulatory flexibility afforded to the pharmaceutical
manufacturer.

It is the responsibility of the pharmaceutical company to relate all

variables that are included in the validated design space to a meaningful metric of product
risk. The control strategy’s objective is to then minimize the quantified risk.
Feedback control is necessary to handle the variability, inaccuracies, and
uncertainties present in the design process, and to make full use of the capacity of the
equipment and measurement systems. There are two options for feedback: negative
feedback or positive feedback. In positive feedback, the measured value is added with
the set point, and in negative feedback the difference between the measured value and the
set point (system error) is calculated. Negative feedback is the more popular control
mechanism because it is more stable and less affected by random variation and error in
the measurement.82 Negative feedback will be considered in all cases in this dissertation.
Feedback control systems are designed so that certain designated signals (errors)
do not exceed predetermined levels (specifications). Making this more difficult is that
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the mathematical models that are used in representing real systems have uncertainty and
the measurements that are used to inform the models contain errors. Rigorous review of
all issues of control system design has been covered extensively.82, 83
The specific design of a control system should be developed based on the needs of
the process that it is controlling. The process to be controlled should be studied and the
types of sensors and actuators that are necessary for the requirements must be selected.
The system must be adequately modeled and simplified if necessary, and the properties of
the final model must be determined. Once the properties are determined, performance
specifications can be implemented to ensure the required product quality. Finally, the
type of controller can be selected that will ensure production within the defined
specifications. It is important that a theory of feedback not only leads to good designs
when possible, but also indicates directly and unambiguously when performance
objectives cannot be met.83
The current dissertation will use a combination of first principle calculations and
online process measurements in a combination feedforward/feedback (multicomponent)
control system with real-time optimization (RTO).84 An RTO system is a model based,
upper-level control systems in a closed loop that provides set points to lower-level
control systems to maintain the process at its optimum state. 76 At the lowest level, simple
logic, linear loops, and proportional-integral-derivative controllers (PID) adjust
manufacturing controls based on the needs of the upper level models. The system is
illustrated in chapter 2.
A PID controller is a control loop feedback mechanism that is the most common
for industrial applications. The controller attempts to minimize the error between a
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measured process variable and the desired set point. There are three separate calculations
that are used to adjust the process variable toward the set point. The first calculation
(proportional) depends on the current error, the second (integral) on the accumulation of
past errors, and the third (derivative) on the prediction of future errors. The weighted
sum of these three calculations is used to adjust the process parameter to minimize error
from the set point.84

 de 
u  K p e  K i  edt  K d  
 dt 

(1.2)

In equation 1.2, u is the control variable value, e is the error, and K is the weight for each
of the three calculations. The weights of these can be adjusted for the needs of a given
control loop, with the derivative calculation often down-weighted because it is
significantly affected by process noise. The final equation for manipulating the control
variable to approach the set point is called the transfer function. The PID controller is a
basic form of feedback control, and is crucial for the automated control of manufacturing
processes.
Higher level control loops are needed to determine the values of the set points to
be passed to the lower level PID controls. Real-time optimization is the feedback control
strategy that enables these optimum set points to be calculated. Traditional RTO required
the system to reach a steady state before any adjustments were implemented, resulting in
very long response times. Recent applications have used high frequency RTO to perform
real-time evolution, so that the process can be adjusted toward the optimum state
continuously before a system steady state is reached.76 These principles are incorporated
into the control system described in this dissertation, and the models that are developed
within these control strategies will be discussed in detail in later sections.
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Well characterized systems (which often incorporate first principle controls) can
be improved when feedback control is combined with a feedforward function. The
feedforward function is basically an inverse model of the process, and can be used to
inform the process of variability with respect to incoming material or process factors.
The advantage of feedforward control is that corrective action is taken for a change in a
disturbance input before it affects the control parameter. For example, the heated air
temperature can be adjusted to maintain a constant drying rate in a fluid bed dryer based
on a measurement of a change in input air humidity. Even when there are modeling
errors, feedfoward control can often reduce the effect of the measured disturbance on the
output better than feedback control alone. This leads to more stable processes.
Feedforward control is always used in combination with feedback control because
feedback control is always required to track set point changes and suppress unmeasured
disturbances that are always present in real processes. Process analytical technology is
crucial for the successful implementation of either control strategy because it is these
online measurements of the process or raw materials that provide all of the information
needed for adjustments. Without PAT, process or material disturbances could not be
identified and process improvement would be impossible.
The system described in this dissertation will use a combination of engineering
process control and statistical process control. Engineering process control is applied to
processes in which successive observations are related over time and where the mean
drifts dynamically. It seeks to minimize variability by transferring it from the output
variable to a related process input.85 This is the overall control strategy in the proposed
multicomponent control system, but statistical process control, which seeks to minimize
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variability by detecting and eliminating assignable causes of variation on processes that
vary about a fixed mean, is used to reduce variability within local control loops of
process inputs at the lowest levels of control loops.
All extensive control systems for dynamic processes use a hierarchical system of
control loops of different kinds to achieve full automation.81

At the highest level,

complex models relate product quality measurements to process parameter inputs to
control the actual manufacturing process.

These controls are called process or

engineering controls. An example of these controls is the final moisture content of a
pharmaceutical granulation that provides the optimum granule properties, and the process
parameters that are required to reach the optimum moisture content. These process
controls are the most difficult to develop and require extensive DOE. They often include
complex interactions between process factors in real manufacturing examples, and may
contain large amounts of uncertainty. The largest investment is made for development of
this layer of controls.
Below the process controls are the analytical controls, which relate spectroscopic
or process measurements to individual markers of the process trajectory. Analytical
models produce the data about product quality that is used to inform the process controls
to adjust the manufacturing process. Using the same example, the analytical model
would be the model that generates a moisture prediction from an online spectroscopic
measurement. The complexity of an analytical model depends on the measurement.
Simple univariate models can be used to predict airflow from pressure differential
measurements, but more commonly, complex multivariate and chemometric treatments
are necessary for spectroscopic data.

The investment required for an analytical model
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should be proportional to the risk or importance associated with the property
measurement.

If the measurement is informing the process models for the most

important quality metric, then a high degree of model performance is required. Each
analytical model must be validated and maintained to assure future performance.
Still below the analytical models are the simple ladder logic or PID loops. These
loops are used by the control software to maintain the process parameters at their given
set points. For example, they inform the heater when to pulse on or cycle off to maintain
a temperature at a given set point. The transfer functions associated with PID loops are
optimized to either reduce the risk of over-adjusting a process measurement, or to reduce
the time associated with reaching a desired set point. In most practical systems, the
control software will optimize the PID loops based on default settings, and must be
changed by the user if a different performance criterion is required.
All levels of the control strategy require a maintenance system to assure model
robustness over time. The maintenance system is crucial for long term feasibility because
all systems drift. Machine parts and motors age, causing them to respond differently to
process adjustments, so the transfer functions must be updated to maintain performance.
Additionally, the responses of instruments and sensors drift, requiring model update for
prediction of product properties.86 Finally, new variability that was not included in the
original models inevitably is encountered, requiring some degree of model update or
augmentation. The control system should have a regular maintenance schedule whose
frequency is related to drift magnitude or frequency.
The complexity of these systems and the significant development that is necessary
for successful implementation is the central theme of this dissertation. The structure of
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the control system developed and the derivation of the models associated with the control
system will be discussed rigorously in later sections. The dissertation will prove that the
automation system developed provides improvements to both manufacturing quality and
efficiency in the systems that were investigated.

1.3.5 Gabapentin
Gabapentin (1-(aminomethyl)cyclohexaneacetic acid) is the API that was used in
several of the manufacturing control and design space studies of this dissertation. It was
chosen by the FDA as the drug formulation to study in a quality by design (QbD) project
through the National Institute for Pharmaceutical Technology and Education (NIPTE)
titled, “Development of Quality by Design (QbD) Guidance Elements on Design Space
Specifications Across Scales with Stability Considerations.” It was chosen because it
was a marketed drug that had problems due to physical and chemical stability. The FDA
believed that manufacturing stress had a direct impact on the stability of gabapentin
tablets.

This made gabapentin an ideal case study for the development of a

manufacturing controls strategy because the operation had to be well understood to
ensure final product stability.
Gabapentin is in a class of medications called anticonvulsants or antiepileptic
drugs (AEDs), and it is used to control certain types of seizures in patients who have
epilepsy.87,88 It is indicated as an adjunctive therapy of partial seizures and treats seizures
by decreasing the abnormal excitement in the brain. Gabapentin is particularly effective
against complex-partial seizures as occurring in temporal lobe epilepsy. 89 It is also
indicated for the management of pain associated with post-herpetic neuralgia (PHN) by
changing the way the body senses pain. 87 Additionally, gabapentin is prescribed for off40

label uses including relieving the pain of diabetic neuropathy and to treat or prevent hot
flashes in post menopausal women or women who are being treated for breast cancer.
The drug was derived by adding a cyclohexyl group to the backbone of γaminobutyric acid (GABA), so that gabapentin would cross the blood-brain barrier,
unlike GABA, but retain the physicochemical properties of GABA. 89 It has a molecular
mass of 171.24 g/mole. The structures of gabapentin, GABA, and gabapentin’s primary
degradant are displayed in Figure 1.3. Gabapentin, however, exhibits no activity at
GABA receptors in vivo. It does not modify GABAA or GABAB radioligand binding and
it is not converted metabolically into GABA or a GABA agonist. It does, however,
increase the synthesis of GABA in the human brain, enhance GABA release, and
potentiate GABAergic inhibition in the portion of the brain thought to be critically
involved in seizure propagation. This increases the threshold for seizures and decreases
seizure propagation.89

Figure 1.3. Reproduced from Potschka et al.,89 the chemical structure of GABA, gabapentin, and
gabapentin lactam.

Gabapentin has a pKa1 of 3.7 and a pKa2 of 10.7. It is a BCS class III drug,90
meaning it is freely soluble in water but has low permeability with a log of the partition
coefficient (n-octanol/0.05M phosphate buffer) at pH 7.4 of -1.25.91 Combined with the
fact that it is a low potency drug, gabapentin must be dosed in large amounts to achieve a
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pharmacological effect. It also displays delayed pharmacodynamic effects after systemic
administration because it does not penetrate the blood-brain barrier via passive diffusion
due to its zwitterionic and hydrophilic properties. Therefore, it passes via a saturable
active transport process.89
It is dosed perorally in capsules, tablets, and oral solutions. Single doses are
marketed in hard shell capsules containing 100, 300, or 400 mg, elliptical film coated
tablets containing 600 or 800 mg, or oral solutions containing 250 mg/5 mL. 91
Manufacture of 889 mg elliptical tablets containing a 600 mg unit dose of gabapentin is
the subject of a portion of this dissertation. The exact formulation will be presented in
later sections.
Systemic absorption of gabapentin is not dose proportional, meaning that a lower
percentage of the total dose is absorbed as dose increases, which is another reason that
high dose delivery systems are required. Food has only a slight effect on the rate of
absorption, so it does not have to be administrated in a specific fed state. Less than 3% of
the drug is circulated bound to plasma protein, and the approximate fraction of
gabapentin in cerebrospinal fluid (CSF) is 20% of the plasma concentration. 91
Gabapentin is eliminated from systemic circulation via renal excretion, and the
drug molecule is unchanged. Hepatic metabolism of gabapentin in humans does not
occur. The half-life is 5-7 hours, which is not affected by dose or multiple dosing. The
pharmacokinetics is not affected by gender, and there has been no evidence to indicate it
is affected by race. Elimination is strongly influenced by a patient’s renal function, so
plasma clearance is significantly reduced in elderly patients or patients with impaired
renal function. Dosage adjustments are required in these situations. Clearance is slightly
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increased in pediatric patients under the age of 5, but children over the age of 5 have
clearance and plasma concentrations similar to adults. The elimination rate constant is
directly proportional to a patient’s creatinine clearance, a measure of renal function.91
The exact mechanism by which gabapentin exerts its anticonvulsant or analgesic
effect is not well understood, but it prevents seizures with a similar effectiveness
compared to other marketed anticonvulsants. It has been tested in a wide array of
common radioligand binding assays at concentrations up to 100 µM and did not exhibit
affinity for any of them.

91

It does not alter cellular uptake of dopamine, noradrenaline,

or serotonin. The only potential source of activity was revealed by in vitro studies of
radiolabeled gabapentin, where a gabapentin binding site in areas of rate brains including
the neocortex and hippocampus was shown. Functional correlates of gabapentin binding
have yet to be elucidated.

Gabapentin as an adjunctive therapy was shown to

significantly reduce the frequency of seizures and secondarily generalized tonic-clonic
seizures in several clinical trials.91 It has been shown to reduce seizure generation and
seizure propagation, leading to its broad anticonvulsant effect.
For the analgesic effect, gabapentin prevents allodynia and hyperalgesia in animal
models. It has not been shown to alter immediate pain related behaviors, but it did
prevent pain related responses in animal models of neuropathic pain and decreased pain
related responses after peripheral inflammation. The relevance of these animal model
results to humans is not known. A clinical study for pain management of PHN showed a
significant decrease in the pain experienced by the treatment group. 91
Like all AEDs, gabapentin increases the risk of suicidal thoughts or behavior in
patients using the drug. The FDA suggests that patients treated with any AED for any
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indication should be monitored for the emergence or worsening of depression, suicidal
thoughts or behavior, or any unusual changes in mood or behavior. In clinical trials,
patients in the treatment group had approximately twice the risk of suicidal thinking or
behavior as those in the placebo group, an increase in one case for every 530 patients.91
Drug reaction with Eosinophilia and Systemic Symptoms (DRESS) or multiorgan
hypersensitivity has been reported in AEDs including gabapentin. Gabapentin may cause
dizziness, somnolence, and other symptoms related to central nervous system (CNS)
depression. Other adverse events occurred in children age 3-12 years old and included
emotional lability, hostility, thought disorders, and hyperkinesia. An unexpectedly high
incidence of pancreatic acinar adenocarcinomas was identified in male rats that were
given gabapentin, so it also has some tumorigenic potential. 91
Gabapentin, as a drug substance, is a crystalline solid with four known
polymorphs. Form I is a monohydrate, while Forms II-IV are anhydrous. Form II is the
marketed and most stable form, but polymorphic transformations have been reported
following mechanical or thermal stress.92 Polymorphic transformations have also been
demonstrated by the NIPTE research team to depend on the moisture available from the
environment and excipient interactions.
Form II has been shown to chemically degrade at a slow rate, while the
metastable forms have significantly poorer chemical stability. Therefore, the physical
stability is crucial in determining the long term chemical stability because chemical
degradation is typically preceded by conversion of Form II to the metastable Form IV.
The only chemical degradant of gabapentin known to date is its lactam analogue
(gabapentin lactam) (3,3-pentamethylene-4-butyrolactam) (Figure 1.3).
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Gabapentin

lactam is dangerous because it has been shown to exhibit a convulsant inducing effect
(demonstrated on rats).89 A recall of a generic gabapentin product occurred in 2007 due
to excessive impurities, and it is believed that the quantity of gabapentin lactam exceeded
the specification prior to the expiration date.93
The FDA believed that the amount of degradation was directly proportional to the
mechanical and thermal stress experienced during manufacturing, which made it
interesting as a case study for manufacturing controls and design space development.
The amount of gabapentin lactam must not exceed 0.4 mole % in the final tablets
throughout their shelf life.94 Completed research by the NIPTE research group as part of
this dissertation has proven that manufacturing stress does have an effect on the
magnitude and rate of degradation in gabapentin tablets.
Gabapentin easily forms gabapentin lactam via intramolecular cyclization.95,96 As
stated previously, degradation of gabapentin Form II is preceded by a polymorphic
transformation. In a study of polymorphic transformations resulting from milling, Lin et
al. showed that milling Form II resulted in trace amounts of gabapentin lactam and
transformation to form III.92 The lactamization was attributed to the heating effect
induced by milling. Further milling resulted in further transformation to form IV and an
additional amount of gabapentin lactam. Metastable forms of gabapentin show higher
chemical degradation kinetics over time, so even small amounts of physical
transformations can impact long term stability. The polymorphic transformations were
both retarded or accelerated in the presence of different excipients.
Hsu and Lin investigated the solid state lactamization kinetics of gabapentin upon
heating.97 There proposed pathway for intramolecular lactamization of gabapentin in the
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solid state is displayed in Figure 1.4. Since gabapentin is a zwitterion in the solid state,
the lactam formation was proposed to occur by the negatively charged carboxyl group in
the zwitterionic state attacking the protonated amino group. This eventually leads to
cyclization and the formation of gabapentin lactam and release of a water molecule.
There studies again showed that lactamization was preceded by formation of gabapentin
Form IV. It appears that this form significantly reduces the activation energy required to
initiate lactamization.

Figure 1.4. The proposed scheme by Hsu and Lin97 for the intramolecular lactamization of gabapentin in
the solid state.

The kinetic mechanism by which the overall physical and chemical degradation
occurs following thermal and mechanical stress during processing and storage is
hypothesized by the NIPTE research group to be a reversible, autocatalytic branching of
crystalline gabapentin to an unstable form of gabapentin, followed by a spontaneous
dehydration of the unstable form to gabapentin lactam. This process is displayed in
Figure 1.5. The unstable form of gabapentin (G*) was not identified as a separate
polymorphic form in NIPTE studies, but as Form II with significant crystal damage,
disorder, and higher energy. This high energy form and subsequent dehydration agree
with the formerly proposed mechanisms.
Figure 1.5 illustrates that the amount of gabapentin lactam formed is dependent
on the ratio of the k1 and k2 rate constants to the k3 rate constant. Manufacturing stress
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(shear and thermal) is believed to cause a small amount of gabapentin lactam formation
directly from crystalline gabapentin, but the bulk of the degradation is from the
disordered crystalline state. The stress applied creates the disordered gabapentin, and the
amount formed is dependent on the magnitude of the stress applied and the amount of
disordered gabapentin from previous stress.

To prevent degradation, k 1 must be

decreased by limiting the amount of stress applied. Once disordered gabapentin is
formed, the rate constant k2 is then significantly higher than the rate constant for direct
degradation of Form II, and the only method for reducing the rate of gabapentin lactam
formation is to recover or heal the stable crystalline form. Therefore, the larger k 3 is in
relation to k2, the less disordered gabapentin is available for degradation per unit time.

autocatalytic branching

spontaneous dehydration

k1 GG *

Gabapentin
(G)
(stable form)

k3 GG *

Gabapentin
(G*)
(unstable
form)

k2 G *
Gabapentin
Lactam (L)

crystal disorder recovery
Figure 1.5. The proposed degradation mechanism from gabapentin to gabapentin lactam during processing.

The presence of moisture increases the molecular mobility of the gabapentin
crystals, so while polymorphic transformations are more probable with added moisture,
recovery/recrystallization of the stable crystalline form from the disordered state occurs
at a much higher rate. The probability of polymorphic transformation of gabapentin at
moisture contents encountered during processing or storage is very small, so the main
effect of moisture is to increase k3. Therefore, moisture remaining in the finished product
or storage at an elevated humidity actually facilitates crystal recovery of Form II and
decreases the rate of lactamization during storage.
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The susceptibility of gabapentin to thermal and mechanical stress, the potential
interactions with excipients, the dangerous effects of the lactam degradant, and the
unique effect of moisture with respect to stability make the optimization of
manufacturing controls critical. This supports the choice of gabapentin as a good case
study for manufacturing design space development. This dissertation will develop an
automated control system for the fluid bed drying of a model gabapentin formulation and
determine a design space that assures product stability over the required shelf life.
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Chapter 2: Hybrid Controls Combining First Principle
Calculations with Empirical Modeling for Fully
Automated Fluid Bed Processing

2.1 Introduction
The pharmaceutical industry has invested a substantial amount of resources in
recent years to develop manufacturing systems that offer improved product quality while
limiting costs. The United States Food and Drug Administration (FDA) has encouraged
the use of the guidelines put forth by the International Conference on Harmonization
(ICH-Q8)2 that allow for operational flexibility within a design space to allow fully
automated systems that incorporate real-time data management to be possible. These
systems offer the opportunity for continuous improvement of the process and resulting
drug product by allowing information gained during manufacturing through online
process measurements to inform the process to ensure constant product quality.3
Fluid bed processing of pharmaceutical powders is an excellent case study for the
development of a fully automated control system because of its complexity and the
multiple phases that are encountered during a given fluid bed process.4,5 A single fluid
bed unit operation can take raw powders through blending, wet granulation, drying, and
cooling. A fully automated control system must be able to define the state of the process,
define meaningful end points of each phase before moving into the next phase, and
incorporate information from process measurements back into the process so that the
manufacturing parameters can be adjusted to control the process. This requires a well
developed communication system that can synchronize multiple process measurements
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and organize data for analytical and process models. The models require comprehensive
experimental designs to be performed so that prediction results are assured to be accurate
and robust. Development of these systems requires a substantial initial investment, but
leads to a rapid return on investment through improvements in product quality and
efficiency, reduced batch failures, reduced inventory storage, and the potential for realtime release.
Two separate approaches have traditionally been used to model and control the
fluid bed unit operation. The first approach uses first principle calculations based on
thermodynamic heat and mass balance equations to define and control the environment
inside the fluid bed chamber. The second approach is empirical and uses online process
measurements, spectroscopy, design of experiments (DOE), and process modeling to
control the unit operation.

Each method has benefits and disadvantages, often

complimentary, but they have not been used together to their full extent in a single
system. This chapter demonstrates the development and implementation of a hybrid
control system that uses both first principle calculations and empirical data management
for the manufacture of pharmaceutical granules to tight specifications.
First principle controls have been used for several decades to model drying,
aqueous film coating, and fluid bed processes. The controls include the temperature
difference method,26-28 thermodynamic environment controls,29-31 fluidization regimes,4
computational fluid dynamics,32-36 and transport phenomena.37, 38 All of these methods
use material properties and measurements of mass, humidity, and heat at different points
of the process to define the thermodynamic state of the bulk powder or surrounding
environment.
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The thermodynamic calculations used for this dissertation were Ebey’s
environmental equivalency factor (EFF),29 which was established in 1987 for aqueous
film coating. The same evaporative drying mechanisms control spray granulation and
drying in aqueous fluid bed processing.
The first principle controls offer several advantages that are essential for robust
and efficient processes.

By definition the calculations are based on material and

environmental properties, so the calculations are universal for all systems. Separate
calibrations for new or adjusted formulations are unnecessary. The equations are also
independent of scale or specific equipment, meaning all controls based in first principles
are directly scalable and transferable.

Scaling up processes from lab scales to full

manufacturing scales is a major hurdle for pharmaceutical processes,24,25 therefore
eliminating any variables that need to be adjusted between scales is a major advantage.
The internal fluid bed environment, which is defined using the EEF calculations,
controls the evaporative drying mechanism and resulting drying rate to allow the final
granule properties to be controlled more precisely. The rate at which water is removed
from granules is often a significant factor in determining final granule material attributes.
Even if all process parameters remain constant, small fluctuations in the external
environment will affect the incoming air stream, thus altering the drying mechanism
without additional controls. To maintain a constant drying rate without a control system,
input air must be preconditioned to have constant properties. These preconditioning
HVAC systems are expensive, and thermodynamic controls, which continuously modify
the air temperature to account for moisture variation, make preconditioning systems
unnecessary.

51

The final advantage offered by first principle controls is variable reduction. This
is the most significant advantage in terms of reducing experimentation and cost. As an
example, the EEF calculation takes nine measurements – inlet air temperature, inlet air
humidity, heated air temperature, product temperature, outlet air temperature, exhaust air
temperature, exhaust air humidity, airflow velocity, and spray rate – and produces a
single value (EEF).

Four of the nine measurements, inlet air humidity, heated air

temperature, airflow velocity, and spray rate, are factors that would be typically altered
independently in a purely empirical approach. By reducing the number of input factors to
be explored in a DOE by three, the cost of development can be significantly reduced.
There are several disadvantages to first principle controls, however.

The

calculations do not account for effects of atomizing air, changes in the droplet size of the
spray, changes in the kinetic energy of process air and water vapor, and loss of heat from
the drying bowl. Typically, these are minor factors, but can have more serious effects in
sensitive processes. These factors can be used to control the final particle distribution to
narrow specifications with additional optimization. The measurements associated with
the first principle calculations do not give actual moisture or chemical concentrations in
the product, nor do they provide estimates of particle size. Therefore, the definition of
phase end points are difficult to determine.

There is also no access to additional

information such as material phase changes or chemical decomposition.

Finally,

measurements including temperature, which are critical to the first principle controls,
often have slow response times, so the full extent of excursions from the process
trajectory are often detected minutes after they occur.
consequences for a particular batch.
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This can have deleterious

Full empirical controls for fluid bed processors have become feasible with the
success of online spectroscopy, multivariate modeling, and complex communication and
data management systems. These systems began with traditional DOE studies of the
fluid bed process factors,42 expanded to include online measurements of critical material
attributes (CMA) using spectroscopy,46-49 imaging systems,50,51 and other probes,52, 53 to
finally creating fully automated processes54, 55 of limited complexity.
The advantages of empirical controls complement those of the first principle
controls. Online sensors provide direct moisture and particle size measurements of the
product in real time for immediate CMA information and the simple and intuitive
definition of phase end points. The information contained in near infrared (NIR) or
Raman spectra, common online techniques, also includes chemical and physical phase
information and gives insight into the water-solid interactions for improved process
understanding.70-72 For example, an API’s crystalline phase or percent purity can be
followed in real time.

Finally, the online sensors reflect changes in the process

immediately. Any excursion from a desired process trajectory can be identified and
corrected before the batch is lost.
Disadvantages of empirical controls include calibration building and large
experimental designs.

Spectroscopic calibrations are formulation-, equipment-, and

scale-specific, so a new calibration must be created for each system, or a rigorous transfer
technique must be applied. The process DOE for these systems are large, especially
when considering external environment factors.

Including any variable that could

potentially affect the process creates unreasonably large designs. Adding to this problem,
empirical process models are not directly scalable.
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Therefore, the DOE must be

replicated for new equipment, scale-up, or formulation adjustments. These factors lead to
substantial costs in development and maintenance.
Two final disadvantages of the empirical approach address sampling of the
process. Online measurements of full scale fluid bed processes require several probes for
each measurement to ensure that the measurements represent the bulk material. This
requires complex data management systems and calibration transfer techniques. The
windows through which the sensors collect data can also become clogged, rendering the
measurement irrelevant, with possible product quality consequences.
This chapter was part of a project through the National Institute for
Pharmaceutical Technology and Education (NIPTE) titled, “Development of Quality by
Design (QbD) Guidance Elements on Design Space Specifications Across Scales with
Stability Considerations.”

The research was originally published in the Journal of

Pharmaceutical Innovation.129 This chapter introduces a hybrid fluid bed drying control
system that combines first principle calculations with empirical modeling. The EEF
calculations allow the internal fluid bed environment to be defined despite external
environment fluctuations for tight product specifications. The reduction of fluid bed
processing parameters allows the empirical models to be created efficiently.

These

models track granule CMAs in real time to provide immediate process feedback and
intuitive phase end points. The system is designed to negate the drawbacks of the
traditional approaches, while allowing the system to be developed efficiently. Although
the controls are designed to take a product through all four fluid bed process phases, this
chapter will focus on developing drying controls only. Expansion of the controls to
blending and spray granulation will be addressed in chapter 5.
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2.2 Theory
Data matrices will be represented by bold, capital letters (X), vectors will be bold,
lowercase letters (x), and scalars will be italics, lowercase letters (x). A summary of
variables can be found in Table 2.1.

The nomenclature used in Ebey’s original

manuscript29 is used for the description of the EEF calculations in this chapter.
Table 2.1. Nomenclature used in this chapter.

AH

Heat-transfer surface area

AH

Mass-transfer surface area

Cp

Specific heat capacity of air

hH

Average heat-transfer coefficient

hM

Average mass-transfer coefficient

htg
Le
M

R
T∞

Enthalpy of vaporization
Lewis Number
Molecular weight of water
Partial pressure of water vapor at
heated air stream
Partial pressure of water vapor at
mass-transfer conditions
Ideal gas constant
Temperature of the heated air stream

TB

Heat-transfer surface temperature

Tw
ρ

Mass-transfer surface temperature
Density of air stream

p∞
pw

.

m

Mass rate of water evaporation

2.2.1. First Principle Calculations: The Environmental Equivalency Factor (EEF)
The EEF calculations are based on conservation of mass and the first law of
thermodynamics, namely the conservation of internal energy. It is assumed that the
system is adiabatic and that any deviation from this condition can be modeled linearly.
Therefore, the temperature, flow rate, and humidity of the inlet airstream and delivery
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rate of the solution are compared to the temperature and humidity of the exhaust air, and
the difference is the work performed by the system. By this description, fluid bed
granulation and drying are adiabatic evaporative cooling processes, with the evaporation
rate controlling the quality of the granules.
The evaporation of water from the surface of granules results from two competing
mechanisms, heat and mass transfer. The heat transfer mechanism is driven by the
difference in temperature between the heated airstream and the surface of the granules. 29
.

hH AH (T  TB )  m htg

(2.1)

The mass transfer mechanism is driven by the vapor pressure differential between the
heated airstream and the surface of the granules. 29
 Mp
Mp  .
hM AM  w 
m
 RTw RT 

(2.2)

These equations assume ideal behavior in the system.
Equations 2.1 and 2.2 can be equated using the mass of water evaporation rate
.

( m ) and rearranged to relate the effective area in which the heat transfer mechanism acts
on the granules to the effective area in which the mass transfer mechanism acts on the
granules.29
 Mp w Mp 


 hM htg
RT
RT
AH
 
 w
AM
hH (T  TB )

(2.3)

This ratio describes the contribution that each mechanism provides to the drying rate and
is defined as the EEF.
The ratio of the heat and mass transfer coefficients can be written29
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hH
 C p ( Le 2 / 3 )
hM

(2.4)

with the Lewis number (Le) approximately equal to 1. Substituting equation 2.4 into
equation 2.3 results in the EEF calculation that is used to control the fluid bed drying rate.
 Mp w Mp 


 htg
RTw RT 

EEF 
C p (T  TB )

(2.5)

The EEF calculations were derived for an equilibrium drying system or a steady
state operation. Spray granulation and drying are not steady state operations due to the
substantial change in mass with additional and removal of water. As a result, the EEF
calculation is more accurate in determining the overall drying rate during the constant
rate drying period when heat transfer is the rate limiting mechanism for evaporation of
water and an equilibrium condition is maintained. During the falling rate drying period,
diffusion of water from granule cores to the surface of particles is the rate limiting step,
and the EEF calculation is less accurate at calculating the drying rate. The calculations
still provide information to the control system needed to approach the target drying rate,
however, and the variability in the drying rate is reduced compared to a constant
temperature system. The major value of the EEF calculations is reducing the batch to
batch variability with respect to the drying rate caused by fluctuations in the inlet air
humidity over time.
Empirical testing is necessary to define the optimum EEF value for a given
system, which is defined by the best final product CQAs or minimum patient risk. Once
determined, any of the fluid bed parameters can be adjusted as long as the EEF value
remains unchanged, the granule properties that are affected by the drying rate will remain
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unchanged. Variable EEF programs can be established, as long as the EEF profile for a
given experiment is the same as the validated process. The fluid bed system can be run at
different temperatures and airflow velocities using trial batches to estimate the heat
exchange with the environment over a range of EEF values. This knowledge can be used
to correct the above calculations for errors associated with the adiabatic assumption.

2.3 Materials and Methods
2.3.1 Granule Formulation
The granule formulation for this project consisted of 93.75% gabapentin
(Hangzhou Starshine Pharmaceutical Co., LTD, Hangzhou, China, Batch 0803023) as the
API and 6.25% hydroxypropyl cellulose (HPC) (Klucel EF, Ashland Aqualon Functional
Ingredients, Wilmington, DE, USA) as the binder. Gabapentin was selected as the API
because it has processing induced stability concerns, so the control systems were very
important.
Gabapentin and HPC were granulated using a Collette MicroGral (GEA Pharma
Systems, Columbia, MD, USA), a top driven high shear granulator with a 4L glass bowl.
The two powders were dry mixed in the granulator by the impeller at 500 rpm for five
minutes. Water was sprayed onto the dry mixture using a six-inch atomization nozzle
(Spraying Systems Co., Wheaton, IL, USA) with a stainless steel, flat, fan spray pattern
and peristaltic pump (323U/D, Watson-Marlow, Wilmington, MA, US).

The water

addition rate was 16 mL/min with 15 psi atomization air pressure, and the total water
amount was 5% by weight. The impeller speed and chopper speed during granulation
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was 500 and 1000 rpm, respectively. The impeller and chopper continued mixing after
spray granulation was complete for 30 seconds (wet massing period).

2.3.2 Fluid Bed Processor (FBP)
Fluid bed drying was performed using a Diosna Minilab (Dierks & Sohne GmbH,
Osnabruck, Germany) fitted with an 11 L insert.

The inlet airflow velocity was

optimized to maintain a constant bed height, and is constant for a given batch size after
an initial burst to ensure fluidization. The 450 gram batch sizes required 5 m3/hr, while
the 650 gram batches required 10 m3/hr. The filter bags were cleared using a back
pressure pulse every 60 seconds at 30 psi for all experiments.
The FBP contained an internal EGE-Electronik series LN/LG air flow sensor
(Spezial-Sensoren GmbH, Gettorf, Germany) to measure volumetric airflow velocity in
the inlet air pipe. Three internal thermocouples measured temperature of the heated air,
product temperature, and outlet air. Two series RHL temperature/humidity transmitters
(Dwyer Instruments, Inc., Michigan City, IN, USA) were added to the system to measure
the temperature and humidity of the inlet and exhaust air, respectively. A series 616
differential pressure transmitter (Dwyer Instruments, Inc, Michigan City, IN, USA) was
added to the system to measure the pressure drop across the fluid bed. Near infrared
spectra were collected through the front viewing window of the FBP using a model
NIR256L-2.2T2 spectrometer (Control Development Inc., South Bend, IN, USA). It is a
256 element photodiode array spectrometer with an extended InGaAs detector (10852229 nm). An external halogen light source (Control Development Inc., HL-2000) was
used with a fiber optic probe (Control Development Inc., South Bend, IN, USA, 6 around
1 reflectance probe). A schematic of the FBP and its sensors is presented in Figure 2.1.
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The EEF value (which adjusts and controls the heated air temperature to
maintain a constant drying rate), heated drying end point (NIR predicted moisture
content), cooling amount (product temperature at discharge), and batch size were factors
varied in a 24 full factorial design to study the drying factors that were identified during
risk analysis as potentially influencing granule properties.

The drying DOE and

measured results are listed in Table 2.2.

Figure 2.1. The FBP schematic of the available input controls, measurements for the EEF calculation, and
empirical measurements.
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Table 2.2. The FBP DOE factor levels and response results. (Yellow = experiments pooled for error estimates.)
Two-level 4-Factor Full-Factorial Design
Combination
Run Order
Factors
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a
b
ab
c
ac
bc
abc
d
ad
bd
abd
cd
acd
bcd
abcd
Repeat
Repeat
Repeat
Repeat

8
7
13
14
16
2
1
3
11
12
4
5
10
6
9
15
17
18
19
20

EEF
(a)

Target Mois.
End pt. (%) (b)

Batch Size
(grams) (c)

Prod. Temp at
Completion (oC) (d)

0.450
0.175
0.450
0.175
0.450
0.175
0.450
0.175
0.450
0.175
0.450
0.175
0.450
0.175
0.450
0.175
0.450
0.450
0.450
0.450

0.5
0.5
1.0
1.0
0.5
0.5
1.0
1.0
0.5
0.5
1.0
1.0
0.5
0.5
1.0
1.0
0.5
0.5
0.5
0.5

450
450
450
450
650
650
650
650
450
450
450
450
650
650
650
650
650
650
650
650

25
25
25
25
25
25
25
25
30
30
30
30
30
30
30
30
25
25
25
25

Responses
Lactam
Median PS
Concentration
(µm)
(Mole %)
289
296
328
0.019
298
334
310
0.028
330
353
0.016
274
0.016
290
284
0.021
332
338
0.022
316
0.026
329
0.016
351
0.018
0.016
0.017
0.019

2.3.3 Control System
A schematic of the control system is presented in Figure 2.2. The system was set
to sample data and send commands at a set frequency of 5 seconds. The FBP internal
measurements, which included airflow velocity, heated air temperature, product
temperature, and outlet temperature, were collected by an onboard programmable logic
controller (PLC) (Allen-Bradley, Rockwell Automation, Milwaukee, WI, USA). The
PLC also communicated the process set points to the FBP and contained the necessary
ladder logic to run the heater and airflow motor.

The PLC sent the FBP process

measurements and the previous set points to a DeltaV digital automation system
(Emerson Process Management, Equipment & Controls, Inc., Lawrence, PA, USA) via
open process control (OPC).
DeltaV received the process measurements from the PLC and the 4-20 mA
analogue inputs from the temperature/humidity sensors and differential pressure
transmitter and transformed the inputs into digital readings.

The DeltaV software

contained internal logic for safety switches, alarms, and unit conversions, as well as PID
controllers for the fluid bed set points. It also tagged readings from the FBP and input
controls from the control software to organize the communication between these two
systems.
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Figure 2.2. A schematic presenting the control systems’ communication network.

The control software for the system was synTQ version 3.5 (Optimal, Bristol,
UK). This software synchronized all measurements on the FBP at a fixed cycle, so that
each measurement could be compared for a specific moment.

SynTQ received all

process measurements from DeltaV via OPC and received NIR spectra directly from the
spectrometer. SynTQ organized the raw data and sent the information to the necessary
analytical models. All of the analytical and process models were compiled and input
directly into the synTQ software.

The analytical models output product or process

property predictions, which were then passed within synTQ to the process models. The
process models took the property predictions and predicted the process parameters
(airflow velocity and heated air temperature) necessary to continue the process along the
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trajectory for the next cycle. These parameter predictions were then passed via OPC
from synTQ to DeltaV, which translated the parameters for communication to the PLC,
and the PLC finally adjusted the process parameters as directed.
Also included within the synTQ software was all of the necessary logic to define
phase boundaries within a batch. A given batch’s logic chart is called an orchestration.
A flow chart depicting the orchestration for all four phases of a fluid bed process is
shown in Figure 2.3. In the current chapter, the process began at phase 3 (drying) and
continued through phase 4 (cooling) before ending. The orchestration collected all of the
data inputs and sent them to their proper analytical models to predict product and process
properties (e.g. granule moisture content, EEF, etc.).

A decision directed the

orchestration to the proper FBP phase, where the logic conditions for the phase were
contained. A logic decision determined how far into a given phase the process was at the
moment of data collection. The analytical predictions were then sent to their proper
process models to predict the process parameters that needed to be sent to the FBP.
For a full, four phase FBP process, the dry blending phase was set to a constant
airflow velocity, ambient heat, and no spray for a set amount of time. It is possible to
train a NIR chemical concentration model to predict end point homogeneity, and
moderate heat can be applied to preheat the system. When the allotted time for blending
is complete, synTQ moves the system to phase 2, to begin spray granulation.
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Figure 2.3. FBP synTQ orchestration flow chart.
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For the spray granulation phase, a constant spray rate is used and the airflow
velocity is adjusted to maintain a constant bed height using the differential pressure
measurement. The inlet air temperature is adjusted to maintain a constant EEF after
accounting for all other factors. Spray granulation continues until the NIR predicted
moisture content reaches a predetermined threshold over a set number of consecutive
cycles. The parameters over a typical drying batch are displayed in Figure 2.4. When the
threshold is reached, synTQ moves the system to phase 3, the drying phase.
During drying, the liquid addition was ceased, but the airflow velocity continued
to be adjusted by the differential pressure measurement, while the inlet air temperature
was altered to maintain a constant EEF. The phase continued until the NIR predicted
moisture content reached a minimum threshold and a window containing the previous
one minute of moisture predictions reached a minimum standard deviation threshold.
In the current chapter, wet granulate from the high shear granulator was charged
into the FBP and the orchestration began at phase 3. An initial burst of maximum airflow
(100 m3/hr) was necessary to fluidize the wet powder, but once fluidized, the granules
dried rapidly enough that a constant airflow that was dependent on the batch size could
maintain a constant bed height. The moisture threshold was adjusted as part of the drying
DOE with the low moisture level being 0.05% because the dry powder moisture content
was approximately the same. The standard deviation threshold was 0.005% moisture
content. This assured that the bulk of the granules had reached the threshold. Once the
threshold was reached, synTQ moved the system to phase 4, the cooling phase.
When cooling began, the heater was turned off and the airflow motor was set to
remain at a constant velocity. This continued until the product temperature reached a
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minimum threshold. The static airflow velocity was dependent on the batch size for the
current system, and the minimum product temperature threshold was adjusted as part of
the drying DOE.

2.3.4 Data Analysis
The analytical and process models that were included in the control system were
created using MATLAB v. 7.1 R14 (The Mathworks, Natick, MA, USA) equipped with
the PLS_Toolbox v. 3.0.4 (Eigenvector Research Inc., Wenatchee, WA, USA) and
programs written in house. MATLAB code was compiled using MATLAB Compiler
(The Mathworks, Natick, MA, USA) for use by the synTQ software. The DOE results
were analyzed using the statistical software, jmp 8 (SAS, Cary, NC, USA). All possible
main effects and second order interactions were investigated, and variables were screened
for significance using the p-value statistic at the α-level 0.10.
The NIR calibration for moisture content was created by sampling granules from
several trial drying batches. The moisture content was measured using loss on drying
(LOD) on a Computrac Max-2000 moisture analyzer (Arizona Instruments, Chandler,
AZ, USA).

The model was created using partial least-squares (PLS) regression on

standard normal variate (SNV) corrected spectra. The model required one PLS latent
variable.
The heated air temperature needed to maintain a constant EEF value was
determined by solving the EEF equation (2.5) for the T∞ variable. This required solving a
quadratic equation, with the negative solution (-b) being the solution that resulted in the
meaningful temperature estimate. Figure 2.4 displays the calculations that are required
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for controlling the three major process set points - heated air temperature, fluid bed
phase, and airflow velocity – for a batch in the drying DOE.
For systems requiring the spray granulation phase, a simple univariate regression
with differential pressure being the independent variable and volumetric airflow velocity
being the dependent variable was necessary to predict the airflow velocity to maintain a
constant bed height. The model was trained by running several trial granulations while
adjusting the airflow velocity to maintain a constant bed height via visual observation. In
this chapter, the process began at drying with a maximum moisture content of only 5%,
so after the initial airflow burst, a static velocity set point was used to maintain a constant
bed height.

Figure 2.4. The calculations required for the three main controls of a fluid bed drying operation. The top
row displays the calculations necessary to define the heated air temperature. Nine measurements are used
to calculate the EEF value, which is then used to calculate the heated air temperature necessary to maintain
the EEF at it set point. The second row displays the online moisture monitoring. NIR spectra are collected
and generate moisture predictions via a PLS calibration. When the moisture threshold is reached, the
process begins cooling. The third row displays the airflow calculations. A measurement of the pressure
differential informs a univariate model to adjust the airflow velocity to maintain a constant bed height.
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A 24 full factorial design was created to study the 4 drying factors (Table 2.2). It
was assumed prior to experimentation that the third and fourth order interactions would
not be significant variables, so the experiments to discover these effects were pooled for
error estimates. Upon completion of the design, the experiment that resulted in the best
granule properties (run order 16 in Table 2.2) was repeated with four additional
experiments to increase the power of the models and estimate experimental precision.
Many granule, blend, and tablet response variables were measured as part of the
NIPTE study to determine the effects of each unit operation. Reporting the significant
process models that create the final design space will be addressed in chapter 3, so
granule median particle size and a stability indicator were chosen as examples of product
properties than can be controlled using the control system designed in this chapter.
The median particle size was determined by sieve analysis of 100 gram granule
samples using U.S. standard test sieves (Fisher Scientific, Pittsburgh, PA, USA & VWR,
West Chester, PA, USA).

The samples were shaken using a sieve shaker (CSC

Scientific, Fairfax, VA, USA) for five minutes at level five.

Ten sieve cuts were

collected for each sample (U.S. standard mesh #s: 18, 25, 35, 45, 60, 80, 120, 170, 230,
and pan). A cumulative mass distribution was determined for each sample and the linear
portion of the distribution was fit by linear least-squares to solve for the median (dm50)
value. The four replicate experiments were not sampled for particle size to conserve
material for further studies. Therefore, the models to predict median particle size contain
16 samples (Table 2.2).
The chemical degradent for gabapentin is gabapentin lactam, so the gabapentin
lactam concentration (mole %) in the final blends of these dried granule experiments was
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measured as a response (stability). The lactam concentration was measured via high
pressure liquid chromatography (HPLC) with a SpectraSystem P4000 quaternary gradient
pump, AS3000 variable-volume autosampler, and UV 6000 LP photodiode array
detection system (Thermo Fisher Scientific Inc., Waltham, MA, USA) by collaborators at
the University of Iowa using a µBondpak CN-RP 3.9x300 mm column (Waters, Milford,
MA, USA). The HPLC method used 5% acetonitrile in phosphate buffer as the mobile
phase and a flow rate of 1.0 mL/mL and collected UV data at 210 nm. All of the drying
experiments were not taken through the blending and compression unit operations for the
NIPTE study because of material constraints, so the optimum point based on the granule
particle size distribution, extreme points of the DOE, and all replicates were selected for
further study. Therefore, the stability models contained 12 samples (Table 2.2).

2.4 Results and Discussion
The two response factors chosen for investigation in this study were selected to
demonstrate the control systems’ ability to create process models using efficient designs
to predict two of the major properties that are affected during drying: granule physical
properties and stability. The process model statistics for the response variables are
presented in Table 2.3. Measured versus predicted plots and surface plots depicting the
modeled experimental space for the response factors are presented in Figure 2.5.
The results for the prediction of median particle size were consistent with sieve
analysis. This technique is associated with variability (note the variability within the four
groups in Figure 2.5a) because a range of particle sizes are present within each sieve
fraction.

Despite the inherent reference variability, the control system was able to

identify significant process factors that affected particles size. The two factors from the
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drying DOE that were predictors of particles size were batch size and the end moisture
target (EMT). The EMT variable was an expected factor when considering particle size
because residual moisture in the granulation reduced the total drying time, reduced the
amount of attrition among particles, and led to a higher probability of larger granules
staying together.
Table 2.3. Model statistics for two of the response variables investigated during the drying DOE. (*Root
mean squared error)
Model Statistics
Median PS (µm) Lactam Mole %
Samples
16
12
Number of
Model
2
3
Parameters
R2
RMSE*
P-Value

0.67
15.12 µm
0.0007

0.78
0.0023 Mole %
0.0057

The batch size (BS) variable’s relationship with particle size was unexpected. For
the drying operation, a larger mass may have created enough force at the bottom of the
bowl during powder transfer to create stronger interactions, but the major influence more
likely resulted from the high shear granulation unit operation. A change in batch size
also changed the ratio of the powder fill height to bowl diameter, which changed the
mixing characteristics in the granulator. The 200 gram difference in batch size in the
DOE experiments was a significant difference in a four liter granulator bowl, so the
mixing characteristics were substantially altered. This change had the greatest potential
for affecting particle size from different batch sizes.
The models to predict granule stability (lactam mole %) were important for this
study because the gabapentin lactam degradant is harmful to patients and must be limited
to less than 0.4 mole %. All of the samples had significantly less than the required limit

71

(Figure 2.5b), however the time allotted for the study was inadequate to characterize long
term stability. Therefore, it was important to understand the drying factors that caused
changes in stability, so that the amount of lactam or the propensity to form the lactam
over time as a result of manufacturing could be minimized.
Considering the complexity of the fluid bed drying unit operation, the reduced
sample set, and the lack of a large number of replicate experiments, the model statistics
for predicting stability were satisfactory (Table 2.3). The three factors that significantly
affected granule stability include EEF, EMT, and their interaction term. The effect of the
EEF variable was expected because it controlled the amount of thermal stress applied
during fluid bed drying.

Low EEF values, which correspond to higher heated air

temperature (EEF = 0.175; high drying rate) increased the degradation kinetics and
created a larger amount of gabapentin lactam in the final blends. The EEF variable was
the second most influential drying factor, however, because NIR moisture predictions in
the drying controls stop the drying process immediately when the granules reach their
desired moisture threshold. Therefore, the granule temperatures were kept significantly
lower than the heated air temperature due to the cooling imparted by evaporation (data
not shown). Without the strict, automated controls and online spectroscopy, continued
heating of dried granules could have resulted in elevated granule temperatures, which
would have had a severe stability consequence.
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Figure 2.5. Measured versus predicted plots for a) Median Particle Size and b) Blend Pre-Stressed
Gabapentin Lactam Concentration; and surface plots depicting the modeled drying space for the c) Median
Particle Size and d) Blend Pre-Stressed Lactam Concentration. The red lines in a) and c) represent the 95%
confidence interval for the best fit line. The blue line represents the mean response of the samples.

The EMT variable was the strongest predictor of gabapentin lactam mole % in the
blend samples. Moisture in a pharmaceutical product often effects stability, but for this
gabapentin formulation higher residual moisture resulted in more stable granules. This
result was confirmed repeatedly throughout the NIPTE study and with several stability
stress tests. Part of this effect in the drying operation was the result of suppressing the
temperature of the granules with increased moisture, but increased stability was also
observed with higher moisture content samples in stability tests where temperature was
not a factor. In a separate stability study (data not shown) residual moisture was shown
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to facilitate crystal recovery of damaged gabapentin crystals back to the stable crystalline
form.102 This prevented higher rates of chemical decomposition.
The significance of the interaction term resulted from experiments that were dried
at higher temperatures (EEF = 0.175) and low residual moisture (EMT = 0.5%) whose
samples had higher concentrations of lactam than would have been predicted by the main
effects themselves. These factors must be controlled together to fully minimize the
formation of the gabapentin lactam degradant.
To summarize the results of the process models, samples dried at higher
temperatures resulted in similar drying times because of extended cooling (data not
shown,) and resulted in increased lactam formation, so the data showed that drying at
lower temperatures (EEF = 0.45; low drying rate) was beneficial. With low drying
temperatures, the EPTT variable was irrelevant because the product temperature never
increased beyond the 25oC threshold, so cooling was unnecessary.

The batch size

variable was more significant in the granulation unit operation than the drying unit
operation. Residual moisture in the granules (high EMT) resulted in increased stability,
but had poorer downstream product properties. High levels of residual moisture cause
granules to exhibit poor flow behavior, resulting in poor mixing during blending and
difficulty in filling dies of the rotary tablet press. Therefore, the drying DOE showed that
it was important to control the EEF and EMT variables for optimum product properties,
with lower drying temperatures and a moderate EMT threshold as the optimum drying
condition.
The automated drying controls with the hybrid control strategy facilitated the
creation of the drying DOE, the collection of data, and the analysis of the results. The
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system allowed for all data measurements and calculations to be collected simultaneously
at five second increments for all of the experiments, while providing a wealth of available
data. The EEF calculations reduced three process factors – inlet air temperature, inlet air
humidity, and heated air temperature – to a single factor, which reduced the DOE from
64 experiments to 16 experiments. In a real setting, a full factorial design with 6 factors
would not be performed due to economic concerns, so the 64 experiments is an
overestimate. Reducing the number of drying factors to 4 allowed a full factorial design
to be performed, however, which significantly increases the information available to the
analyst.

All main effects and first order interactions could be investigated in an

economically feasible design. This was important for the gabapentin study because there
was a strong interaction between the EEF and EMT drying factors. This interaction may
not have been indentified with a simple, less rigorous design, which would have limited
the effectiveness of the control system.
The EEF calculations also eliminated the need to have laboratory controls of room
temperature and humidity or a preconditioned air system. When the moisture content of
the inlet air fluctuated, the heated air temperature was modified accordingly so that the
capacity to absorb moisture within the dryer remained the same, thus controlling the
drying rate. The controls made expensive building or equipment designs unnecessary.
Examining the heated air temperature profiles in Figure 2.6a for all 16
experiments demonstrates the importance of the EEF calculations for maintaining a
constant drying mechanism across several days and environmental conditions.

The

experiments were randomized over only nine days, and the heated air temperature needed
to maintain the two EEF levels was quite variable. Much of the offsets among the
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temperature profiles within each EEF group in Figure 2.6a were the result of day to day
fluctuations in laboratory humidity. The sinusoidal fluctuations resulted from the heater
controls inability to maintain a constant temperature, while others are due to variable
drying end points as part of the drying DOE. If the runs were extended over several
climate seasons or years, these fluctuations become more severe and increase the
importance of utilizing an EEF-based control system.
The high temperature (high drying rate, low EEF) EEF experiments had
temperature differences between runs as large as 30oC to maintain a constant drying rate,
while the lower temperature (low drying rate, high EEF) EEF experiments had
temperature differences as large as 20 oC between runs.

Without the EEF controls,

experiments would have been dried at a constant temperature and the drying rate would
have fluctuated substantially between runs, resulting in product variability. Figure 2.6b
illustrates the results of simulating the EEF and thus the drying rate of each of the batches
if a constant temperature was used for all batches within each group.
The temperature profiles also display the importance of varying the temperature
during a batch as moisture was removed from the powder bed. Batch processes are not
steady state experiments, so the environment inside the FBP changed as more moisture
was removed. The temperature had to be adjusted accordingly to maintain a constant
drying rate.

The NIR prediction of moisture content assured that the process ended

precisely when it should. This limited the time that granules were exposed to heat energy
with low moisture contents, and thus reduced the maximum temperature experienced by
the granules resulting in stability improvements. All of these benefits are impossible
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without the fully automated control system that combines first principle calculations with
empirical modeling and rigorous designs of experiments.

Figure 2.6. a) Heated air temperature profiles for the drying DOE separated by the EEF variable. b)
Simulated EEF (and thus drying rate) of the 16 batches if a constant temperature was used for each of the
two groups.

The hybrid control strategy also controlled the major factors and mechanisms that
affect the granule properties – evaporation rate/drying mechanism, final granule moisture
content, and the temperature of the product at discharge – instead of controlling process
factors through empirical models that affect these important mechanisms. This allowed
for greater control of product properties and reduced variability between similar runs,
which facilitated data analysis and allowed for the extraction of significant drying factors
with fewer experiments and increased statistical power.

2.5 Conclusion
This study demonstrated the creation of a hybrid control system for fluid bed
processing that combines first principle calculations with online data collection and
empirical modeling. The control system was fully automated and enabled tight control of
granule properties affected by drying and potentially for all four fluid bed phases. The
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system reduced the number of experiments necessary in the DOE by describing the
drying environment with a single value, eliminated the need to install expensive
preconditioned air systems, and provided a wealth of information about the process and
the granule properties via online spectroscopy. The controls facilitated the identification
of significant FBP factors for the definition of optimum process conditions, and reduced
the risk of batch failures due to stability concerns.
The study demonstrated the control system’s ability to control two significant
responses from the drying unit operation – particle size and stability – on a formulation
that required strict controls to minimize process induced instability. The results of the
drying DOE showed low variability in granule properties among similar runs, which
allowed significant process models to be developed with the reduced data set. The FBP
controls and sensors facilitated the collection of precise data in an efficient manner,
which would, ideally, be implemented for the creation of design spaces for the FBP unit
operation.
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Chapter 3: Development of a Statistical Tolerance Based
Fluid Bed Drying Design Space

3.1 Introduction
Fully automated control systems are feasible and desirable in the pharmaceutical
industry since the FDA encouraged the use of the guidelines put forth by the International
Conference on Harmonisation (ICH-Q8)2 that allow for operational flexibility within a
validated design space. These systems offer opportunities for continuous improvement of
the process and resulting quality improvement through drug product information gained
during manufacturing via online process measurements to inform process adjustments to
ensure constant product quality.3

They have also been established to provide an

economic incentive for pharmaceutical manufacturers. 1, 78-80
The process set points within the automated control system are optimized using
empirical design of experiments to establish the relationship to final product quality
metrics called critical quality attributes (CQAs).

The process parameters that are

significant predictors of final product CQAs are identified as critical process parameters
(CPPs), and they can be adjusted in real time to consistently meet product specifications
despite external environmental fluctuations, raw material variability, equipment aging,
and sensor drift.

The entire modeled space is defined as the knowledge space.

Specification limits are placed on the predicted CQAs, and the combinations of CPPs that
manufacture product within the CQA specifications constitute the design space.
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Appropriately developed designs of experiments (DOE) are typically necessary to
elucidate the relationship between CPPs and CQAs in an economically efficient manner.
An adequate number of experiments is necessary to investigate all possible main effects
and first order interactions of the material and process variables that are identified during
the initial risk analysis.

Information regarding statistical power and the necessary

confidence in the process model predictions is used to inform the DOE, so that optimized
models can be created that fulfill user or process needs. A stochastic DOE approach is
popular, where a large number of possible factors are screened efficiently, a secondary
DOE more rigorously investigates the significant factors to create the knowledge space,
and a third level of experiments are augmented to local regions of the knowledge space to
increase statistical power in the future operating or design space. High order process
interactions are rarely found to be statistically significant, so experiments to investigate
these effects are typically eliminated to reduce development costs.
First principle equations that quantitatively describe the mechanisms that affect
the product properties in a manufacturing process are desirable because they reduce the
dimensionality of the final DOE. These equations describe the multidimensional effect
of traditional input variables that would have to be investigated independently in a purely
empirical design.
The current chapter will use a fully automated, hybrid control system to
incorporate first principle controls for variable reduction and mechanistic control, while
also using empirical models and online sensors to provide immediate feedback of product
properties during the process. This control system was discussed extensively in chapter
2. The environmental equivalency factor (EEF)29 was used to quantitatively describe the

80

thermodynamic environment within the fluid bed chamber that was the driving force for
the removal of water, the major mechanism through which the fluid bed drying unit
operation impacts product quality. It combined three variables that affected the water
removal rate (heated air temperature, inlet air humidity, and airflow velocity) into a
single value.

This substantially reduced the number of experiments necessary for

establishing a design space. In addition, the EEF allowed for direct scale-up because it is
based in first principles, and eliminated the need for a preconditioned air system.
Environmental fluctuations that impacted the air properties and affected the drying rate
were measured, and process variables (airflow velocity and heated air temperature) were
adjusted to maintain a constant drying rate. All of these qualities of the automated
control system allowed for substantial reductions in developmental and equipment costs.
The addition of online sensors to the automated control system allowed for
product properties to be monitored in real time, so that each phase of the unit operation
could be ended reproducibly with respect to product CQAs. The current study used an
online near infrared (NIR) sensor to monitor the water content of the pharmaceutical
granules so that the drying operation was ended consistently from batch to batch.
Additionally, a differential pressure transmitter was used to measure the pressure drop
across the fluid bed, which was used to predict the airflow velocity that is necessary to
maintain a constant bed height despite the substantial change in total mass and granule
density within the dryer as water was removed. The automated control system reduced
developmental costs, facilitated data collection and process understanding, enabled
feedback control for continuous process improvement, and reduced the variability
between batches. These advantages allowed for the identification of significant CPPs
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with fewer repeat experiments during development and assured product quality in future
production.
In addition to good development practices and process/product understanding,
rigorous statistical analysis was necessary for robust modeling and design space
identification.

A design space is a global model that incorporates multiple process

models that are limited by a series of specifications. As such, it must be developed
rigorously and maintained over time. 98 Each prediction within the process models is
associated with a finite amount of uncertainty, which increases as the predictions move
away from the center of the model. Therefore, the knowledge space can be created to
reflect either the confidence or risk associated with each point in the modeled space. The
design space can then be defined by the area of the knowledge space that maximizes user
confidence with regards to producing CQAs within specifications during future
production. This chapter aims to provide a case study for this development.
This study was part of a project through the National Institute for Pharmaceutical
Technology and Education (NIPTE) titled, “Development of Quality by Design (QbD)
Guidance Elements on Design Space Specifications Across Scales with Stability
Considerations.” The research was originally published in the Journal of Pharmaceutical
Innovation.130 As part of the requirements of the project, the formulation was fixed, so
the specifications on the CQAs had to be met through optimization of the CPPs of the
manufacturing unit operations.

The active pharmaceutical ingredient (API) for the

formulation, gabapentin, was chosen due to its stability considerations,89 so the CQAs for
the product include stability indicators, final tablet release indicators, and manufacturing
variables that include particle flow and tablet strength properties.
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3.2 Materials and Methods
3.2.1 Granule Formulation
The granule formulation for this project consisted of 93.75% gabapentin
(Hangzhou Starshine Pharmaceutical Co., LTD, Hangzhou, China, Batch 0803023) as the
API and 6.25% hydroxypropyl cellulose (HPC) (Klucel EF, Ashland Aqualon Functional
Ingredients, Wilmington, DE, USA) as the binder.
Gabapentin and HPC were granulated using a Collette MicroGral (GEA Pharma
Systems, Columbia, MD, USA), a top driven high shear granulator with a 4L glass bowl.
The two powders were dry mixed in the granulator by the impeller at 500 rpm for five
minutes. Water was sprayed onto the dry mixture using a six inch atomization nozzle
(Spraying Systems Co., Wheaton, IL, USA) with a stainless steel, flat, fan spray pattern
and peristaltic pump (323U/D, Watson-Marlow, Wilmington, MA, USA). The water
addition rate was 16 mL/min with 15 psi atomization air pressure, and the total water
amount was 5% by weight. The impeller speed and chopper speed during granulation
was 500 and 1000 rpm, respectively. The impeller and chopper continued mixing after
spray granulation completed for a 30 second wet massing period.

3.2.2 Fluid Bed Processor (FBP)
Fluid bed drying was performed using a Diosna Minilab (Dierks & Sohne GmbH,
Osnabruck, Germany) fitted with an 11 L insert. The FBP contained an internal EGEElectronik series LN/LG air flow sensor (Spezial-Sensoren GmbH, Gettorf, Germany) to
measure volumetric airflow velocity in the inlet air pipe. Three internal thermocouples
measured temperature of the heated air, product temperature, and outlet air. Two series
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RHL temperature/humidity transmitters (Dwyer Instruments, Inc., Michigan City, IN,
USA) were added to the system to measure the temperature and humidity of the inlet and
exhaust air, respectively.

A series 616 differential pressure transmitter (Dwyer

Instruments, Inc, Michigan City, IN, USA) was added to the system to measure the
pressure drop across the fluid bed. Near infrared spectra were collected through the front
viewing window of the FBP using a model NIR256L-2.2T2 spectrometer (Control
Development Inc., South Bend, IN, USA).

It is a 256 element photodiode array

spectrometer with an extended InGaAs detector (1085-2229 nm). An external halogen
light source (Control Development Inc., South Bend, IN, USA; HL-2000) was used with
a fiber optic probe (Control Development Inc., South Bend, IN, USA; 6 around 1
reflectance probe).
The EEF value, drying end point (End Moisture Target (EMT) (%w/w), end
product temperature target (EPTT) (oC), and batch size (g) were factors varied in a 24 full
factorial design to study the drying factors identified during risk analysis. The drying
DOE and major results are listed in Table 3.1. The inlet airflow velocity was optimized
to maintain a constant bed height, and is constant for a given batch size after the initial
constant rate drying period. The 450 gram batch size required 5 m3/hr, while the 650
gram batches required 10 m3/hr. The filter bags were cleared using a backpressure pulse
every 60 seconds at 30 psi for all experiments.
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Table 3.1. The FBP DOE factor levels and response results. (Yellow = Experiments pooled for error estimates).
Two-level 4-Factor Full-Factorial Design
Run
Combination
Factors
Order
EEF (a)

End Moisture
Target
(%w/w) (b)

Batch
Size
(grams)
(c)

End Prod.
Temp Target
o
( C) (d)

Responses

Median
PS (µm)

Blend
Lactam
(mole %)

Cohesion
(kPa)
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a
b
ab
c

8
7
13
14
16

0.450
0.175
0.450
0.175
0.450

0.5
0.5
1.0
1.0
0.5

450
450
450
450
650

25
25
25
25
25

289
296
328
298
334

0.019

0.377

ac

2

0.175

0.5

650

25

310

0.028

0.439

bc

1

0.450

1.0

650

25

330

abc

3

0.175

1.0

650

25

353

0.016

0.352

d

11

0.450

0.5

450

30

274

0.016

0.273

ad

12

0.175

0.5

450

30

290

bd

4

0.450

1.0

450

30

284

0.021

abd

5

0.175

1.0

450

30

332

cd

10

0.450

0.5

650

30

338

acd
bcd
abcd

6
9
15

0.175
0.450
0.175

0.5
1.0
1.0

650
650
650

30
30
30

316
329
351

Tablet Crushing
Force (kP)
Compaction
Force
(lbs F)

2815
2195
1435

5.52
4.52
3.42

3045
2230
1700
2675
1930

3.84
5.48
4.34
5.06
4.14

0.4

2955
2230

5.48
4.42

0.022

0.289

3030
2425
1560

5.56
4.9
3.56

0.026
0.016

0.725
0.373

Two-level 4-Factor Full-Factorial Design (Continued)
Combination

Run
Order

Factors

EEF

End Moisture
Target (%w/w)

Batch
Size
(grams)

Responses
End Prod.
Temp Target
o
( C)

Median
PS (µm)

Blend
Lactam
(mole %)

Cohesion
(kPa)

Repeat

17

0.450

0.5

650

25

0.018

0.591

Repeat

18

0.450

0.5

650

25

0.016

0.506

Repeat
Repeat

19
20

0.450
0.450

0.5
0.5

650
650

25
25

0.017
0.019

0.407
0.407

Tablet Crushing
Force (kP)
Compaction
Force
(lbs F)
2655
4.4
1840
3.9
1540
3.3
2870
5.6
2160
4.4
1540
3.4
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3.2.3 Fluid Bed Processor Control System
The control system was set to sample data and send commands at a set frequency
of 0.2 Hz. The FBP internal measurements, which included airflow velocity, heated air
temperature, product temperature, and outlet temperature, were collected by an onboard
programmable logic controller (PLC) (Allen-Bradley, Rockwell Automation, Milwaukee,
WI, USA). The PLC also communicated the process set points to the FBP and contained
the necessary ladder logic to run the heater and airflow motor. The PLC sent the FBP
process measurements and the previous set points to the DeltaV Ver.9 digital automation
system (Emerson Process Management, Equipment & Controls, Inc., Lawrence, PA,
USA) via open process control (OPC).
DeltaV received the process measurements from the PLC and the 4-20 mA
analogue outputs from the temperature/humidity sensors and differential pressure
transmitter and transformed the inputs into digital readings.

The DeltaV software

contained internal logic for safety switches, alarms, and unit conversions, as well as PID
controllers. It also tagged readings from the FBP and input controls from the control
software to organize the communication between these two systems.
The control software for the system was SynTQ version 3.5 (Optimal, Bristol,
UK). This software synchronized all measurements on the FBP at a fixed cycle, so that
all measurements within a cycle could be compared for a specific moment. SynTQ
received all process measurements from DeltaV via OPC and received NIR spectra
directly from the spectrometer. SynTQ organized the raw data and sent the information
to the necessary analytical models.

All of the analytical and process models were

compiled and input directly into the SynTQ software. The analytical models output
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product or process property predictions, which were then used as inputs for the control
models. The control models took the property predictions and predicted the process
parameters necessary to continue the process along the desired trajectory for the next
cycle. These parameter predictions were then passed via OPC from SynTQ to DeltaV,
which translated the parameters for communication to the PLC, and the PLC finally
adjusted the process parameters as directed. The automated, hybrid control system was
described in detail in chapter 2.

3.2.4 Blending
A 3.5 quart, stainless steel, custom made V-blender was used to mix the dried
granules with the extragranular excipients: 11.25% microcrystalline cellulose (MCC)
(Comprecel M102D+, Mingtai Chemical Company Ltd., Taoyuan Hsien, Taiwan), 6.75%
starch (Lycatab C, Roquette America Inc., Geneva, IL, USA), 4.50% HPC, 2.47%
crospovidone (Polyplasdone XL, ISP Chemicals, Wayne, NJ, USA), 1.23% Poloxamer
407 (WLS Enterprises, Indianapolis, IN, USA), 1.01% talc (IMI FABI LLC/Mutcher
Inc., Benwood, WV, USA), 0.79% magnesium stearate (Mg. St., Mallinckrodt,
Hazelwood, MO, USA) for powder blending. The final concentration of Gabapentin in
the blend was 67.49% and the final concentration of HPC (intra- and extra-granular) was
9.00%.
The blender was charged in the same order for each experiment, from the bottom
of the vessel. Two SpectralProbe Process NIR spectrometers (Thermo Fisher Scientific,
Wilmington, MA, USA; Serial numbers 1277 and 1502) were used to monitor the two
arms of the v-blender in real time. The instruments collected 100 absorption values
between 1,600 and 2,400 nm in reflection mode (interpolation from 8.71 to 7.31 nm) and
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were triggered by a light intensity sensor (intensity rises when powder falls against the
sampling window, enabling collection). Measurements were made through a sapphire
window in the top of either arm of the blender. Spectra were sent wirelessly to a
computer and imported into a custom-made acquisition and analysis system. The system
had a response time of less than two seconds to allow real-time, online monitoring of the
blend homogeneity.
The Root Mean Squared Error from the Nominal Value (RMSNV) algorithm was
used to monitor blending.99 The RMSNV statistic is a weighted, cumulative, pooled
standard distance metric that takes into account the deviation of the predicted
concentration of the major components (gabapentin, starch, MCC, and HPC) of a mixture
from their target concentration, over a given number of rotations (1 minute of blending).
The blend end point was determined by the trend of the pooled RMSNV of the two
sensors and defined as the time at which the pooled RMSNV remained constant for a
minimum of two minutes.
Models for predicting constituent concentration were developed using an efficient
calibration approached, which is described in detail in chapter 6.

The CLS/PLS

algorithm for multivariate modeling was used to calculate the regression vector for each
component.100 All components except magnesium stearate were blended until the
homogeneity criterion was reached. Finally, magnesium stearate was added and blended
for five minutes in an additional lubrication blend that was not monitored by NIRS.

3.2.5 Tablet Compression
The final blends were compressed on a 16-station, instrumented tablet press (B2
Stokes, Key Industries, Farmingdale, NJ, USA), fitted with load cells to measure the
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tablet compression forces. Only one set of 12.7 mm (0.5'') flat faced, beveled edge,
round punches and a cylindrical die was used. The press speed was kept constant at 27
rpm. Each batch was compressed at 3 compression forces (3000, 2000, and 1500 lbs.).
Each compression force was allowed to stabilize and then tablets were collected during
the steady state into one minute time bins for each of the six minutes of compression.
Tablets were randomly sampled from each time bin for the crushing strength
measurements.

3.2.6 Data Analysis
The analytical and process models that were included in the control system were
created using MATLAB v. 7.1 R14 (The Mathworks, Natick, MA, USA) equipped with
the PLS_Toolbox v. 3.0.4 (Eigenvector Research Inc., Wenatchee, WA, USA) and
programs written in house. MATLAB code was compiled using MATLAB Compiler
(The Mathworks, Natick, MA, USA) for use by the SynTQ software. The DOE results
were analyzed using the statistical software, jmp 8 (SAS, Cary, NC, USA). All possible
main effects and first order interactions were investigated, and variables were screened
for significance using the p-value statistic at the α-level 0.10.
The NIR calibration for moisture content was created by sampling granules from
several trial drying batches. The reference moisture content was measured using loss on
drying (LOD) on a Computrac Max-2000 moisture analyzer (Arizona Instruments,
Chandler, AZ, USA). The predictive model was created using partial least-squares (PLS)
regression on standard normal variate (SNV) corrected NIR spectra. The model required
one PLS latent variable.
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A 24 full factorial design was created to study the 4 drying factors (Table 3.1). It
was assumed prior to experimentation that all interactions above first order would not be
significant, so the experiments to discover these effects were pooled for error estimates.
Upon completion of the design, the experiment that resulted in the best granule properties
(run order 16 in Table 3.1) was repeated with four additional experiments to increase the
power of the models and estimate experimental precision.
Four response factors of each batch were selected during the initial risk analysis
to represent the product CQAs. These properties included the median particle size of the
finished granules, the amount of gabapentin lactam in the final blend (stability indicator),
the cohesion of the final blend (flow indicator), and the mean tablet crushing strength for
each compression force within each batch. The median particle size was determined by
sieve analysis of 100 gram granule samples using U.S. standard test sieves (Fisher
Scientific, Pittsburgh, PA, USA & VWR, West Chester, PA, USA). The samples were
shaken using a sieve shaker (CSC Scientific, Fairfax, VA, USA) for five minutes at level
five. Ten sieve cuts were collected for each sample (U.S. standard mesh #s: 18, 25, 35,
45, 60, 80, 120, 170, 230, and pan). A cumulative mass distribution was determined for
each sample and the linear portion of the distribution was fit by linear least-squares to
solve for the mass median (dm50) value.

The four replicate experiments were not

sampled for particle size to conserve material for further studies. Therefore, the models
to predict median particle size contained 16 samples (Table 3.1).
The chemical degradent for gabapentin is gabapentin lactam, so the gabapentin
lactam concentration (mole %) in the final blends of these dried granule experiments was
measured as the stability response. The lactam concentration was measured via reverse
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phase high pressure liquid chromatography (HPLC) with a SpectraSystem P4000
quaternary gradient pump, AS3000 variable-volume autosampler, and UV 6000 LP
photodiode array detection system (Thermo Fisher Scientific Inc., Waltham, MA, USA)
at the University of Iowa using a µBondpak CN-RP 3.9x300 mm column (Waters,
Milford, MA, USA). The HPLC method used 5% acetonitrile in phosphate buffer as the
mobile phase and a flow rate of 1.0 mL/mL and collected UV data at 210 nm. All drying
experiments were not taken through the blending and compression unit operations for the
NIPTE study because of material constraints, so the optimum point based on the granule
particle size distribution, extreme points of the DOE, and all replicates were selected for
further study. Therefore, the stability models contained 12 samples (Table 3.1).
The flow measurements were performed at Rutgers University. Cohesion, which
is inversely proportional to flowability, was measured using the shear cell module of an
FT4 powder rheometer (Freeman Technology, Malvern, UK) on 85 cm3 samples.
Cohesion is the shear strength at zero consolidation stress of a bulk powder. It was
measured using samples from the same dried granule experiments that were taken all the
way through blending and compression, so their models also contained 12 samples (Table
3.1).
Tablet compression and subsequent crushing strength measurements were
performed at the University of Maryland, Baltimore.

The crushing strength was

determined using a diametric compression tester (Model HT-300, Key International, Inc.,
Englishtown, NJ, USA). During the test, the compressive force is applied at a constant
rate. Fifteen tablets were randomly sampled across all time bins within each compression
force for each batch and tested to determine the mean crushing strength.
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3.3 Results and Discussion
In the QbD paradigm of the pharmaceutical industry, the CQAs should reflect
properties of the final product that have an impact on the effectiveness or safety of the
product.101

These include drug release properties, drug stability, batch uniformity,

product physical properties that are conducive to handling, packaging, shipping, etc., and
properties that ease the manufacturability of the dosage form (flow properties, etc.). It is
unnecessary to optimize upstream product properties (e.g. granule particle size) that are
not demonstrated to impact downstream manufacturing or final tablet properties.
Upstream CPPs, such as fluid bed drying parameters, must be related to final product
characteristics or downstream product properties that have a clear correlation to final
product properties. For this reason, it is ideal to adjust drying CPPs in a DOE and take
each batch all the way through tablet compression and release testing.
A 24 full factorial design (Table 3.1) was developed to investigate the four major
drying factors that were identified as potential CPPs during risk analysis. These factors
included the EEF set point (EEF), the end moisture target (EMT), the end product
temperature target (EPTT), and the batch size (BS). The EEF set point controlled the
drying rate, and the automated controls used the EEF set point to calculate the heated air
temperature necessary to provide the drying rate, given the airflow velocity and inlet air
humidity. The EMT was the NIR predicted moisture content (%w/w) of the granules that
ended the heating cycle and sent the process into the cooling phase. The EPTT was the
product temperature (oC) that ended the drying unit operation. It controlled the length of
the cooling phase. Finally, the batch size (g) was investigated over a small range based
on the usable capacity of the FBP.

93

High order interaction terms (2 nd order and above) were not anticipated to be
significant, so experiments to investigate these effects were pooled as repeat experiments
for error calculations. This provided an efficiency benefit using a priori information.
Additionally, four true repeat batches were manufactured to determine experimental
repeatability, which created a total of 20 experimental batches (Table 3.1).
Ideally, all batches would have been blended and compressed, but due to material
and time constraints put on the NIPTE research project, only 12 of the 20 batches were
blended and compressed. The midpoint experiments and all extremes of the DOE were
chosen for full tablet manufacturing, and all batches to investigate the interaction of the
EEF and EMT variables, because these were identified as the most likely CPPs during
risk assessment.
The CQAs were identified during the initial risk assessment and were refined after
initial trial experimentation. Gabapentin stability, reflected by limiting the amount of the
gabapentin lactam degradant in the product, was identified as the most important CQA.
Tablet and shelf life stability results were not available for this portion of the project, so
the furthest downstream stability data was the amount of gabapentin lactam (mole %) in
the final blends. As mentioned previously, 12 of the 20 batches were blended.
Table 3.2. Model statistics for the CQA response variables investigated during the drying DOE. (*Root
mean squared error)
Model Statistics
Cohesion
Tablet Crushing
Median PS (µm) Lactam (Mole %)
(kPa)
Forces (kP)
Samples
16
12
12
19
Number of
Model
2
3
3
4
Parameters
R2
RMSE*
P-Value

0.67
15 µm
0.0007

0.78
0.0023 Mole %
0.0057

94

0.73
0.077
0.0109

0.95
0.23
<0.0001

The process model to predict gabapentin lactam concentration in the final blends
based on drying CPPs, as with all process models, were calculated using mixed (forward
and backward) stepwise regression in jmp 8. Statistical results for all optimized process
models are presented in Table 3.2, while the prediction results are presented in Figure
3.1.
The drying CPPs with regards to the stability CQA were the EEF and EMT
variables. The EEF variable controlled the amount of heat energy used during drying
(drying rate), so increased heat energy (low EEF) resulted in increased gabapentin lactam
formation. The amount of moisture allowed to remain in the granules was inversely
proportional to the amount of gabapentin lactam formed. Increased moisture reduced the
temperature experienced by the granules during drying, reduced the drying time and thus
particle collisions, and allowed for crystal healing of the gabapentin molecules that had
been damaged during high shear granulation, which reduced the rate that the degradation
pathway progressed.102 There was also a strong interaction between the EEF and EMT
variables, causing curvature in the process model (Figure 3.1a). Therefore, the lowest
amount of gabapentin lactam was formed at high EEF (low temperature) and larger
amounts of residual moisture over the studied range.
The second highest priority among the CQAs was tablet crushing strength. The
formulation had a high dose of gabapentin, which limited the mechanical strength of the
finished tablets. Additionally, gabapentin is a BCS class III drug (high solubility, low
permeability), so tablet disintegration and dissolution were not an issue with any of the
investigated batches. The drying CPPs for the prediction of tablet crushing strength were
the same as the stability process model (EEF, EMT, and interaction term) (Figure 3.1b).
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As expected, increased residual moisture resulted in stronger tablets. Higher drying rates
(low EEF, higher temperatures) also resulted in stronger tablets, which may have resulted
from a decrease in drying time and less work hardening of the granules during drying.
Therefore, high EMT and low EEF are ideal in terms of the tablet crushing strength CQA
because it was necessary to maximize the possible tablet strength.

Figure 3.1. The process models (knowledge space) for each of the 4 CQA response factors: a.) Gabapentin
Lactam Concentration b.) Tablet Crushing Force c.) Blend Cohesion d.) Granule Median Particle Size.

The third highest priority among the CQAs was final blend flow properties,
because these impacted tablet manufacturability and the ability to fill compression dies
efficiently. Powder cohesion, which is inversely proportional to powder flow, was used
as the CQA for final blend flow properties. The EEF, EPTT, and their interaction term
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were the significant drying CPPs that predicted blend cohesion (Figure 3.1c). Drying
batches that were not allowed to cool to ambient conditions (high EPTT) had poor flow
compared to batches that were cooled. The upper right corner of the process model in
Figure 3.1c shows good flow at high EPTT, but this area reflected the results of drying at
low temperatures. These batches were dried at close to ambient temperatures, so the
product temperature never increased to require cooling, despite having the same ending
target. Therefore, the ideal combination of drying factors with regards to the flow CQA
is low EPTT at all EEF levels except for the absolute highest (slowest drying).
The final CQA for the drying unit operation was the median particle size of the
dried granules. Increased drying times or batches with increased energy input can cause
elutriation of the granules, which results in an increase in the fraction of fines. Some
granule attrition is desirable, however. The force of a granule collision is proportional to
the mass of particles, so the largest particles have a higher probability of breaking. This
allows large clumps to break and return to the middle of the particle size distribution. A
finite number of fine particles were also necessary to assure efficient packing inside
tablet dies during the compression operation leading to low tablet weight variability.
The batch size and EMT variables were identified as drying CPPs to predict the
median particle size of the dried granules (Figure 3.1d). The effect of residual moisture
was expected. Increased moisture provided more interactions between particles and
shortened drying times, which resulted in reduced granule attrition and elutriation. It was
determined during data analysis that the batch size effect was a function of the wet
granulation unit operation, not fluid bed drying. A change in batch size inherently
changed the high shear granulator bowl fill height to diameter ratio, which changed the
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mixing dynamics and effected moisture distribution. Therefore, the batch size variable
was not considered significant for the drying unit operation.
Figure 3.1 constitutes the total knowledge space of the CQAs obtained through
investigation of the DOE. The predicted value of all four CQAs can be determined
within the given knowledge space at any combination of the fluid bed drying CPPs. The
single point prediction drying design space can now be identified by using the
specifications of all four CQAs to limit the process models to determine the combination
of CPPs that are predicted to result in CQAs that pass specifications.
The USP specification for the amount of gabapentin lactam in the final product is
less than 0.4 mole % over the course of a 2 year shelf life. Using projections from the
initial lactam formation kinetic studies for this formulation (data not shown), the
specification for gabapentin lactam in the final blend was less than or equal to 0.02 mole
%.

The tablet crushing strength specification was an industry standard that requires

tablets to have a crushing strength of at least 6 kiloponds to be feasible for future
handling, packaging, or film coating. The specifications for cohesion and median particle
size were determined from trial batches that were compressed on a rotary tablet press.
Blend cohesion was required to be less than 0.45 kPa, while granule median particle size
was required to be between 250 and 500 µm. With these specifications, the single CQA
design spaces for the fluid bed drying unit operation are presented in Figure 3.2.
From Figure 3.2 and from the rankings of the CQAs, it can be seen that drying at
low temperatures (high EEF) with higher EMT values was necessary to prevent
gabapentin lactam formation. This decision to dry at low temperatures and allow residual
moisture rendered the EPTT variable insignificant because granules dried at low
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temperatures never reached the high temperature threshold (30 oC).

The batch size

variable had already been eliminated as a CPP, so the final drying CPPs were the EEF
and EMT variables. The tablet crushing strength specification was also satisfied at high
EMT values, while needing medium EEF values. All batches met the granule median
particle size specification. For the cohesion specification, only the low EPTT section was
relevant, so all EEF values except for the very highest (lowest drying rate, upper-lefthand corner of Figure 3.2c) satisfied the flow CQA. The final single point prediction fluid
bed drying design space where the combination of the two fluid bed drying CPPs are
predicted to produce all CQAs within specifications is displayed in Figure 3.3.
It is important to note, however, that the knowledge/design space is a combination
of process models, which by definition, contain uncertainty. This uncertainty should be
reflected in the final design space. The range over which an experimental result may
reside around the prediction can be defined be either the confidence interval or the
tolerance interval, and the magnitude of either range depends on the level of confidence
the user requires, the error associated with the model, the pure process/experimental
variability, the number of samples in the calibration set, the structure of the calibration
set, and the distance from the center of the model in the experimental space. Uncertainty
can be reduced in certain areas of the modeled space by including a large number of data
points to reduce model error in this region, but there is a diminishing return. A model
cannot produce lower error than reference error or pure process variability. A completed
DOE can be augmented with additional samples within desired regions of the modeled
space to reduce uncertainty in important regions.
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Figure 3.2. The single point prediction design space for each of the 4 CQA response factors: a.)
Gabapentin Lactam Concentration b.) Tablet Crushing Force c.) Blend Cohesion d.) Granule Median
Particle Size

In linear modeling, the user often assumes a normal distribution of error (pure
random error) around the predictions, so the width of the confidence or tolerance interval
is defined by the percent likelihood that the interval will contain the actual experimental
result.

A typical confidence/tolerance level is 95% (α = 0.05), but the level of

confidence/tolerance should be defined by the user to fulfill the needs of a given
application. As the level of confidence/tolerance required increases, a wider interval is
used. The intervals around predictions are not constant either. As experiments move
away from the center of the model, the resulting intervals become wider. Linear models
define step changes of the response variable away from the mean that result from step
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changes in the independent variables. Therefore, larger distances from the mean are
associated with larger uncertainty.

Figure 3.3. The single point prediction design space where the predictions of all 4 CQAs meet
specifications for the combination of the 2 fluid bed drying CPPs (EEF & EMT).

A confidence interval reflects the probability that the mean of all future batches
will reside within the given range. 103

yˆ  t n1,1 S.E.

(3.1)

In equation 3.1, ŷ is the point estimate or prediction, t is the critical value of Student’s t
distribution that satisfies α, which is the accepted risk of committing a Type I error, n is
the number of samples, and S.E. is the estimated standard error of the predictions. For
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manufacturing processes, the confidence interval does not adequately mitigate process
risk. While the user may have a high degree of confidence that the mean of all future
responses meets specifications; the risk of a single batch failing specifications may not
have been mitigated. Therefore, tolerance intervals, which are wider than confidence
intervals, provide the more appropriate risk evaluation tool to assure batch quality during
future production.

yˆ  k  s

(3.2)

In equation 3.2, ŷ is the point estimate or prediction, s is the standard deviation of the
predictions, and k defines the width of the tolerance interval and is calculated by

k

 1
(n  1)1   z (21 p ) / 2
 n

(3.3)

 2,n 1

where n is the number of samples, z is the critical value of the standard normal
distribution that includes p, the desired proportion of the population, χ2 is the critical
value of the chi-square distribution that is exceeded by probability γ, which is the
necessary percent confidence. Tolerance intervals reflect the probability that a certain
portion (defined by the user) of the future population of batches will meet
specifications.67
Due to model uncertainty, it is not rigorously correct to define a design space by
the portion of the knowledge space where the predictions alone satisfy the CQA
specifications (Figure 3.3). A tolerance interval must be defined for each prediction, and
the probability that a portion of future experimental results falls outside of the CQA
specifications should be considered. For example, it is possible to define 95% tolerance
intervals around all of the predictions within the gabapentin lactam knowledge space
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(Figure 3.4). This tolerance interval reflects the range around each prediction where
there exists a 95% probability that 95% of the future batch population will meet the
required CQA specifications. The specification on the gabapentin lactam is a one sided
criterion (<0.02 mole %), so the upper tolerance limit is the only side that is important.
For any combination of CPPs within the knowledge space, there is a 95% chance that the
amount of gabapentin lactam produced in 95% of the future batches is below the upper
confidence surface in Figure 3.4. This surface should be used to define the one factor,
tolerance design space, not the actual predictions.
A continuous “tolerance design space” that reflects the probability that a given
combination of CPPs will produce CQAs within specifications was produced by creating
tolerance surface plots for each process model (Figure 3.5), and then combining the
results for the final tolerance design space (Figure 3.6) that reflects the overall probability
of 95% of future batches meeting all 4 CQA specifications. The probability results in
Figure 3.5 were a function of model uncertainty for each point in the model and also the
predicted distance from the specification threshold. If a combination of CPPs resulted in
less than 50% probability of success, the resulting response was forced to zero.
Figure 3.6 reflects the final probability that the combination of the two significant
fluid bed drying CPPs will result in acceptable CQAs for all four response factors.
Figure 3.6a reflects the overall probability when each of the 4 CQAs was weighed by
their relative risk (lactam 90%, crushing strength 5%, cohesion 2.5%, and particles size
2.5%). For this reason, Figure 3.6a most closely resembles the tolerance surface of the
gabapentin lactam knowledge space within the region that is acceptable for all CQAs.
This figure is recommended as the most rigorous form of a design space. The user can
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now make an informed decision regarding an acceptable combination of CPPs that results
in an adequate probability that quality product will be produced in future batches.

Figure 3.4. The process model (knowledge space) for the prediction of gabapentin lactam concentration
with the 95% tolerance interval of 95% of the population displayed around the predictions.

Figure 3.6b reflects the overall probability surface if all CQAs were given equal
weight. The overall probability of success goes down when the chance of any of the 4
CQAs being out of specifications are considered simultaneously. Therefore, the final
probability surface or design space has a much lower probability of success.

This

calculation assumes that the four CQAs are orthogonal and completely independent, and
therefore the probability of failure for each CQA does not overlap. It considers the
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probability of success using four independent comparisons, or the Bonferoni method of
multiple comparisons.104 This is the most pessimistic measure of future success, so it
may put overly restrictive limits on the manufacturing process. In reality, the four CQAs
are correlated as shown in Figure 3.7, so the probability of a portion of the batch failing
each CQA overlaps, and the probability of success is higher than considering four
independent comparisons. As expected, granule median particle size was 50% correlated
to tablet crushing strength, and tablet crushing strength is also 50% correlated to
gabapentin lactam formation.

Figure 3.5. Tolerance surfaces (design spaces) that display the percent probability that the combination of
CPPs will produce 95% of future batches within CQA specifications for a.) Gabapentin Lactam
Concentration b.) Tablet Crushing Force c.) Blend Cohesion d.) Granule Median Particle Size.
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It must be noted that Figure 3.6 represents the real probability of producing
batches within specifications during future manufacturing under two different criteria. If
the desired or necessary probability is not achieved with the optimum criterion, then the
original calibration set must be augmented and the model regenerated to reduce model
uncertainty within a local region of the knowledge space.

Figure 3.6. The final tolerance surface, which creates the final design space. It displays the probability
that the combination of the 2 fluid bed drying CPPs (EEF & EMT) will produce 95% of future batches with
all 4 CQAs within specifications: a.) Shows the probability weighed by the risk of each CQA (Lactam
90%, Crushing Strength 5%, Cohesion 2.5%, Particle Size 2.5%) b.) Shows the probability when the 4
CQAs are given equal weight.

When determining the final operating space, other factors such as manufacturing
cost, efficiency, equipment constraints, and ease of processing may also be considered to
reduce the final design space further into an operating target. Finally, the models that
create a final design space, as with all models, must be continually maintained and
updated as equipment ages, raw materials change, or new sources of variance are
identified.
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Figure 3.7. The correlation matrix, which displays the magnitude of the correlation between response
factors (CQAs). Response Factor 1 = Median Particle Size; Response Factor 2 = Gabapentin Lactam %;
Response Factor 3 = Cohesion; Response Factor 4 = Tablet Crushing Strength.

3.4 Conclusions
This chapter provided a demonstration of the development of a rigorous design
space for a single pharmaceutical unit operation within the QbD paradigm. The hybrid
controls and the design of experiments enabled four drying factors and all first order
interaction terms to be investigated with a limited number of experiments. The results of
the small scale experimentation allowed the number of drying factors identified during
risk analysis (4) to be reduced by 50% for production control and future scale up
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experimentation. The automation system allowed the drying process parameters to be
modified in real time to control the drying rate in the presence of external environmental
fluctuations. Further, the chapter has demonstrated reduced dimensionality of the DOE,
reduced experimental variability that allowed identification of significant factors with
fewer repeat experiments, eliminated the need for a preconditioned air system, and
increased total process understanding.
The study also showed the importance of using statistics to appropriately
implement the process models that create the knowledge space and final design space.
Uncertainty must be understood throughout the knowledge space and reflected in its use.
Thus, a rigorous design space can be identified using tolerance surfaces that maximizes
the probability of future success and reduces the risk of process failure. All models must
be continually maintained to ensure robustness throughout their use. These principles
must be implemented to ensure product quality in a QbD pharmaceutical application.
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Chapter 4: Efficient Scale-Up of a Fluid Bed Drying
Laboratory Scale Design Space

4.1 Introduction
The benefits of automated control systems that are developed rigorously have
been discussed in the previous chapters. They are the most efficient method for ensuring
continuous improvement of a manufacturing process and for ensuring constant product
quality.

Without identifying and measuring variability in real-time and using that

information to adjust the process accordingly, batch to batch and intrabatch variability
increases significantly. Pharmaceutical companies are beginning to accept the benefits of
these systems and provide the initial investment required. Quality by Design (QbD) and
real-time release (RTR) applications are climbing significantly. 105
Rigorous and well constructed design of experiments (DOE) are required to
define and validate the relationship between drug product raw materials and
manufacturing critical process parameters (CPPs) with drug product response factors
known as critical quality attributes (CQAs). Developmental studies require a substantial
investment by the pharmaceutical company, so it is imperative for the experimentation to
be as efficient as possible while still providing the necessary information and statistical
confidence. Leveraging the initial investment is important so that the maximum amount
of information and monetary return can be realized.
Developing the raw material and manufacturing controls is most efficient at
laboratory scale due to equipment and material costs, but the need to scale up the initial
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controls for use at full production scale is a significant challenge that must be overcome
to maximize the utility of initial laboratory scale studies.

This challenge has been

extensively studied in traditional batch manufacturing, 106, 107 but a universal solution has
yet to be achieved. These issues continue to be studied in pharmaceutical development.
The fluid bed drying unit operation has several challenges that make scale-up
difficult. Changes in equipment geometry can drastically change the fluid dynamics and
mixing characteristics, while the size of the production scale equipment creates
temperature gradients and hot spots than can impact product quality. If the challenges
provided by process scale-up cannot be minimized, development in the quality by design
(QbD) paradigm becomes exponentially more expensive and less feasible.
Chapter 2 developed an automated hybrid control system for the fluid bed
granulation and drying unit operation that can be developed efficiently at laboratory scale
and assures product quality. The control system used the environmental equivalency
factor (EEF)29 to control the rate of water addition/removal despite changes in the input
air properties from batch to batch to control the major mechanism through which the fluid
bed unit operation impacts product quality.

Additionally, online near infrared

spectroscopy (NIRS) was used to monitor the granule moisture content to provide
immediate process feedback and define phase end points within the manufacturing
process. The control system reduced the variability between replicate batches, allowing
CPPs to be identified in fewer experiments, reduced the dimensionality of the DOE,
enabled the calculation of process models with a minimum number of experiments, and
rendered a pre-conditioned air system unnecessary.
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In chapter 3, the hybrid control system was used in combination with DOE and
rigorous statistical analyses to define a design space for the fluid bed drying of a
gabapentin formulation at laboratory scale.

The development process provided

substantial process understanding, reduced the CPPs identified during risk analysis by
50%, and created a statistical tolerance surface so that an informed decision could be
made regarding the design and/or operating space. These previous studies have provided
a template for rigorous and efficient pharmaceutical development of unit operations, but
the value of these advances is significantly reduced if the challenges of scale-up are not
overcome.
The current chapter aims to demonstrate how the hybrid control system and
laboratory scale design space can be efficiently scaled-up using the process
understanding gained during development. The first principle controls within the hybrid
system are directly scaleable, a substantial reason that first principle controls are
universally desirable. The random fluctuations within a batch are wider at larger scale,
resulting from larger environmental gradients within larger pieces of equipment, but
median responses are statistically indistinguishable. The process data gained from online
spectroscopy can also provide feedback, regardless of scale, to control the mechanisms of
the manufacturing process. More importantly, however, is that the information gained
from the empirical models gleaned from the laboratory scale DOE can be leveraged
during scale-up. Half of the originally identified CPPs were eliminated at laboratory
scale, and it is unlikely that a main effect would be significant at one scale and not at
another. Therefore, the number of experiments that are needed at larger scales can be
reduced by 75% when comparing full factorial designs (22 versus 24).
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A stochastic approach to scale-up can also provide enhanced process
understanding and more efficient development. An intermediate scale can be undertaken
to inform the stakeholders how empirically derived predictors will have to be transferred
as the scale increases without substantial material costs being incurred. The CPPs and
their interactions identified at laboratory scale should still be significant predictors at all
scales. However, the regression coefficients that describe their effect on the CQAs
typically require adjustments. The shape of the transfer function is expected to be similar
across substantial scale-up, with the magnitude of the transfer function being proportional
to the magnitude of the scale-up. Therefore, much of the process understanding needed
for a successful scale-up can be determined by performing an initial, intermediate scaleup study.
The range studied for each CPP can be significantly reduced upon scale-up. The
statistical analysis performed to define the laboratory design space provides the necessary
proof of the important region of the knowledge space. This area may shift upon scale-up,
but the entire knowledge space studied at laboratory scale does not have to be replicated.
Therefore, a local space that encompasses the initial design space can be studied during
the initial scale-up, which can inform the stakeholders how the design space will shift and
increases the statistical confidence within the local space. Upon scale-up to production
scale, an even narrower region is expected to be probed using DOE. That region is
defined by the initial design space and the transfer functions calculated during the initial
scale-up.
This study was part of a project through the National Institute for Pharmaceutical
Technology and Education (NIPTE) titled, “Development of Quality by Design (QbD)
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Guidance Elements on Design Space Specifications across Scales with Stability
Considerations.” The research was originally published in the Journal of Pharmaceutical
Innovation.131 As part of the requirements of the project, the formulation was fixed, so
the specifications on the CQAs had to be met through optimization of the CPPs of the
manufacturing unit operations.

The active pharmaceutical ingredient (API) for the

formulation, gabapentin, was chosen due to its stability considerations,89 so the CQAs for
the product include stability indicators and manufacturing variables that include particle
flow and tablet strength properties.

4.2 Materials and Methods
4.2.1 Pharmaceutical Formulation
The granule formulation for this project consisted of 93.75% gabapentin
(Hangzhou Starshine Pharmaceutical Co., LTD, Hangzhou, China, Batch 0803023) as the
API and 6.25% hydroxypropyl cellulose (HPC) (Klucel EF, Ashland Aqualon Functional
Ingredients, Wilmington, DE, USA) as the binder. The granules, which comprise 71.99%
of the final blend, were combined with the extragranular excipients - 11.25%
microcrystalline cellulose (MCC) (Comprecel M102D+, Mingtai Chemical Company
Ltd., Taoyuan Hsien, Taiwan), 6.75% starch (Lycatab C, Roquette America Inc., Geneva,
IL, USA), 4.50% HPC, 2.47% crospovidone (Polyplasdone XL, ISP Chemicals, Wayne,
NJ, USA), 1.23% Poloxamer 407 (WLS Enterprises, Indianapolis, IN, USA), 1.01% talc
(IMI FABI LLC/Mutcher Inc., Benwood, WV, USA), and 0.79% magnesium stearate
(Mg. St., Mallinckrodt, Hazelwood, MO, USA) - for powder blending.
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The final

concentration of Gabapentin in the blend was 67.49% and the final concentration of HPC
(intra- and extra-granular) was 9.00%.

4.2.2 High Shear Granulation
4.2.2.1 Laboratory Scale (400-600 g batch size)
Gabapentin and HPC were granulated using a Collette MicroGral (GEA Pharma
Systems, Columbia, MD, USA), a top driven high shear granulator with a 4 L glass bowl.
The two powders were dry mixed in the granulator by the impeller at 500 rpm for five
minutes. Water was sprayed onto the dry mixture using a six inch atomization nozzle
(Spraying Systems Co., Wheaton, IL, USA) with a stainless steel, flat, fan spray pattern
and peristaltic pump (323U/D, Watson-Marlow, Wilmington, MA, USA). The water
addition rate was 16 mL/min with 15 psi atomization air pressure, and the total water
amount was 5% by weight. The impeller speed and chopper speed during granulation
were 500 and 1000 rpm, respectively. The impeller and chopper continued mixing after
spray granulation completed for a 30 second wet massing period.
4.2.2.2 Intermediate Scale (1 kg batch size)
Gabapentin and HPC were granulated using a Collette High Shear Mixer Gral 10
(GEA Pharma Systems, Columbia, MD, USA), a top driven high shear granulator with a
10 L stainless steel bowl. The two powders were dry mixed in the granulator by the
impeller at 420 rpm for five minutes. Water was sprayed onto the dry mixture using a six
inch atomization nozzle with a stainless steel, flat, fan spray pattern and peristaltic pump
(Spraying Systems Co., Wheaton, IL, USA). The water addition rate was 28.5 mL/min
with 40 psi atomization air pressure, and the total water amount was 5% by weight. The
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impeller speed and chopper speed during granulation were 420 and 1500 rpm,
respectively.

The impeller and chopper continued mixing after spray granulation

completed for a 30 second wet massing period.
4.2.2.3 Pilot Scale (9.72 kg batch size)
Gabapentin and HPC were granulated using a Collette High UltimaGral 75 (GEA
Pharma Systems, Columbia, MD, USA), a top driven high shear granulator with a 75 L
stainless steel bowl. The two powders were dry mixed in the granulator by the impeller
at 290 rpm for five minutes. Water was sprayed onto the dry mixture using a six inch
atomization nozzle with a stainless steel, flat, fan spray pattern and peristaltic pump
(Spraying Systems Co., Wheaton, IL, USA). The water addition rate was 277 mL/min
with 50 psi atomization air pressure, and the total water amount was 5% by weight. The
impeller speed and chopper speed during granulation were 290 and 1500 rpm,
respectively.

The impeller and chopper continued mixing after spray granulation

completed for a 30 second wet massing period.

4.2.3 Fluid Bed Drying
4.2.3.1 Laboratory Scale (400-600 g batch size)
Fluid bed drying was performed using a Diosna Minilab (Dierks & Sohne GmbH,
Osnabruck, Germany) fluid bed processor (FBP) fitted with an 11 L insert. The FBP
contained an internal EGE-Electronik series LN/LG air flow sensor (Spezial-Sensoren
GmbH, Gettorf, Germany) to measure volumetric airflow velocity in the inlet air pipe.
Three internal thermocouples measured temperature of the heated air, product
temperature, and outlet air. Two series RHL temperature/humidity transmitters (Dwyer
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Instruments, Inc., Michigan City, IN, USA) were added to the system to measure the
temperature and humidity of the inlet and exhaust air, respectively.

A series 616

differential pressure transmitter (Dwyer Instruments, Inc, Michigan City, IN, USA) was
added to the system to measure the pressure drop across the fluid bed. Near infrared
spectra were collected through the front viewing window of the FBP using a model
NIR256L-2.2T2 spectrometer (Control Development Inc., South Bend, IN, USA). It is a
256 element photodiode array spectrometer with an extended InGaAs detector (1,0852,229 nm). An external halogen light source (Control Development Inc., South Bend, IN,
USA; HL-2000) was used with a fiber optic probe (Control Development Inc., South
Bend, IN, USA; 6 around 1 reflectance probe). The EEF value, drying end point (End
Moisture Target (EMT)) (%w/w), end product temperature target (EPTT) ( oC), and batch
size (g) were factors varied in a 24 full factorial design to study the drying factors
identified during risk analysis. The drying DOE and major results are listed in Table 4.1.
The inlet airflow velocity was optimized to maintain a constant bed height, and is
constant for a given batch size after the initial constant rate drying period. The 450 g
batch size required 5 m3/hr, while the 650 gram batches required 10 m3/hr. The filter
bags were cleared using a backpressure pulse every 60 seconds at 30 psi for all
experiments.
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Table 4.1. Laboratory scale fluid bed drying DOE and selected response variables. (Yellow = Experiments pooled for error estimates).
Two-level 4-Factor Full-Factorial Design
Run
Combination
Responses
Order
Factors
End
Tablet Crushing
End Prod.
Moisture
Batch
Blend
Force (kP)
EEF
Temp Target
Median
Cohesion
Target
Size (g)
Lactam
o
(a)
( C)
PS (µm)
(kPa)
Compaction
(%w/w)
(c)
(mole %)
(kP)
(d)
Force (lbs F)
(b)
8
0.450
0.5
450
25
289
a
7
0.175
0.5
450
25
296
b
13
0.450
1.0
450
25
328
0.019
0.377
ab
14
0.175
1.0
450
25
298
c
16
0.450
0.5
650
25
334
2815
5.52
ac
2
0.175
0.5
650
25
310
0.028
0.439
2195
4.52
1435
3.42
bc
1
0.450
1.0
650
25
330
3045
3.84
abc
3
0.175
1.0
650
25
353
0.016
0.352
2230
5.48
1700
4.34
2675
5.06
d
11
0.450
0.5
450
30
274
0.016
0.273
1930
4.14
ad
12
0.175
0.5
450
30
290
2955
5.48
bd
4
0.450
1.0
450
30
284
0.021
0.4
2230
4.42
abd
5
0.175
1.0
450
30
332
3030
5.56
cd
10
0.450
0.5
650
30
338
0.022
0.289
2425
4.9
1560
3.56
acd
6
0.175
0.5
650
30
316
0.026
0.725
bcd
9
0.450
1.0
650
30
329
0.016
0.373
abcd
15
0.175
1.0
650
30
351

Two-level 4-Factor Full-Factorial Design (Continued)
Combination

Run
Order

Factors

Responses

EEF
(a)

End
Moisture
Target
(%w/w)
(b)

Batch
Size (g)
(c)

End Prod.
Temp Target
o
( C)
(d)

Median
PS (µm)

Blend
Lactam
(mole%)

Cohesion
(kPa)

Repeat

17

0.450

0.5

650

25

0.018

0.591

Repeat

18

0.450

0.5

650

25

0.016

0.506

Repeat
Repeat

19
20

0.450
0.450

0.5
0.5

650
650

25
25

0.017
0.019

0.407
0.407

Tablet Crushing
Force (kP)
Compaction
Force (lbs F)

(kP)

2655
1840
1540
2870
2160
1540

4.4
3.9
3.3
5.6
4.4
3.4
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4.2.3.2 Intermediate Scale (1 kg batch size)
Fluid bed drying for the 1 kg batch size was performed using a Versa Glatt
Particle Coater (Glatt GmbH, Binzen, Germany) with a 1,251.05 in3 conical insert on a
150 mesh screen (no additional distributor plate). The FBP did not contain an internal
airflow sensor or an NIR sensor because the viewing window was not transparent to NIR
radiation. A calibration predicting the airflow velocity at different flap % was created by
measuring the linear velocity of the exhaust air using an Alnor Compuflow 8585 thermoanemometer (FLW, Inc., Huntington Beach, CA, USA). A calibration to predict the
granule moisture content using the outlet air temperature was created by sampling the
FBD and recording loss on drying data using the Mark 3 Moisture Analyzer (Sartorious
Mechatronics, Bohemia, NY, USA). Two internal thermocouples measured temperature
of the heated air and outlet air. Two EasyLog temperature/humidity loggers (Lascar
Electronics Ltd., Salisbury, UK; EL-USB-2) were added to the system to measure the
temperature and humidity of the inlet and exhaust air, respectively. The airflow velocity
was adjusted to maintain a constant bed height, but remained constant during the falling
rate drying period with 25% of the airflow flap open. The EEF value and drying end
point (End Moisture Target (EMT) by outlet air temperature) were factors varied in a 2 2
full factorial design to study the significant drying factors identified at laboratory scale.
The drying DOE and major results are listed in Table 4.2. The filter bags were cleared by
shaking once every 60 seconds for a five-second duration.
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Table 4.2. Intermediate scale fluid bed drying DOE and selected response factors.
Two-Level, 2-Factor Full Factorial Design with 3 Repeats
Factors

Responses

Exp

EEF

1

0.175

0.5%

277

0.026

0.304

4600

13.56

2

0.175

1.0%

283

0.024

0.487

4450

13.39

3

0.45

0.5%

302

0.015

0.271

4530

15.69

4250

15.26

3500

12.76

2200

8.07

1270

3.78

4325

12.32

3130

9.94

1950

6.09

950

1.82

4

5

0.45

0.45

1.0%

0.5%

Median
PS (µm)

Blend
Lactam
(Mole %)

Blend
Cohesion
(kPa)

Tablet Crushing
Force (kP)

End
Moisture
Target

297

0.016

280

0.016

0.227

0.252

Compaction
Force (lbs F)

6

0.45

0.5%

289

0.015

0.262

4725

15.48

7

0.45

0.5%

293

0.018

0.306

4515

15.84

4.2.3.3 Pilot Scale (9.72 kg batch size)
Fluid bed drying for the 9.72 kg batch size was performed using a Glatt GPCGPRO-5 (Glatt GmbH, Binzen, Germany) on a 150 mesh screen with no additional
distributor plate. The FBP control system contained an internal airflow sensor that output
volumetric airflow velocity (f3/m), five internal thermocouples that measured temperature
of the inlet air, heated air, product, outlet air, and exhaust air, and two humidity sensors
to measure the temperature and humidity of the inlet and exhaust air. The FBP did not
contain an NIR sensor. A calibration to predict the granule moisture content using the
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product temperature was created by sampling the FBP and recording loss on drying data
using the Mark 3 Moisture Analyzer (Sartorious Mechatronics, Bohemia, NY, USA).
The airflow velocity was adjusted to maintain a constant bed height, but remained
constant during the falling rate drying period at 300 f3/m. Only thee experiments were
performed at the pilot scale. Two replicates of the target operating condition were
performed to test the design space and transfer functions developed during the initial
scales, while an additional experiment that varied the EEF variable was performed to
validate that it was directly scaleable. The experiments and major results are listed in
Table 4.3. The filter bags were cleared by shaking for a ten-second duration at 1 minute
intervals.
Table 4.3. Pilot Scale fluid bed drying DOE and selected response factors.
Two-Level, 1-Factor Design of Experiments with 1 Repeat
Factors

Responses

End
Moisture Median PS (µm)
Target

Blend
Lactam
(Mole %)

Tablet Crushing
Blend
Force (kP)
Cohesion
Compaction
(kPa)
Force (lbs F)

Exp.

EEF

1

0.175

0.5%

422

0.0229

0.347

3000

10

2

0.45

0.5%

272

0.0225

0.384

3200

10.5

4700

13.9

3200

10.6

2100

7.2

1250

3.3

3

0.45

0.5%

284

0.0214

4.2.4 Fluid Bed Drying Control System
4.2.4.1 Laboratory Scale (400-600 g batch size)
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0.334

The control system at laboratory scale was fully automated and was set to sample
data and send commands at a set frequency of 5 seconds.

The FBP internal

measurements were collected by an onboard programmable logic controller (PLC)
(Allen-Bradley, Rockwell Automation, Milwaukee, WI, USA).

The PLC also

communicated the process set points to the FBP and contained the necessary ladder logic
to run the heater and airflow motor. The PLC sent the FBP process measurements and
the previous set points to the DeltaVv.9 digital automation system (Emerson Process
Management, Equipment & Controls, Inc., Lawrence, PA, USA) via open process control
(OPC).
The DeltaV system received the process measurements from the PLC and the 420 mA analogue outputs from the temperature/humidity sensors and differential pressure
transmitter and transformed the inputs into digital readings.

The DeltaV software

contained internal logic for safety switches, alarms, and unit conversions, and PID
controllers. It also tagged readings from the FBP and input controls from the control
software to organize the communication between these two systems.
The control software for the system was synTQ v. 3.5 (Optimal, Bristol, UK).
This software synchronized all measurements on the FBP at a fixed cycle, so that all
measurements within a cycle could be compared for a specific moment. The synTQ
software received all process measurements from DeltaV via OPC and received NIR
spectra directly from the spectrometer. It organized the raw data and sent the information
to the necessary analytical models.

All of the analytical and process models were

compiled and input directly into the synTQ software. The analytical models output
product or process property predictions, which were then passed within synTQ to the
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control models. The control models took the property predictions and predicted the
process parameters necessary to continue the process along the desired trajectory for the
next cycle. These parameter predictions were then passed via OPC from synTQ to
DeltaV, which translated the parameters for communication to the PLC, and the PLC
finally adjusted the process parameters as directed.

The automated, hybrid control

system was described in detail in chapter 2.
4.2.4.2 Intermediate Scale (1 kg batch size)
The FBP at intermediate scale was not instrumented with an automated control
system.

A custom macro was created using Microsoft Excel 2007 (Microsoft

Corporation, Redmond, WA, USA) to automatically calculate the EEF value at a given
moment and the heated air temperature to maintain the EEF value at its set point. The
process measurements were manually added to the Excel spreadsheet.

The process

measurements were recorded and the process factors adjusted at 30-second intervals. The
airflow flap was manually adjusted to maintain a constant bed height and a univariate
model was created to predict the granule moisture content using the outlet air
temperature.
4.2.4.3 Pilot Scale (9.72 kg batch size)
The control system at pilot scale was semi-automated. All measurements were
automated at a fixed frequency of 0.07 Hz (once every 15 seconds), but process
adjustments had to be input manually. The system was controlled using the PITOPS Plus
OPC control system (PiControl Solutions LLC, Katy, TX, USA).

The automated

measurements included inlet air temperature, inlet air humidity, heated air temperature,
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product temperature, outlet air temperature, exhaust air temperature, exhaust air
humidity, pressure drop across the fluid bed, and volumetric airflow velocity.

The

measurements were downloaded in real time into Microsoft Excel 2007 every 15
seconds, and a macro was created to automatically calculate the process set points for the
next cycle, which were input manually by a technician. Near infrared spectroscopy was
not available at pilot scale, so a univariate model was calculated to predict granule
moisture content using the measured product temperature.

4.2.5 Blending
4.2.5.1 Laboratory Scale (400-600 g batch size)
A 3.5 quart, stainless steel, custom made V-blender was used to mix the dried
granules with the extragranular excipients.

Two SpectralProbe Process NIR

spectrometers (Thermo Fisher Scientific, Wilmington, MA, USA; Serial numbers 1277
and 1502) were used to monitor the two arms of the V-blender in real time.

The

instruments collected 100 absorption values between 1,600 and 2,400 nm in reflection
mode (interpolation from 8.71 to 7.31 nm) and were triggered by a light intensity sensor
(intensity rises when powder falls against the sampling window, enabling collection).
Measurements were made through a sapphire window in the top of either arm of the
blender. Spectra were sent wirelessly to a computer and imported into a custom-made
acquisition and analysis system.

The system had a response time of less than two

seconds to allow real-time, online monitoring of the blend homogeneity.
The Root Mean Squared Error from the Nominal Value (RMSNV) algorithm was
used to monitor blending.99 The RMSNV statistic is a weighted, cumulative, pooled
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standard distance metric that takes into account the deviation of the predicted
concentration of the major components (gabapentin, starch, MCC, and HPC) of a mixture
from their target concentration, over a given number of rotations (1 minute of blending).
The blend end point was determined by the trend of the pooled RMSNV of the two
sensors and defined as the time at which the pooled RMSNV remained constant for a
minimum of two minutes.
Models for predicting constituent concentration were developed using an efficient
calibration approach (described in chapter 6) with the CLS/PLS algorithm for
multivariate modeling.100 All components except magnesium stearate were blended until
the homogeneity criterion was reached. Finally, magnesium stearate was added and
blended for five minutes in an additional lubrication blend that was not monitored by
NIRS.
4.2.5.2 Intermediate Scale (1 kg batch size)
An IBC Bin Blender and Lifter – Mobile system (Servolift LLC, Wharton, NJ,
USA) with a 5 L, stainless steel insert was used to mix the dried granules with the
extragranular excipients. An ePAT 601 Blend Uniformity Monitoring System (NIR
Spectrometer) (Expo Technologies, LLC., St. Louis, MO, USA) was used to monitor the
blender in real time. The instrument collected 226 absorption values between 1,350-1,800
nm in reflection mode and was triggered by a light intensity sensor (intensity rises when
powder falls against the sampling window, enabling collection). Measurements were
made through a sapphire window on the top of the blender. Spectra were sent wirelessly
to a computer and imported into a custom-made acquisition and analysis system. The
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system had a response time of less than two seconds to allow real-time, online monitoring
of the blend homogeneity.
The RMSNV algorithm was used to monitor blending.

The four major

components (gabapentin, starch, MCC, and HPC) of the mixture were used to determine
the blend end point, which was defined as the time at which the RMSNV (one minute
time window) remained constant for a minimum of two minutes.
Models for predicting constituent concentration were developed independently
from the laboratory scale methods using the same efficient calibration approach and the
partial least squares (PLS) algorithm. All components except magnesium stearate were
blended until the homogeneity criterion was reached. Finally, magnesium stearate was
added and blended for five minutes in an additional lubrication blend that was not
monitored by NIRS.
4.2.5.3 Pilot Scale (9.72 kg batch size)
A 50 L insert was used with the IBC Bin Blender and Lifter – Mobile system
(Servolift LLC, Wharton, NJ, USA) at the pilot scale.

The spectrometer, calibration

method, RMSNV parameters, and decision method was the same as the intermediate
scale.

4.2.6 Tablet Compression
4.2.6.1 Laboratory Scale (400-600 g batch size)
The final blends were compressed on a 16-station, instrumented tablet press (B2
Stokes, Key Industries, Farmingdale, NJ, USA), fitted with load cells to measure the
tablet compression forces. Only one set of 12.7 mm (0.5'') flat faced, beveled edge,
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round punches and a cylindrical die was used. The press speed was kept constant at 27
rpm.

Each batch was compressed at 3 compression forces (Table 4.1).

Each

compression force was allowed to stabilize and then tablets were collected during the
steady state into one minute time bins for each of the six minutes of compression.
Tablets were randomly sampled from each time bin for the crushing strength
measurements.
4.2.6.2 Intermediate Scale (1 kg batch size)
The final blends were compressed on a 10-station, Piccola Rotary Tablet Press
(Model B, Knoll Pharmaceutical Co., Argentina), fitted with load cells to measure the
tablet compression forces. Only one concave, oval (17.45 x 10.35 mm) punch and die set
was used. The press speed was kept constant at 25 rpm, and the tablet target mass was
889 mg.

Each batch was compressed at 3 compression forces (Table 4.2).

Each

compression force was allowed to stabilize and then tablets were collected during the
steady state into one minute time bins for each of the six minutes of compression.
Tablets were randomly sampled from each time bin for the crushing strength
measurements.
4.2.6.3 Pilot Scale (9.72 kg batch size)
The final blends were compressed on a Manesty BB4 35 station Tablet Press
(OYSTAR USA, NJ, USA). Seven concave, oval (17.45 x 10.35 mm) punch and die sets
were used. The press speed was kept constant at 25 rpm, and the tablet target mass was
889 mg. Each batch was compressed at 3 compression forces that were adjusted to meet
3 tablet crushing strength targets (8, 10, and 12 kp) (Table 4.3). Each compression force
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was allowed to stabilize and then tablets were collected during the steady state into one
minute time bins for each of the six minutes of compression. Tablets were randomly
sampled from each time bin for the crushing strength measurements.

4.2.7 Data Analysis
The analytical and process models that were included in each control system were
created using MATLAB v. 7.1 R14 (The Mathworks, Natick, MA, USA) equipped with
the PLS_Toolbox v. 3.0.4 (Eigenvector Research Inc., Wenatchee, WA, USA) and
programs written in house.

MATLAB code was compiled for laboratory scale

automation using MATLAB Compiler (The Mathworks, Natick, MA, USA) for use by
the synTQ software. The DOE results at each scale were analyzed using the statistical
software, jmp 8 (SAS, Cary, NC, USA).

All possible main effects and first order

interactions were investigated, and variables were screened for significance using the pvalue statistic at the α-level 0.10.
The NIR calibration for moisture content at laboratory scale was created by
sampling granules from several trial drying batches. The reference moisture content was
measured using loss on drying (LOD) on a Computrac Max-2000 moisture analyzer
(Arizona Instruments, Chandler, AZ, USA). The predictive model was created using
partial least-squares (PLS) regression on standard normal variate (SNV) corrected NIR
spectra. The model required one PLS latent variable. Granule moisture content was
measured via loss on drying at intermediate and pilot scale using the Mark 3 Moisture
Analyzer (Sartorious Mechatronics, Bohemia, NY, USA).
Four response factors for each batch were selected during the initial risk analysis
to represent the product CQAs. These properties included the median particle size of the
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finished granules, the amount of gabapentin lactam in the final blend as a stability
indicator, the cohesion of the final blend as a flow indicator, and the mean tablet crushing
strength for each compression force within each batch. The median particle size was
determined by sieve analysis of 100-g granule samples using U.S. standard test sieves
(Fisher Scientific, Pittsburgh, PA, USA & VWR, West Chester, PA, USA). The samples
were shaken using a sieve shaker (CSC Scientific, Fairfax, VA, USA) for five minutes at
level five. Ten sieve cuts were collected for each sample (U.S. standard mesh #s: 18, 25,
35, 45, 60, 80, 120, 170, 230, and pan). A cumulative mass distribution was determined
for each sample and the linear portion of the distribution was fit by linear least-squares to
solve for the mass median (dm50) value.
The chemical degradent for gabapentin is gabapentin lactam, so the gabapentin
lactam concentration (mole %) in the final blends of these dried granule experiments was
measured as the stability response. The lactam concentration was measured via reverse
phase high pressure liquid chromatography (HPLC) with a SpectraSystem P4000
quaternary gradient pump, AS3000 variable-volume autosampler, and UV 6000 LP
photodiode array detection system (Thermo Fisher Scientific Inc., Waltham, MA, USA)
at the University of Iowa using a µBondpak CN-RP 3.9x300 mm column (Waters,
Milford, MA, USA). The HPLC method used 5% acetonitrile in phosphate buffer as the
mobile phase and a flow rate of 1.0 mL/mL and collected UV data at 210 nm.
Blend flow measurements were performed at Rutgers University.

Cohesion,

which is inversely proportional to flowability, was measured using the shear cell module
of an FT4 powder rheometer (Freeman Technology, Malvern, UK) on 85 cm3 samples.
Cohesion is the shear strength at zero consolidation stress of a bulk powder.
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Tablet crushing strength was determined using a diametric compression tester
(Lab Scale - Model HT-300, Key International, Inc., Englishtown, NJ, USA; Intermediate
and Pilot Scale – Model VK200, Varian, Inc., Santa Clara, CA, USA). During the test,
the compressive force was applied at a constant rate. The oval tablets at intermediate and
pilot scale were placed parallel to the longest axis.

Fifteen tablets were randomly

sampled across all time bins within each compression force for each batch and tested to
determine the mean crushing strength.

4.3 Results and Discussion
The laboratory scale, intermediate scale, and pilot scale experiments and results
are displayed in Tables 4.1, 4.2, and 4.3, respectively. Only two of the four laboratory
scale drying factors (EEF and EMT) were identified as being CPPs during laboratory
scale statistical analysis, which eliminated the EPTT and batch size variables from further
study. The pilot scale was used to confirm success of the initial laboratory scale design
space and scale-up transfer functions. While it was determined in subsequent analyses
that a higher EMT was optimum, this data was not available when the larger scale
experiments were identified, so the initial target operating conditions included EEF equal
to 0.45 and EMT equal to 0.5%.
Gabapentin is an active ingredient with process induced chemical instability and
the degradent, gabapentin lactam, has undesired biological activity, making it very
dangerous at low concentrations.89 Therefore, the gabapentin lactam concentration in the
final blend was identified as the highest priority CQA during lab scale design space
development, and was the highest priority process model to be scaled-up.

It was

expected that the effect from the EEF variable would be the same regardless of scale
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because it is a variable based in first principles, while the EMT variable could require
scale adjustments. The drying moisture target is similar between scales in traditional
scale-up studies, however.

There was no automation or online NIR monitoring of

granule moisture content available at the intermediate or pilot scale, so the
implementation of the target drying conditions was more difficult and less precise.
The results from the intermediate scale DOE showed that the lab scale process
model for the lactam CQA was successful at predicting the intermediate scale results and
did not need any adjustment.

The 95% confidence intervals for the regression

coefficients and intercepts if the lab scale model and intermediate scale model were
developed independently are displayed in Figure 4.1. It can be seen that the regression
coefficients are statistically indistinguishable. Therefore, no transfer function was needed
to transfer the lab scale model to the intermediate scale.
The lactam prediction performance using the laboratory scale model on the
intermediate and pilot scale is displayed in Figure 4.2. While the model performed
adequately, there were several discrepancies. First, the sizes of the vessels at larger
scales caused larger gradients within the process equipment, which contributed to the
increase in variability and prediction error at larger scales. Additionally, the lack of
automation at intermediate scale, the lack of online NIR moisture monitoring, and the
reduced frequency of the command inputs at either larger scale contributed to the poorer
prediction performance after transfer.

These factors all contributed to the doubled

prediction error upon scale-up to intermediate scale.
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Figure 4.1. A comparison of the 95% confidence intervals for the regression coefficients for the blend
lactam concentration process model between lab scale and intermediate scale. The regression coefficients
are statistically indistinguishable. (LS = Lab Scale; IS = Intermediate Scale)

The results highlight the importance of online moisture monitoring using NIRS.
When online spectroscopy was not used at larger scales, a less precise drying endpoint is
introduced, which increases the risk of over drying. The tolerance surface that describes
the probability that 95% of future batches will meet the lactam specification at the
combination of CPPs for the intermediate scale is displayed in Figure 4.2b. It can be
compared to the corresponding tolerance surface from the laboratory scale model in
Figure 4.2a. The areas in the upper left of both figures are similar, which supports the
success of the EEF variable being directly scaleable. The areas in the bottom right of
each figure show the greatest difference, which resulted from the inaccuracy of the
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intermediate scale controls with regards to meeting the drying end point.

Online

spectroscopy is substantially more accurate when predicting moisture content compared
to an outlet temperature measurement, so the drying endpoint was more accurate at
laboratory scale. Outlet temperatures are held down by the cooling effect of evaporation,
so warming of the outlet temperature indicates that evaporation has slowed or ended.
There is a lag time, however, until the temperature of the outlet air responds to the lower
moisture content, so higher moisture targets are difficult to meet.
Loss on drying measurements confirmed that the moisture content of the 1.0%
moisture end points were consistently over dried (data not shown), causing the increase in
gabapentin lactam formation. This problem worsened at increased drying rates (lower
EEF values), because the lag time resulted in increased over drying. Process analytical
technology (PAT) and online spectroscopy substantially reduced this risk at laboratory
scale. The other three design points from the 22 full factorial design at intermediate scale
and the three experiments at pilot scale were all accurately predicted as meeting or not
meeting lactam specifications by the lab scale process model.
The second highest priority of the four CQAs was tablet crushing strength. The
laboratory process model was challenged because the shape of the tablets changed from
laboratory scale to the larger scales. It was determined after completion of the laboratory
scale DOE that the tablet mass (889 mg) was too large for patients to swallow using the
round, flat-faced punches that were used during the initial studies. Capsule shaped
tablets were used at the intermediate and pilot scales, which introduced a large magnitude
of new variance to the process model that was not in the original calibration.

An

advantage of the capsule shaped tablet was that higher crushing strengths were observed
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using similar compaction pressures, which allowed the tablet crushing strength
specification (> 6 kP) to be satisfied with greater ease and no formulation adjustments. A
transfer function had to be developed to accurately predict capsule shaped tablet crushing
strength using fluid bed drying CPPs from the laboratory scale process model.

Figure 4.2. A comparison of the tolerance surface for the lactam concentration CQA process model
between lab scale and intermediate scale. Three of the four locations of the 2 2 full factorial design were
predicted correctly, and the incorrect prediction resulted from not having online NIR moisture
measurements.

Figure 4.3 displays the process by which the transfer function was calculated.
Figure 4.3a shows the prediction performance of the laboratory scale model applied
directly to the larger scale data. It can be seen that the crushing strength of the capsule
shaped tablets were significantly higher than predicted, which was hypothesized
correctly. The intermediate scale data was used to calculate the necessary scale-up
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transfer function, which was then applied to the pilot scale data with no additional
adjustments. Plotting the intermediate scale predictions versus the measured responses
(Figure 4.3b) shows that the relationship was linear (R2 = 0.91). Therefore, a simple
slope and bias correction was all that was necessary to transfer the predictions for the
new tablet shape and scale-up. The transfer parameters are listed in Figure 4.3b and the
corrected predictions are displayed in Figure 4.3c. The simple transfer function showed a
significant improvement in prediction performance on both the intermediate scale data
and the pilot scale data, demonstrating that the scale-up transfer function was consistent
regardless of the magnitude of the scale change.
The larger scale prediction error was still significantly larger than at smaller scale,
but the most significant errors were observed at the end of the model with larger tablet
crushing strengths. These values were a great distance from the center of the laboratory
scale model, so the increased prediction residuals were partially the results of a large
degree of model extrapolation. The target tablet crushing strength was between 8-10 kP,
where the model residuals were much lower. Therefore, the laboratory scale model in
combination with the slope and bias correction was able to adequately predict tablet
crushing strength in the target region.
The lowest priority process models were for the cohesion and granule median
particle size CQAs. The EPTT variable for the cohesion model and the batch size
variable for the particle size model were eliminated as CPPs during laboratory scale
analysis, so these factors were not investigated upon scale up.

Therefore, when

calculating predictions for these models, the EPTT and batch size factors remained
unchanged (EPTT = 25oC; Batch Size = large group (650 g from lab scale)). When
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calculating the effect of the EEF variable for the cohesion model and the EMT variable
for the particle size model using the data from each scale independently, the regression
coefficients were statistically indistinguishable (Figure 4.4). Therefore, both CPPs were
directly scaleable and required no adjustment between scales.

Figure 4.3. The calculation of the scale-up transfer function for the tablet crushing strength process model.
a.) Tablet crushing strength predictions using the laboratory scale model directly; b.) The scale-up transfer
function (slope and bias) calculation using the intermediate scale data; c.) The crushing strength prediction
after applying the scale-up transfer function.

There was a significant bias between the granule median particle size predictions
and measured responses at the larger scales, as highlighted by the difference between
intercepts and increase in prediction error (Figure 4.4b). The measured particle size was
consistently less than the predicted response. This was because granules produced at the
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laboratory scale were used with no particle size adjustment for blending and
compression. At the larger scales, granules that were greater than 750 µm were removed
using a sieve because it was required for subsequent compression by the intermediate and
pilot scale site managers. This caused a shift in the final particle size distribution as
measured by sieve analysis, causing the consistent bias. A simple bias correction could
have been used to address this change, but it was determined that the laboratory model
could be used without adjustment due to its low priority and low risk.

Figure 4.4. A comparison of the 95% confidence intervals for the regression coefficients for the a.)
cohesion model and b.) granule median particle size model between lab scale and intermediate scale. The
regression coefficients are statistically indistinguishable, except for the intercept in the particle size model.
(LS = Lab Scale; IS = Intermediate Scale)

For the cohesion model, the prediction error at larger scales was approximately 22.5 times larger, which was consistent with the other models investigated. This was
attributed to the larger magnitude of natural variability at larger scales and the decrease in
precision of the controls at larger scales. Therefore, it was concluded that adjustable
process parameters that accounted for environmental variability, a first principle variable,
and a simple transfer function maximized the value of the laboratory scale studies. This
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allowed the laboratory scale design space to be applied at larger scales. The importance
of online spectroscopy for consistent production at all scales was also demonstrated.

4.4 Conclusion
A laboratory scale design space was efficiently scaled-up to a pilot scale by
leveraging the laboratory scale DOE and applying effective transfer functions.
traditional scale-up methodology, DOEs are replicated at all scales.

In

This study

demonstrated that with the use of an automated control system that incorporates
adjustable process parameters, first principle models, online spectroscopy, and an
intermediate scale to calculate scale effects, scale-up development can be accomplished
much more efficiently with no reduction in product quality and enhanced process
understanding.
Half of the initially identified CPPs during risk analysis were eliminated as
insignificant using the laboratory scale DOE. This significantly reduced the number of
experiments necessary at larger scales and improved development efficiency.
Additionally, the scale effects were investigated at an intermediate scale, which was
approximately double from the laboratory scale, and about 1/10 of the pilot scale. One
scale-up transfer function was needed due to a change in tablet shape at larger scales, and
the slope and bias correction that was calculated for the intermediate scale performed
well at the pilot scale. By reducing the number of pilot scale experiments to three,
industrial efficiency was improved further.
Finally, the use of a first principle model in the initial process controls reduced
the dimensionality of the DOEs needed at all scales, and made scale-up efforts
significantly easier because first principle variables are insensitive to scale. This was
138

confirmed in the current study. The highest priority process model for gabapentin lactam
was directly scaled-up and successfully predicted batch success or failure in 3 out of 4
design points. The incorrect design point resulted from over drying, which highlights the
importance of PAT, online spectroscopy, and automated controls for quality production.
There was increased variability in CQAs at larger scales due to larger equipment
gradients and less precise controls. Scientifically rigorous development at early stages
increased the value of all subsequent studies.
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Chapter 5: Development of a Fluid Bed Granulation
Design Space Using CQA Weighted Tolerance Intervals

5.1 Introduction
To this point, this dissertation has demonstrated an automated control system that
provides quality and efficiency benefits for the fluid bed granulation and drying unit
operation, developed a laboratory scale design space for fluid bed drying using DOE and
advanced statistics to assure risk reduction, and demonstrated how the automated control
system and laboratory scale design space could be scaled-up efficiently.

Two

weaknesses of the previous chapters are the limited evidence of the benefits of the
automated controls for the granulation phase of a full fluid bed process and the lack of
formulation or material factors in the DOE and design space development efforts. These
shortcomings will be addressed in this chapter using an excipient platform and full 4phase fluid bed experiments. The research was originally published in the Journal of
Pharmaceutical Sciences.132
A major theme of this dissertation is that it is imperative that controls systems be
efficient and robust so that their implementation over a long period of time is feasible.
This requires well developed design of experiments (DOE), first principle calculations,
and rigorous statistical modeling.

Design of experiments is necessary to identify

important factors, calculate their effects on the response factors, and identify interactions
between factors. First principle controls are desirable because they describe the major
mechanisms by which the manufacturing process impacts product properties, reduce the
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dimensionality of subsequent DOEs, account for external variability that cannot be
eliminated, and provide direct scale-up. Finally, statistical modeling is necessary to
calculate the probability of success at all combinations within the measured knowledge
space.

This enables the analyst to make an informed design when defining the

boundaries of the design space.
The control system that was used in the current chapter has been described in
detail in chapter 2, and utilizes the environmental equivalency factor (EEF) as a first
principle variable.29 The calculation reduces four input variables (heated air temperature,
airflow velocity, spray rate, and inlet air humidity) into a single factor, and calculates the
heated air temperature needed to maintain a constant drying rate so that the water
addition and removal rate can be maintained despite significant environmental
fluctuations.

This removes the need for a preconditioned air system, eliminating a

substantial cost in large production facilities. Additionally, online spectroscopy was used
in the control system to provide direct feedback on in-process material properties,
identify process deviations immediately, and define meaningful phase end points. The
potential for these controls to be efficiently implemented for the control of a
pharmaceutical drying unit operation with a drug that has stability concerns was
demonstrated in chapter 3, and the potential for simplified and robust scale-up was
demonstrated in chapter 4.
The current chapter seeks to extend these principles to a full, four phase fluid bed
process that includes powder mixing, spray granulation, heated drying, and cooling. The
inclusion of the spray granulation phase is a significant step because it has a substantial
impact on downstream physical properties including powder flow, packing efficiency,
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and compactibility. The EEF controls have been shown to provide excellent control of
the drying rate during fluid bed drying, and it is hypothesized that these same controls
can be utilized during spraying to maintain a constant water addition rate, which is a
major factor in controlling particle agglomeration during granulation. Small changes in
the water content of the incoming airstream can significantly impact the water
addition/removal rate, so controls are needed to account for this variability using
feedforward control loops to reduce the variability in product properties between batches.
Online monitoring of granule moisture content is hypothesized to provide a simple
definition of the granulation and drying end points, removing another source of batch to
batch variability.
It should be noted that the control system described herein does not consider the
impact of the spray droplet size, which is another factor that can effect particle
agglomeration during the granulation phase. Droplet size is highly variable in most spray
systems, making it difficult to control. It is also very difficult to match droplet sizes
when scaling-up because of the substantial differences in equipment size. Therefore, it is
the goal of this chapter to demonstrate satisfactory controls of granule particle size
without varying droplet size as part of the DOE. The droplet size variable could be used
to remove another source of variability to control particle size in very sensitive
formulations that require strict particle size specifications, however.
Also included in this chapter’s DOE were two formulation factors (binder
concentration and excipient ratio).

The two excipients (lactose monohydrate and

microcrystalline cellulose (MCC)) that were varied within the excipient ratio had
substantially different wetting properties, which affect the amount of water available on
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the particle surfaces per unit time, thus impacting particle agglomeration.

The two

formulation factors are known to affect the granulation process and final product
properties, but they are often optimized independently during formulation studies. While
this can be effective, there are often interactions between formulation and process
parameters that are overlooked or never identified. These interaction effects can be
extremely important and provide an additional degree of control that can be exploited by
the analyst.
The inclusion of formulation and process factors within a single DOE required the
use of the extended analysis of covariance (ANACOVA) model64 to describe the
interaction of these nominal and continuous variables. This model allowed the difference
in the mean response between groups of a nominal factor to be measured while
simultaneously describing effects of the continuous factors on the response variables
within the nominal groups. This information substantially improved process
understanding so that the most appropriate design space boundaries could be defined.
The final goal of the current study is to demonstrate a scientifically rigorous
calculation of a design space for the fluid bed process, and specifically the granulation
phase. The calculation will use statistical tolerance,67 so that the probability of 95% of
future batches meeting critical quality attribute (CQA) specifications can be defined for
all combinations of critical process parameters (CPPs) and formulation factors. The
necessity of statistical tolerance calculations for the definition of a pharmaceutical design
space was described in chapter 3, but this is the first study that uses statistical tolerance in
the definition of a granulation design space that includes both process and formulation
factors.
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5.2 Materials and Methods
5.2.1 Excipient Platform
An excipient platform was used to investigate formulation factors on the
granulation and drying design space.

Hydroxypropyl methylcellulose (HPMC)

(Pharmacoat 606, Biddle Sawyer Corp., New York, NY, USA) was used as the polymeric
binder. It was added to the fluid bed bowl with the other excipients as a dry powder.
Water was used as the spray solution. Microcrystalline cellulose (MCC) (Avicel PH102,
FMC BioPolymer, Philadelphia, PA, USA) and lactose monohydrate (Granulac 70,
Meggle Excipients & Technology, Wasserburg, Germany) were the additional
pharmaceutical excipients. The binder concentration and the ratio of lactose to MCC
were factors varied as part of the DOE (Table 5.1). The batch size for all experiments
was 650 grams.

5.2.2 Fluid Bed Processor (FBP)
Fluid bed granulation and drying was performed using a Diosna Minilab (Dierks
& Sohne GmbH, Osnabruck, Germany) fitted with an 11 L insert. The FBP contained an
internal EGE-Electronik series LN/LG air flow sensor (Spezial-Sensoren GmbH, Gettorf,
Germany) to measure volumetric airflow velocity in the inlet air pipe. Three internal
thermocouples measured temperature of the heated air, product temperature, and outlet
air.

Two series RHL temperature/humidity transmitters (Dwyer Instruments, Inc.,

Michigan City, IN, USA) were added to the system to measure the temperature and
humidity of the inlet and exhaust air, respectively. A series 616 differential pressure
transmitter (Dwyer Instruments, Inc, Michigan City, IN, USA) was added to the system
to measure the pressure drop across the fluid bed. Near infrared spectra were collected
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through the front viewing window of the FBP using a model NIR256L-2.2T2
spectrometer (Control Development Inc., South Bend, IN, USA). It is a 256 element
photodiode array spectrometer with an extended InGaAs detector (1,085-2,229 nm). An
external halogen light source (Control Development Inc., South Bend, IN, USA; HL2000) was used with a fiber optic probe (Control Development Inc., South Bend, IN,
USA; 6 around 1 reflectance probe).
The three powders were blended in the FBP at an airflow velocity of 8 m3/hr for
three minutes. The system was warmed to 30oC during the blending phase. During spray
granulation, deionized water was sprayed onto the fluidized powder mixture using a
peristaltic pump (Watson-Marlow 323, Wilmington, MA, USA) at 10 mL/min. The
standard, top spray nozzle for the Diosna Minilab was used with an atomization air
pressure of 1.1 bar. The EEF set point for granulation and the end moisture target for
granulation (EMT) were varied as part of the DOE (Table 5.1). The granule moisture
content was measured via online near infrared (NIR) spectroscopy.

The EEF set point

during the drying phase was 0.7, which was optimized during trial experimentation, while
the end of drying was defined when the NIR predicted moisture content was less than
3.0% and the standard deviation of moisture predictions over the previous minute was
less than 0.05%. The inlet airflow velocity was adjusted to maintain a constant bed
height during granulation and drying. The minimum airflow velocity was 10 m3/hr and
the maximum was 45 m3/hr. After the drying end point was reached, the powders were
fluidized at 8 m3/hr until the product temperature and inlet air temperature were less than
30oC. The filter bags were cleared during all phases using a backpressure pulse every 60
seconds at 30 psi for all experiments.

145

146

Table 5.1. The FBP DOE factor levels and response results. (*Yellow = Experiments pulled for error estimates)
Design of Experiments
Input Factors
Response Factors
HPMC
Excipient
End Moisture
Run
EEF
Compressibility
Particle Size
Combination
Concentration
Ratio
Target
Order
(c)
Index
d10 (um)
(%w/w) (a)
(w/w) (b)
(Gran) (%w/w) (d)
25.5
4
(1)
5
1:2
1.1
6.0
48
26.0
23.4
13
a
15
1:2
1.1
6.0
46
24.5
21.2
15
b
5
2:1
1.1
6.0
53
19.8
21.0
11
ab
15
2:1
1.1
6.0
52
22.2
24.2
14
c
5
1:2
0.8
6.0
46
25.0
23.8
10
ac
15
1:2
0.8
6.0
51
24.7
22.0
12
bc
5
2:1
0.8
6.0
51
23.6
27.0
5
abc
15
2:1
0.8
6.0
48
25.8

Particle
Size
Span
1.4
1.7
1.9
2.6
1.6
1.5
1.8
2.8
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Run
Order

Combination

HPMC
Concentration
(%w/w) (a)

6

d

5

3

ad

15

9

bd

5

7

abd

15

2

cd

5

16

acd

15

8

bcd

5

1

abcd

15

Design of Experiments (Continued)
Input Factors
Response Factors
Excipient
EEF End Moisture Target Compressibility
Particle Size d10
Ratio
(c)
(Gran) (%w/w) (d)
Index
(µm)
(%w/w) (b)
25.9
1:2
1.1
9.0
51
24.5
25.5
1:2
1.1
9.0
49
26.2
23.0
2:1
1.1
9.0
59
22.4
26.3
2:1
1.1
9.0
49
26.3
23.4
1:2
0.8
9.0
56
25.3
23.2
1:2
0.8
9.0
42
25.3
25.9
2:1
0.8
9.0
55
29.7
22.3
2:1
0.8
9.0
60
22.0

Particle
Size Span
1.5
2.2
1.4
3.5
1.8
2.3
2.1
3.4

5.2.3 Fluid Bed Processor Control System
The control system was set to sample data and send commands at a set frequency
of 0.075 Hz (one measurement every 15 seconds). The FBP internal measurements,
which included airflow velocity, heated air temperature, product temperature, and outlet
temperature, were collected by an onboard programmable logic controller (PLC) (AllenBradley, Rockwell Automation, Milwaukee, WI, USA). The PLC also communicated the
process set points to the FBP and contained the necessary ladder logic to run the heater
and airflow motor. The PLC sent the FBP process measurements and the previous set
points to the DeltaV v.9 digital automation system (Emerson Process Management,
Equipment & Controls, Inc., Lawrence, PA, USA) via open process control (OPC).
DeltaV received the process measurements from the PLC and the 4-20 mA
analogue outputs from the temperature/humidity sensors and differential pressure
transmitter and transformed the inputs into digital readings.

The DeltaV software

contained internal logic for safety switches, alarms, and unit conversions, as well as PID
controllers. It also tagged readings from the FBP and input controls from the control
software to organize the communication between these two systems.
The control software for the system was synTQ version 3.5 (Optimal, Bristol,
UK). This software synchronized all measurements on the FBP at a fixed cycle, so that
all measurements within a cycle could be compared for a specific moment. SynTQ
received all process measurements from DeltaV via OPC and received NIR spectra
directly from the spectrometer. SynTQ organized the raw data and sent the information
to the necessary analytical models.

All of the analytical and process models were

compiled and input directly into the synTQ software. The analytical models output
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product or process property predictions, which were then passed within synTQ to the
control models. The control models took the property predictions and predicted the
process parameters necessary to continue the process along the desired trajectory for the
next cycle. These parameter predictions were then passed via OPC from synTQ to
DeltaV, which translated the parameters for communication to the PLC, and the PLC
finally adjusted the process parameters as directed.

The automated, hybrid control

system was described in detail in a chapter 2.

5.2.4 Data Analysis
The analytical and process models that were included in the control system were
created using MATLAB v.7.1 R14 (The Mathworks, Natick, MA, USA) equipped with
the PLS_Toolbox v.3.0.4 (Eigenvector Research Inc., Wenatchee, WA, USA) and
programs written in house. MATLAB code was compiled using MATLAB Compiler
(The Mathworks, Natick, MA, USA) for use by the synTQ software. The DOE results
were analyzed using the statistical software, jmp 8 (SAS, Cary, NC, USA). All possible
main effects and first order interactions were investigated, and variables were screened
for significance using the p-value statistic at the α-level 0.10.
The NIR calibration for moisture content was created by sampling granules from
five trial batches, which also varied in their excipient concentrations. The reference
moisture content was measured using loss on drying (LOD) on a Computrac Max-2000
moisture analyzer (Arizona Instruments, Chandler, AZ, USA). The predictive model was
created using partial least-squares (PLS) regression on standard normal variate (SNV)
corrected NIR spectra. The model required three PLS latent variables.
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A 24 full factorial design was created to study the 4 input factors (Table 5.1). The
input factors included a nominal formulation factor (excipient ratio), a continuous
formulation factor (binder (HPMC) concentration), and two continuous process factors
(EEF, EMT). It was assumed prior to experimentation that all interactions above first
order would not be significant, so the experiments to discover these effects were pooled
for error estimates.
Three response factors for each batch were selected to represent the product
CQAs. These properties included a powder flow indicator (compressibility index), the
fraction of fines in the finished granules (d m10), and a metric for the width of the granule
particle size distribution (span). The compressibility index108, 109 is a measure of the ratio
of the dried granules tapped density to their bulk density.

  tapped   bulk 
Compressibility _ Index  100 * 

 tapped 


(5.1)

The bulk density of the final granule samples were measured by pouring granules through
a baffle system into 100 mL graduated cylinders. Approximately 90 mL samples were
collected and their masses were measured using an electronic scale (Mettler PM16K,
Mettler-Toledo Inc., Columbus, OH, USA). Tapped density was measured by tapping
the filled graduated cylinders 525 times using a tap densitometer (Vanderkamp 10705,
LABEQUIP LTD, Markham, Ontario, Canada) and recording the tapped volume. Two
bulk and tapped density measurements were measured for each granule batch.
The other two CQAs were determined by sieve analysis of 100 g granule samples
using U.S. standard test sieves (Fisher Scientific, Pittsburgh, PA, USA & VWR, West
Chester, PA, USA). The samples were shaken using a sieve shaker (CSC Scientific,
Fairfax, VA, USA) for five minutes at level five. Ten sieve cuts were collected for each
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sample (U.S. standard mesh #s: 18, 25, 35, 45, 60, 80, 120, 170, 230, and pan). A
cumulative mass distribution was determined for each sample and three portions of the
distribution were fit by linear least-squares to solve for the particle size that included 10%
(dm10), 50% (dm50), and 90% (dm90) of the cumulative mass distribution. The width of
the particle size distribution was described by using the metric, span,110 which has
traditionally been used to describe the width of the size distribution of droplets,
suspensions, and inhalants.
 d 90  d m 10 
Span   m

d m 50



(5.2)

5.3 Results and Discussion
The measured response variables (CQAs) are listed in Table 5.1, and a summary
of each models’ performance are listed in Table 5.2. The CQAs represent the properties
that are most significantly affected by a wet granulation operation.

Ideally, the

formulation and process factors would have been related to final tablet properties or
biological performance attributes because they are more relevant, but taking the
granulation batches through the compression unit operation was beyond the scope of this
study. Additionally, the design space that was calculated for the current study only
considered formulation and process factors related to the spray granulation phase of the
fluid bed process. A comprehensive design space for the fluid bed unit operation would
include process factors from the drying phase as well, but the expansion of the
dimensionality of the DOE was unnecessary for the aims of the current chapter. A
demonstration of the drying effects on product CQAs and the calculation of a design
space using a similar control system has been reported in chapter 3.
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A major tenet of this study was the inclusion of nominal, formulation factors and
continuous process factors within the same DOE. Many traditional product development
efforts have proceeded stepwise through formulation optimization and then process
optimization.

Stepwise methods overlook possible interactions between formulation

factors and manufacturing parameters which often substantially affect product CQAs and
could result in a lack of control. While it is not typical to have this degree of flexibility
with regards to the pharmaceutical formulation within a design space of a batch process,
the knowledge gained by identifying interactions between formulation and process
factors leads to improved process understanding. This in turn, facilitates development of
optimal formulations and the location of design space boundaries.
Table 5.2. Model statistics for the three process models that predict the granule CQAs
Model Statistics
Compressibility
dm 10
Span
Index
Samples
32
16
16
Number of
Model
5
4
5
Parameters
R2
RMSE*
P-Value

0.33
1.85
0.0513

0.47
3.93 µm
0.0491

0.95
0.19
<0.0001

There are two types of possible interactions between nominal and continuous
variables that significantly impact the model and require the use of the extended analysis
of covariance (ANACOVA) model.64 Each interaction type was identified in different
models within the current study and are displayed in Figure 5.1. The model to predict the
particle size dm10 (Figure 1b) had an effect from the EMT variable that was parallel
between the two excipient ratios. The effect satisfied the assumption of parallelism
within ANACOVA, which means the main effect from the EMT variable was adjusted by
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the difference in mean particle size d m10 between excipient ratio groups, and an
interaction effect was not required.
The model to predict compressibility index (Figure 5.1a) had a reverse
interaction111 between excipient ratio and EEF, which did not satisfy the parallelism
assumption and required the use of the extended ANACOVA model with an interaction
term. This means that the effect of the EEF variable on compressibility index changed
directions between excipient ratio groups, which was crucial information for identifying
an optimum formulation and appropriate design space.
Finally, the model to predict particle size span (Figure 5.1c) had a same-direction
interaction111 between excipient ratio and HPMC concentration. This also did not satisfy
the parallelism assumption and required the use of the extended ANACOVA model with
an interaction term. The effect of the HPMC concentration variable on particle size span
was in the same direction between excipient ratio groups, but the effect was much greater
in the high lactose (2:1 ratio of lactose:MCC) excipient ratio group.
The compressibility index was determined to be the CQA with the highest
priority.

While it has traditionally been used in the pharmaceutical industry as a

measurement of particle flow, it is more appropriately a measure of packing efficiency.
If the granule or powder bulk density was similar to the tapped density (low
compressibility index), then the powder system packed efficiently under low stress. This
correlates to efficiency with respect to filling dies in a rotary tablet press, resulting in
desirable tablet properties (low mass variability, increased strength, etc.) Therefore,
lower compressibility index values correlate to better downstream manufacturability.
The U.S. Pharmacopeia (USP) has seven levels of the compressibility index, with values
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less than or equal to 25 referred to as passable, and values greater than 25 considered
poor.108 Thus, the specification threshold for the compressibility index CQA was 25.

Figure 5.1. The different interaction effects between nominal variables and continuous variables. a.) The
reverse interaction effect of the EEF variable on compressibility index between different excipient ratios.
b.) The parallel effect of the EMT variable on the particle size dm10 between different excipient ratios. c.)
The same direction interaction effect of the HPMC concentration variable on particle size span between
different excipient ratios.

The model that predicted compressibility index included three main effects
(excipient ratio, EEF, EMT) and two interaction effects (excipient ratio*EEF,
EEF*EMT). The significance of the nominal variable (excipient ratio) meant that there
was a significant difference between the mean compressibility index of the two excipient
ratio groups, so a knowledge space that displays the process model predictions is
154

displayed separately for each excipient ratio (Figures 5.2a and 5.3a).

As noted

previously, the interaction between excipient ratio and EEF was a reverse interaction.
Therefore, the mean difference of compressibility index between groups was not as large,
but the effect of the EEF variable was reversed. This can be observed in the difference
along the EEF dimension in Figures 5.2a and 5.3a. There was no interaction between the
excipient ratio and the EMT variable, so the effect along the EMT dimension in Figures
5.2a and 5.3a was similar. The interaction between EEF and EMT caused the curvature
that was observed in the knowledge space of the two figures.
The EMT defined the end point of the spray granulation phase, so a high EMT
allowed for more water to be added to the fluidized powders and increased particle
agglomeration. This additional agglomeration caused an increase in the number of large
particles (>500 µm) and a reduction in the fraction of fines, which reduced the packing
efficiency (increased compressibility index). It was expected that the EMT variable
would have a similar effect on the different excipient ratio groups, which was proven to
be true.
The high lactose excipient ratio group had substantially better wetting properties
than the high MCC group. Lactose is a disaccharide sugar with 8 hydroxyl groups per
molecule, making it polar and increasing its affinity for water molecules.
Microcrystalline cellulose is a naturally occurring polymer derived from wood pulp with
a high degree of internal bonding in the crystalline structure, reducing its affinity for
water molecules. Water interacted with lactose much more easily than MCC, which
allowed liquid bridges to form between lactose particles with a higher probability.
Therefore, the granulation process was more efficient with respect to the amount of water
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added in the high lactose excipient ratio, resulting in larger and more spherical particles.
These properties, combined with favorable flow properties of pure lactose compared to
MCC, caused an increase in the packing efficiency over the range encountered.

Figure 5.2. The process model predictions (knowledge space) for the three CQAs of the high lactose
excipient ratio batches. The predictions of a.) compressibility index, b.) particle size dm10, and c.) particle
size space also include the 95% tolerance surfaces that include the space where there is a 95% probability
that 95% of future batches will reside. The particle size d m10 CQA includes both the low and high
tolerance surfaces because it is a two sided specification, while the compressibility index and particle size
span CQAs only include the high tolerance surface.

Reduced EEF values resulted in improved compressibility index in the high MCC
group. The EEF variable controlled the energy of the input air stream during the spray
granulation phase.

A low EEF corresponded to a higher energy input, which was

primarily achieved through an increase in the heated air temperature. Therefore, at low
EEF, water was removed from the system at a higher rate. The spray rate remained the
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same for all experiments, so the length of the spray granulation phase and the amount of
water added were increased to achieve a similar granule moisture content at the endpoint.
This extra time allowed batches with higher MCC ratios (which granulated with reduced
efficiency) to grow particles to a more ideal size.

As a result, packing efficiency

increased at low EEF in the high MCC excipient ratio batches.

Figure 5.3. The process model predictions (knowledge space) for the three CQAs of the high MCC
excipient ratio batches. The predictions of a.) compressibility index, b.) particle size dm10, and c.) particle
size span also include the 95% tolerance surfaces that include the space where there is a 95% probability
that 95% of future batches will reside. The particle size dm10 CQA includes both the low and high
tolerance surfaces because it is a two sided specification, while the compressibility index and particle size
span CQAs only include the high tolerance surface.

Conversely, the increased energy input and time in the granulation phase was not
favorable for the high lactose excipient ratio batches. This was the result of the high
efficiency with which lactose granulated, which caused an increase in the number of
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particles greater than 500 µm at extended times, widened the particle size distribution,
and reduced the packing efficiency. This effect was exacerbated at high moisture targets
because the change in the duration of spraying was greater. These factors created the
interaction between EEF and EMT.
The compressibility index predictions from the model are displayed in the lower
surfaces of Figures 5.2a and 5.3a. All models contain uncertainty due to random error or
experimental errors, and this uncertainty was not constant throughout the entire modeled
space. Uncertainty was dependent on distances from the center of the model and the
location of calibration samples.

Therefore, it was inappropriate to use the model

predictions themselves to define a design space. For this reason, a tolerance interval67
was calculated that described a range of response values that contained a 95% probability
that 95% of all future responses will be included. Because the specification for the
compressibility index CQA was one-tailed (<= 25), only the high tolerance threshold was
calculated. It is displayed as the upper surface in Figures 5.2a and 5.3a. This surface was
used to determine a design space that reduced the risk of future batch failure.
Figures 5.4a and 5.5a display tolerance surfaces for the compressibility index
process model of the high lactose and high MCC excipient ratio batches, respectively.
The probability of each combination of CPPs producing future product that passes the
compressibility index specification is shown in these figures. They are used to define the
single factor design space. The high lactose excipient ratio provides an increase in the
probability of meeting the compressibility index specification at all locations, and within
these batches, high EEF and low EMT give the optimum combinations for this CQA.
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The second highest priority CQA was the particle size that included 10% of the
cumulative mass distribution (dm10) of a batch from the sieve analysis. This was used as
a measure of the fraction of fines. A low dm10 indicated a large fraction of fines. The
dm10 CQA has a two-tailed specification (45 <= dm10 <= 60) because a low fraction of
fines resulted in poor packing efficiency and poor tablet quality, but a large fraction of
fines resulted in poor flow properties and increased the probability of segregation. The
specification thresholds were optimized for this specific formulation.

Figure 5.4. The single CQA tolerance surfaces (design spaces) for the high lactose excipient ratio that
displays the probability that 95% of future batches will meet the CQA specification at the given location:
a.) Compressibility Index; b.) Particle Size dm10; c.) Particle Size Span.

The model to predict dm10 contained three main effects (excipient ratio, HPMC
concentration, EMT). The prediction results, low tolerance surfaces, and high tolerance
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surfaces are displayed in Figures 5.2b and 5.3b. Not surprisingly, the excipient ratio
again had the strongest effect on dm10.

The high MCC batches did not granulate

efficiently and therefore have a larger fraction of fines (low d m10). The EMT variable
was directly proportional to dm10, which was expected because increased spraying
allowed for more particle agglomeration and a smaller fraction of fines. Conversely, the
HPMC concentration was inversely proportional to dm10. This was unexpected because
it would seem that an increase in the binder concentration would reduce the number of
fines. The high HPMC concentration (15%) was still a minor component of the batch,
however, so it is hypothesized that while there was additional particle agglomeration in
the bulk of the batch, the fraction of fines was not reduced by higher binder
concentrations.
The tolerance surface (single factor design space) for the d m10 process model is
depicted in Figures 5.4b and 5.5b for the high lactose and high MCC batches,
respectively. The optimum space within the high lactose batches (Figure 5.4b) was in the
middle of the investigated space. Locations where dm10 was predicted to be high (high
EEF, low HPMC) had an increased probability of failing the high specification, while
locations where dm10 was predicted to be low had an increased probability of failing the
low specification. For the high MCC batches, there was a much greater probability of
failing the low specification, so the optimum region was in the bottom right of Figure
5.5b.

Overall, there was a greater probability of successfully meeting the d m10

specifications within the high lactose batches, so the optimum process space was at
intermediate EMT and HPMC concentration values with the high lactose excipient ratio.
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The final CQA for this project was the particle size span, which was an indicator
of the width of the particle size distribution. A narrow particle size distribution (low
span) was desirable because it significantly reduces the risk of future batch segregation,
while maintaining adequate flow, packing efficiency, and compaction properties.
Therefore, the span specification was one-tailed (<= 3), and defined the magnitude of the
width of the distribution as being no more than 3 times the median particle size.

Figure 5.5. The single CQA tolerance surfaces (design spaces) for the high MCC excipient ratio that
displays the probability that 95% of future batches will meet the CQA specification at the given location:
a.) Compressibility Index; b.) Particle Size dm10; c.) Particle Size Span.

The model that predicted the span of the particle size distribution included three
main effects (excipient ratio, HPMC concentration, EMT) and two interaction effects
(excipient ratio*HPMC, HPMC*EMT). The predictions and the high tolerance surfaces
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are presented in Figures 5.2c and 5.3c. The main effects were all intuitive. Generally,
any effect that caused more particle agglomeration widened the particle size distribution
because the starting particle size distribution for all batches was narrow at small particle
sizes. There was very little particle size growth in the high MCC batches, so the span of
the particle size distribution remained small. Higher HPMC concentrations created more
particle agglomeration, so the span of the particle size distribution at higher HPMC
concentration was larger. This same effect was observed for the EMT variable.
The interaction effect between the HPMC concentration variable and the EMT
variable was in the same direction as the main effects, but the combined effect of high
HPMC and EMT or low HPMC and low EMT was greater than the predicted effect when
they were considered independently. The HPMC effect on the span of the distribution
was in the same direction for both excipient ratios (Figure 5.1c), but the magnitude of the
effect was much greater in the high lactose batches. This violates the assumption of
parallelism in ANACOVA, which necessitated the excipient ratio*HPMC concentration
interaction term in an extended ANACOVA model. The high MCC batches granulated
inefficiently regardless of the HPMC concentration, so the change in HPMC
concentration did not impact the high MCC batches as substantially.
The tolerance surfaces (single factor design spaces) for the particle size span CQA
for the high lactose and high MCC batches are depicted in Figures 5.4c and 5.5c,
respectively. There is a very high probability of meeting the span specification at all
points of the knowledge space within future high MCC batches.

The same high

probability of success exists with future high lactose batches, but only at combinations at
low HPMC concentration and low EMT. All of these locations are at points where
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particle agglomeration was reduced, the number of large particles (>500 µm) was
reduced, and the span of the distribution was narrow.
To create the final design space the tolerance surfaces for the three CQAs were
combined and decisions on optimum formulation parameters were made. As stated
previously, it is impractical to include variability with respect to formulation
concentrations in a design space for a batch process. Therefore, the knowledge gained
from the DOE was used to choose an optimum excipient ratio and an optimum HPMC
concentration, and the combination of the EEF and EMT variables at these optimum
points created the design space.

Figure 5.6. The final design space for the high lactose excipient ratio that displays the probability that
95% of future batches will meet all CQA specifications at the given location: a.) CQAs are given equal
weight; b.) CQAs are weighed by risk.

There was a much higher probability of passing the compressibility index and
dm10 specifications at the high lactose excipient ratio, and the probability of passing the
particle size span specification was also high at certain locations in the high lactose
excipient ratio. Therefore, the 2:1 ratio of lactose to MCC was identified as the optimum
excipient ratio. It was determined that 8% was the optimum HPMC concentration by
analyzing the tolerance surfaces for the dm10 and particle size span models (Figures 5.4b
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and 5.4c).

Therefore, the probabilities of passing the d m10 and particle size span

specifications for all EMT values at the optimum formulation were multiplied with the
probabilities of passing the compressibility index specification at all EMT and EEF
values. The result was the probability of passing all three CQA specifications in 95% of
future batches. This combined tolerance surface created the final design space and is
displayed in Figure 5.6a.

Figure 5.7. The final design space for the high MCC excipient ratio that displays the probability that 95%
of future batches will meet all CQA specifications at the given location: a.) CQAs are given equal weight;
b.) CQAs are weighed by risk.

The direct combination of probabilities via multiplication gave equal weight to all
CQAs, which may not be appropriate for some formulations. The compressibility index
was identified as being the most significant CQA, followed by dm10 and particle size
span. Therefore, an additional tolerance surface was calculated and displayed in Figure
5.6b, which gives 50% of the total weight to the compressibility index CQA, and 25% to
each of the other CQAs. This figure more closely resembles the compressibility index
tolerance surface, and more adequately describes the risk of the process. For both figures
(5.6a and 5.6b), the optimum region that maximized the probability of future success is

164

located at high EEF and low EMT values. This local region would be where the operating
space would be identified, and the total area of the operating space would depend on the
degree of risk associated with a failure mode. The combined tolerance surfaces for the
high MCC batches are displayed in Figures 5.7a and 5.7b, and the low probabilities of
success prove again that the high lactose excipient ratio was optimal.
Table 5.3. The correlation matrix for the three response factors

Response Factor Correlation Matrix
Compressibility
Index

dm10

Particle
Size Span

Compressibility
Index

1.00

-0.30

0.05

dm10

-0.30

1.00

0.11

Particle Size
Span

0.05

0.11

1.00

Conservative methods for calculating the combined tolerance surfaces are
described here because it was assumed that all CQAs were independent and uncorrelated.
Therefore, it considered the risk of failure for each CQA specification independently, and
lowered the overall probability of success. Most manufacturing response variables have
some degree of correlation, which was the case for this particular example (Table 5.3).
Therefore, there is at least a 30% probability that failure of one CQA will have
simultaneous failures of other CQAs, which reduces the number of future batches that
have at least 1 failure mode. The probabilities within the combined tolerance surface
could be adjusted accordingly, but reporting the most conservative results will reduce
greatly the risk of underestimating future failures. If the desired probability of success

165

was not met, additional experiments must be augmented to the original DOE at the local
region where a high probability of success is necessary (operating space). This would
reduce the model error in the operating space and shift the center of the model toward the
operating space, both of which would lower uncertainty.

5.4 Conclusion
The quality by design (QbD) paradigm in the pharmaceutical industry is moving
product development in a much more rigorously scientific direction that requires well
designed experiments and control systems, but results in higher degrees of product
quality and substantial economic incentives over time. The current chapter described a
hybrid control system that was developed efficiently and was able to control the fluid bed
granulation and drying unit operation through four manufacturing phases. The control
system made use of a first principle relationship to control the major mechanism of the
manufacturing process using a single variable. Online spectroscopy provided increased
process understanding and immediate feedback for control of phase end points.
Combined, these controls resulted in reduced variability with respect to manufacturing
quality using a limited number of experiments.
The DOE that was developed to optimize the manufacturing process for the given
combination of materials included both formulation and process factors. The subsequent
analysis of the data identified significant interactions between variables including a
nominal formulation factor and continuous process factors. This information would not
have been identified in traditional stepwise developmental efforts, which could have
resulted in misidentifying the optimum combination of formulation and process factors in
the final design space. Additionally, a rigorous statistical analysis that utilized extended
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ANACOVA models and tolerance intervals around the response factor predictions was
used to define the optimum design space that reduced the risk of future batch failure to a
specified level.
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Chapter 6: Efficient Near Infrared Spectroscopic
Calibration Methods for Pharmaceutical Blend
Monitoring

6.1 Introduction
The benefits of a hybrid control system that combines first principle calculations
and empirical modeling for the fluid bed granulation and drying unit operation have been
well established in the previous chapters. The described control systems were designed
specifically for the needs of the unit operation and were ideal for the complexities
associated with fluid bed granulation and drying. The level of complexity, the type of
online measurements, and the control strategy may not be necessary for all formulations,
systems, or unit operations, however. A control system must be designed for each system
to meet all of the quality requirements while incurring the smallest possible costs.
The powder blending unit operation for most pharmaceutical formulations is a
system that lacks the level of complexity associated with fluid bed granulation and
drying. It is a unit operation that is required for almost all solid formulations in the
pharmaceutical industry, and inputs mechanical stress to charged powders via vessel
rotation to assure a homogeneous distribution of solid components throughout the batch
for further processing. Powder mixing is never the same from batch to batch, so a control
system is needed to simply monitoring the homogeneity of the blend in real-time so that
the blend can be stopped when a satisfactory and consistent level of homogeneity is
reached for every batch. This chapter will discuss a method for efficient and robust
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development of a multivariate spectral calibration, the most challenging and cost
consuming step in the development of a control system for powder blending.
The use of near infrared (NIR) spectroscopy in the pharmaceutical industry has
become increasingly popular over the past several decades.112

Little or no sample

preparation is needed, which allows for efficient data collection and the ability to monitor
processes online. However, there can be a substantial cost in generating and maintaining
robust quantitative multivariate NIR calibrations. This chapter seeks to demonstrate
efficient means of generating calibrations and maintaining them through the life-cycle of
the method.
Large sample sets are typically created using experimental design techniques.113
These sets contain enough samples to span the expected variance of chemical and
physical characteristics, while also including several replicate samples. In a system that
has four chemical components and two physical components, a calibration set with only
two levels of each component would require a minimum of 70 independent samples. The
sample size increases exponentially when additional component levels are added (as is
frequently necessary for more sensitive calibrations). Additionally, it is necessary to
generate a validation set and calibration transfer samples (for update or transfer).
Considering all of the samples required, the development and maintenance of a robust
NIR calibration can be an expensive undertaking.
A potential advantage that a pharmaceutical analyst has for reducing the required
number of design points is access to pure components samples.

The highest

concentration point for all chemical components is available by scanning pure
components, thereby requiring minimal preparation. Similarly, scans of all other pure
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components serve as zero concentration points for the analyte(s) of interest.

The

concentration for constituents that is the point of interest (e.g. the final formulation for a
pharmaceutical blend or tablet) for each component is typically available during process
development.

Therefore, three concentration levels are available for all chemical

components without creating new samples. Utilizing these available samples is the basis
of this efficient calibration study. This technique is intended to be a low cost effort
during research and development to provide satisfactory predictions during process
development. It is not intended to be a final method used for product testing or process
optimization, but the initial models can be updated with additional samples created by
design to improve model sensitivity over a specific concentration range.
This chapter demonstrates the development and performance of efficient NIR
calibrations for pharmaceutical blend monitoring. It addresses the performance of several
popular multivariate calibration algorithms including partial least-squares (PLS)
regression, classical least-squares (CLS) regression, augmented classical least-squares
(ACLS) regression, classical least-squares/partial least-squares (CLS/PLS) regression,
artificial neural networks (ANN), and least-squares support vector machines (LSSVM).
Due to the differences in the calculation of the regression vectors for each algorithm,
some are more appropriate for the creation of robust calibrations with reduced sample
sets. A critical analysis of the performance of each algorithm is provided, as well as a
discussion of the blend end point determination.
The transfer ability of the two best performing models is presented as an
additional indication of model robustness. Calibration transfer is a vital portion of any
online spectroscopic method because multiple NIR instruments are necessary and each
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instrument drifts over time, requiring a change or update in the calibration. The ease at
which this transfer process is successful is a major contributor to the success of the
method and is a strong indicator of the original calibration’s robustness.
This study was part of a major research project through The National Institute for
Pharmaceutical Technology and Education (NIPTE) funded by the U.S. Food and Drug
Administration. The project title is “Development of Quality by Design (QbD) Guidance
Elements on Design Space Specifications Across Scales with Stability Considerations.”
It is focused on improving pharmaceutical product quality and maximizing process
innovation and continuous quality improvements by developing control systems and
process design spaces across several unit operations and several scales. The research was
originally published in the Journal of Pharmaceutical Innovation. 133

6.2 Theory
6.2.1. Multivariate Calibration Algorithms
The PLS algorithm is the most widely used calibration algorithm for quantitative
predictions using spectral data because of its data reduction capabilities and its
performance in prediction statistics.

Partial least-squares regression is a bilinear

modeling algorithm based on Herman Wold’s general PLS principle.114 A thorough
review of the PLS algorithm is provided by Bjorsvik and Martens.115
The PLS algorithm calculates the regression vector by maximizing the covariance
between the spectral data matrix and the reference data. Therefore, a PLS calibration is
only as good as its reference data. An accurate and robust PLS calibration must have
reference samples covering the entire concentration range that will be encountered in
future predictions. The greater the number of concentration levels and replicates over the
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range, the better the prediction statistics. Therefore, the PLS algorithm was hypothesized
to be less effective for efficient calibrations using reduced samples sets.
The CLS algorithm has not been widely applied for NIR calibrations in the
pharmaceutical industry because it is very difficult to estimate the pure component
contribution for all spectrally active components in the sample matrix. Spectral shapes
imparted by an instrument, light source, sample particle size, etc. are very difficult to
determine when creating a calibration model, and thus CLS calibrations typically result in
reduced accuracy statistics.

Classical least-squares regression assumes that the Y

variable(s) is a random variable with a distribution that depends on the X variable(s),
which is considered non-random and controlled by the experimenter. The CLS algorithm
is based upon explicit linear additive models (Beer’s Law) that require quantitative
knowledge of all spectrally active components in the calibration set,75 and the regression
vector becomes the portion of each components’ pure component spectra that is
orthogonal to the other pure components.
The ACLS technique, developed by Haaland and Melgaard,75, 116, 117 is a method
intended to enhance the CLS algorithm. The calibration procedure and calculation of the
pure component matrix is the same as with the CLS algorithm, but ACLS allows the user
to augment the predicted pure component matrix with empirically derived spectral
shapes. For example, if a user determines that a difference between two lots of an
excipient is causing prediction errors, samples of each lot can be collected and the
difference spectrum or loading(s) from a principal component analysis (PCA) can be
added to the predicted pure component matrix, K̂ . This effectively orthogonalizes the
regression vector for all other components to the newly derived spectral interference
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shape. This can be repeated for all known interferences during calibration or prediction
(prediction augmented CLS: PACLS).
The ACLS and PACLS techniques make calibrations more robust, but often lower
prediction accuracy statistics because more of the measured pure component signal is
removed from the regression vector due to orthogonalization.

Therefore, the major

drawback with the CLS algorithm is not solved, but a very intuitive calibration transfer
and/or update method is introduced.

A calibration transfer or update can be

accomplished with a reduced sample set by simply deriving the spectral shape of the new
instrument or interference and adding it to the pure component matrix.
Another simple improvement aimed at utilizing the advantages of CLS and PLS
together is the hybrid (CLS/PLS) algorithm, also developed by Haaland and Melgaard.100,
118, 119

In this method, a CLS, ACLS, or PACLS model is developed as discussed

previously.

A subsequent PLS model is calculated to relate the spectral residuals from

the initial CLS model to the concentration residuals for each component. The predicted
concentration residuals are then added to the original CLS predictions.
The PLS step of the hybrid algorithm models the structured noise remaining in the
spectral data matrix, X, after the CLS model is calculated. This structured noise is
affecting predictions and results from additional spectrally active components (particle
size, instrument, etc.) that are not included in the predicted pure component matrix. The
hybrid algorithm is hypothesized to be the ideal candidate for the creation of efficient
calibrations using reduced sample sets. The inclusion of measured pure component scans
in the CLS step allows the model to be specific for each component, while the PLS step
can reduce prediction errors for better accuracy and precision. The ability to augment the
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CLS portion of the hybrid algorithm makes it ideal for efficient calibration transfer or
update, which is especially important for reduced sample set calibrations where
significant spectral interference shapes may be encountered during prediction.
Artificial neural networks are pattern recognition methods that have been adapted
to solve regression problems. It is a nonlinear modeling technique that may be more
appropriate for complex data matrices. As stated in its name, ANN mimic the function of
biological neural networks by being constituted of individual neurons positioned on
interconnected layers. A typical ANN has an input layer, one or more hidden layer(s),
and an output layer. The number of neurons on the input and the hidden layers can vary.
Compared to PLS and CLS based methods, ANN do not assume linearity between inputs
and outputs and can successfully be deployed in situations where the distribution of the
residuals is not normal. Numerous publications show cases where ANNs provided more
accurate and precise results than linear techniques.120-123
Artificial neural networks are particularly subject to overfitting and a good
validation strategy must be developed. They perform poorly when trying to predict values
outside of the training range, while linear methods can extrapolate quite well. Finally, due
to the large number of elements to estimate during the development of an ANN, the
number of samples must be large.124

However, its ability to model non-linear

relationships can be highly beneficial in efficient calibrations where it is highly
hypothetical that the relationship between spectral data and sample concentration is linear
between 0 and 100%.
Support vector machines (SVM) were originally developed for binary
classification situations.125 The idea behind SVM is to determine samples that define the
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most appropriate cluster limits (support vectors) as well as reduce the misclassification
rate. In regression situations, support vector regression (SVR) and least-squares support
vector machines (LSSVM) try to find the best fit of the data by limiting the number of
samples outside an error range set by the user.
Least-squares support vector machines has been developed to perform on data
presenting non-linear relationships with a limited number of observations. The main
advantage of LSSVM is that only two parameters need to be determined. Its main
drawback is the computation time; it is exponentially proportional to the size of the
dataset and can take several hours to perform on a set of several hundred samples. This
problem is minimized using reduced sample sets. Cogdill and Dardenne 126 provided a
good overview of LSSVM. Shawe-Taylor et al.127 and Suykens et al.128 are references
for theoretical aspects of support vector machines.

6.2.1 Blend End Point Determination
The Root Mean Squared Error from the Nominal Value (RMSNV) statistic for
blend end point determination is a moving window, weighted error statistic.99 It is
calculated by:



t

RMSNV =

t i

t
t
W1 (Yˆ1  Y1 ) 2  t i W2 (Yˆ2  Y2 ) 2  ...t i Wn (Yˆn  Yn ) 2

i(W1  Ww  ...Wn )

(6.1)

where W is the weight given to a component and i is the number of data points used in a
single window. The reference concentration for a given component (Y n) is the nominal
concentration of the component in the final blend and is compared to the predicted
concentration value for that species ( ). The weight for a given component can be
adjusted based on the requirements and/or performance of the measurement.
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The

blending end point is reached when the RMSNV statistic reaches a pre-determined
minimum threshold over the previous window. The adjustable parameters make the
RMSNV statistic ideal for meeting the needs of a specific blending operation.

6.3 Materials and Methods
6.3.1. Pharmaceutical Formulation
The formulation contained eight components, and Gabapentin (Hangzhou
Starshine Pharmaceutical Co., LTD, Hangzhou, China, Batch 0803023) was the active
pharmaceutical ingredient (API).

Granules comprising 93.75% API and 6.25%

hydroxypropyl cellulose (HPC) (Klucel EXF, Ashland Aqualon Functional Ingredients,
Wilmington, DE, USA) were manufactured using a bottom driven, high shear granulator
(Diosna P1-6, Dierks & Söhne GmbH, Osnabruck, Germany, 6 L bowl) and tray dried at
Purdue University. The granules were created as part of a design of experiments to
optimize the wet granulation unit operation for this formulation.

Three granulation

batches of 1.2 Kg were granulated with 1.0%, 2.0%, and 2.5% water by weight,
respectively. All three batches were dried to 0.5% moisture by weight. The median
particle size for the three batches were 233 µm, 450 µm, and 590 µm, respectively.
These batches were then sampled for the small scale blend experiments.
The granules, which comprise 71.99% of the blend, were combined with the
extragranular excipients: 1.23% Poloxamer 407 (WLS Enterprises, Indianapolis, IN,
USA), 2.47% crospovidone (Polyplasdone XL, ISP Chemicals, Wayne, NJ, USA), 6.75%
starch (Lycatab C, Roquette America Inc., Geneva, IL, USA), 11.25% microcrystalline
cellulose (MCC) (Comprecel M102D+, Mingtai Chemical Company Ltd., Taoyuan
Hsien, Taiwan), 1.01% talc (IMI FABI LLC/Mutcher Inc., Benwood, WV, USA), 4.50%
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HPC, 0.79% magnesium stearate (Mg. St., Mallinckrodt, Hazelwood, MO, USA) - for
powder blending. The final concentration of Gabapentin in the blend was 67.49% and
the final concentration of HPC (intra- and extra-granular) was 9.00%.

6.3.2 Blending, Sampling, and Instrumentation
Blending was performed at the Duquesne University Center for Pharmaceutical
Technology (DCPT) with a 5.5 L bin blender (L.B. Bohle LLC, Warminster, PA, USA)
with DeltaV (Emerson Process Management, Equipment & Controls, Inc., Lawrence, PA,
USA) controls. The blender was run at 15 rpm for 15 minutes with all components
except Mg. St. to ensure that each blend was completely homogenous. Magnesium
stearate was then added to the blender and an additional 5 minute lubrication blend was
performed.

The lubrication blend was not considered in any of the following data

analysis.
6.3.2.1 Side Sensor
Blends that were performed for data collection by the side sensor were completed
using a small scale blend simulator that was mounted inside the 5.5 L bin blender against
the side axis window. The small scale blends had a total mass of 30 grams, with an
approximate fill volume of 85%. The system was designed to make the calibration
processes as efficient, with respect to raw materials, as possible.
Pure component scans of each material and the pharmaceutical granules were
collected by filling the blend simulator with 30 grams of a given component. Granule
scans for each granulation batch were collected by filling the blend simulator with 30
grams of granules. Data were collected with the same procedure as the blends. This
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procedure allowed for the pure component and granule scans to be similar in terms of
physical properties and noise as compared to the dynamic or tumbling blends. The
calibration curves for gabapentin and HPC had four concentration points (other
components (0%), blend concentration (67.49% API, 9.00% HPC), granule concentration
(93.75% API, 6.25% HPC), pure component (100%)), while the calibration curves for all
other excipients had three concentration points (other components (0%), blend
concentration (nominal %), pure component (100%)).
Diffuse reflectance NIR spectral data were collected using a model NIR256L2.2T2 spectrometer from Control Development Inc. (South Bend, IN, USA). It is a 256
element photodiode array spectrometer with an extended InGaAs detector (1085-2229
nm). An external halogen light source (Control Development Inc., HL-2000) was used
with a fiber optic probe (Control Development Inc., South Bend, IN, USA, 6 around 1
reflectance probe). The side sensor was stationary, with the fiber optic probe placed
against a sapphire window on the rotation axis of the blender. The spot size for this
system was approximately 400 µm. Spectra were collected with 16 coadditions averaged
for a single scan with an integration time of 0.028 seconds. A single scan was collected
every five seconds. A dark reference was collected by disconnecting the lamp from the
fiber optic probe and a light reference was collected by measuring the diffuse reflectance
from a 99% Spectralon Reflectance Standard (Labsphere Inc., North Sutton, NH, USA).
Reference scans were collected once daily.
6.3.2.2 Top Sensor
Blends that were performed for data collection by the top sensor were lab scale
blends with a total mass of approximately 800 g. The fill ratio of these blends in the 5.5
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L bin blender was less than 50%. The top sensor was set to collect spectra when inverted
to assure that each scan had powder directly in front of the sensor. At 15 rpm, the scans
were collected at four second intervals.

Pure component and granules scans were

collected by filling the blender and spinning at 15 rpm in the same procedure that was
performed on the small scale blend simulator. The calibration curves for the top sensor
had the same concentration levels for each component as the side sensor calibrations.
Diffuse reflectance NIR spectral data was collected using the Blend Uniformity
Analyzer from Control Development Inc. (South Bend, IN, USA). It is a 256 element
photodiode array wireless spectrometer with an InGaAs detector (910-1680 nm) and an
internal dual tungsten halogen lamp. This spectrometer was attached to the lid of the
blender and rotated with the blender. The spot size for this system was 25 mm. Spectra
were collected with 16 coadditions averaged for a single scan with an integration time of
0.033 seconds. The dark and light reference scans are internal for the top sensor and
were collected once daily.

6.3.3 Data Analysis
All of the data analysis was performed using MATLAB v. 7.1 R14 (The
Mathworks, Natick, MA, USA) equipped with the PLS_Toolbox v. 3.0.4 (Eigenvector
Research Inc., Wenatchee, WA, USA), LSSVM Lab v1.5 (Katholieke Universiteit
Leuven, Belgium),128 the neural network toolbox v5.1 (The Mathworks, Natick, MA,
USA), and programs written in house.
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Table 6.1. The number of spectra and independent samples for the calibration set, test set, and prediction set for the top and side sensor.
Top Sensor Data Sets
Test
Calibration Set
Set
Blend Granule Blend
Pure Component Scans
Scans Scans
Scans
API HPC MCC Starch Poloxamer Crospovidone Talc
Number of
19
23
18
16
12
16
15
68
53
30
Spectra
Number of
Independent
1
1
1
1
1
1
1
4
3
2
Samples
Side Sensor Data Sets
Test
Calibration Set
Set
Blend Granule Blend
Pure Component Scans
Scans Scans
Scans
API HPC MCC Starch Poloxamer Crospovidone Talc
Number of
28
30
30
30
30
30
30
30
133
35
Spectra
Number of
Independent
1
1
1
1
1
1
1
2
3
3
Samples

Prediction
Set
Full Blend
Profile
227
1

Prediction
Set
Full Blend
Profile
367
1

The calibration set for the side sensor consisted of 371 spectra from 12
independent samples. The wavelength range was truncated to the 1151-2229 nm range to
eliminate the noisy portion of the detector at shorter wavelengths. Further information on
the calibration set, test set, and prediction set are included in Table 6.1. The blend scans
in the calibration set represent the final minute of 2 independent blends. The 1.0% and
2.0% moisture content granulation batches supplied the granules for these 2 blends,
respectively.
The calibration set for the top sensor contained 240 spectra from 14 independent
samples. The wavelength range was truncated to the 924-1656 nm range to remove the
noisy ends of the spectrometer. Further information on the top sensor data sets can be
found in Table 6.1. The blend scans in the calibration set represent the final minute of
four independent blends. Each granulation batch was represented in one of the four
independent blends, with the 2.0% moisture content batch represented twice.
Calibrations for both instruments were created using the algorithms described
previously to predict each of the concentrations of the four major blend components
(Gabapentin, MCC, HPC, and Starch), which comprise 94.49% of the final blend. The
other minor components were present in concentrations less than 2.5%, which is too low
for consideration in this context. The prediction performances for the reported efficient
calibrations are of magnitudes that would constitute a significant portion of these low
concentrations.
The calibrations for each of the four major components were optimized for the
minimum cross-validation error independently by preprocessing methods, augmentation,
number of modeling factors, etc.; even calibrations using the same algorithm.
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For

example, the spectral preprocessing and number of latent variables were optimized for
the gabapentin PLS calibration; similarly, the same parameters were independently
optimized for the starch PLS calibration. For ANN and LSSVM, a randomly selected
stop set of 20% of the calibration was used to tune the parameters. The stop set acted like
a 1-block cross validation approach and allowed model parameters to be tuned. Both nonlinear approaches were developed based on principal component scores. For ANN, 10
independent generations were created to ensure that results were not based on a local
minimum. All parameters (for ANN: network structure, momentum, learning factor,
transfer function, etc.; for LSSVM: kernel and regularization factor) were independently
tuned for each parameter and each material.
The calibration performance was reported with multiple statistics including the
coefficient of determination (R2), root mean squared error of the calibration (RMSEC),
standard error of the calibration (SEC), bias, slope, and offset. The test performance was
reported using the R2, root mean squared error of prediction (RMSEP), standard error of
prediction (SEP), bias, slope and offset statistics. Finally, the spectra collected from a
separate full blend that is not in the calibration or test sets was used for prediction
purposes to study the effect of the blend end point determination using different
algorithms.
For all calibration algorithms studied in this manuscript, the RMSNV statistic was
determined using the four major components of the pharmaceutical blend with each
component receiving an equal weight (1/4). The moving window contained enough
samples to comprise one minute of blending (12 samples for the side sensor; 15 samples
for the top sensor).
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Different test sets were used for the side and top sensor. The side sensor utilized
the final 15 scans of two additional independent, small scale blends created using
granules from the 1.0% and 2.0% moisture granulation batches and the final five scans of
a third independent blend with granules form the 2.0% moisture granulation batch (35
total spectra) as an independent test set. An additional independent blend using granules
from the 2.0% moisture granulation batch was used as a prediction set for determining
blend homogeneity. For the top sensor, the final 15 spectra from two separate blends
using granules from the 1.0% and 2.0% moisture granulation batches, respectively, were
used as an independent test set and a third independent blend using granules from the
2.0% moisture granulation batch was used for prediction of the blend end point.

6.3.4 Calibration Transfer
The two best performing algorithms from the calibration study were studied
further in a calibration transfer study. The common wavelength range (1151-1680 nm)
between the two sensors’ truncated calibration sets were used so that the calibrations
could be applied to both instruments. Calibration transfer was attempted from the side
sensor to the top sensor (S-T) and from the top sensor to the side sensor (T-S) for all
transfer techniques.

The same test and prediction sets were used to evaluate the

performance of the transferred calibrations with the RMSEP, SEP, and bias statistics
reported.
Each calibration was applied directly to the other spectrometer data as the
simplest possible prediction scenario. Robust calibrations were created using different
numbers of spectra from both instruments’ calibration sets (100%, 50%, and 25%) as a
baseline to compare the performance of the transfer techniques.
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For each transfer

technique, the 10 samples from the calibration set having the lowest residuals were
removed to create the transfer set. Each calibration was then transferred using bias
correction, direct standardization (DS), and piecewise direct standardization (PDS),73, 74
and the results were compared for performance. Standardization samples were removed
prior to developing calibrations. Thus, all calibration models were developed without the
10 best samples.

6.4 Results and Discussion
6.4.1. Calibration Study
Performance results from the calibration study can be found in Table 6.2, which
contains the pooled calibration statistics for the four major components for both sensors.
The top sensor data contained less noise than the side sensor data; as a result, the
calibration statistics were generally better for the top sensor. There were exceptions, and
the differences between the two instruments depended on the multivariate algorithm
employed.
In all models, the error statistics were notably lower for nonlinear methods (ANN
and LSSVM) than for the linear multivariate algorithms. The ANN models had the
lowest error statistics, but these models lacked sensitivity, which was observed when
predicting full blend profiles (Figures 6.1 and 6.2). The ANN models predicted all
samples in a range around the blend point as having the nominal blend concentration, so
blends that were not homogenous would have been predicted to be homogenous by the
ANN method. The ANN algorithm has many more parameters to optimize than linear
methods, which are not intuitive and require an extensive validation method.

The

number of independent samples that were available in this efficient calibration setting did
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not allow for a rigorous ANN optimization. The ANN algorithm was not considered
further.
Table 6.2. The pooled calibration performance statistics across the 4 major blend components for both
sensors using multiple calibration algorithms.
Top Sensor Calibration Statistics

R2

0.9869

Pooled Statistics for 4 Major Components
AugAug
CLS
CLS/PLS
LSSVM
CLS
CLS/PLS
0.9853 0.9850
0.9945
0.9936
0.9999

RMSEC

0.0399

0.0426

0.0431

0.0261

0.0279

0.0042

0.0036

SEC

0.0399

0.0427

0.0431

0.0261

0.0279

0.0042

0.0036

Bias

0.0000

0.0000

0.0000

0.0000

0.0000

0.0000

0.0005

Slope

1.0000

0.9585

0.9850

0.9945

0.9936

1.0001

1.0030

Offset

0.0000

0.0030

0.0030

0.0011

0.0013

0.0000

0.0000

R

0.9893

0.9875

0.9892

0.9689

0.9701

0.9999

1.0000

RMSEP

0.0323

0.0397

0.0379

0.0455

0.0448

0.0080

0.0004

SEP

0.0322

0.0385

0.0457

0.0449

0.0078

0.0004

Bias

0.0021

-0.0104

0.0006

0.0026

0.0016

0.0000

Slope

0.9337

0.9089

0.0366
0.0103
0.9109

0.9772

0.9747

0.9967

Offset

0.0177

0.0122

0.0118

0.006

0.0086

0.0024

1.0000
0.0004

Calibration

PLS

Test

2

ANN
0.9999

Side Sensor Calibration Statistics

R2

0.9700

Pooled Statistics for 4 Major Components
AugAug
CLS
CLS/PLS
LSSVM
CLS
CLS/PLS
0.9844 0.9843
0.9927
0.9953
0.9999

RMSEC

0.0632

0.0458

0.0461

0.0313

0.0252

0.0034

0.0074

SEC

0.0632

0.0459

0.0461

0.0313

0.0252

0.0034

0.0074

Bias

0.0000

0.0000

0.0000

0.0000

0.0000

0.0000

0.0000

Slope

1.0000

0.9844

0.9843

0.9927

0.9953

1.0000

Offset

0.0000

0.0029

0.0030

0.0014

0.0009

0.0000

R2

0.9756

0.9179

0.9778

0.9795

0.9843

0.9972

1.0002
0.0001
0.9998

RMSEP

0.0416

0.0738

0.0408

0.0383

0.0339

0.0180

0.0035

SEP

0.0412

0.0741

0.0392

0.0384

0.0336

0.0180

0.0034

Bias

0.0054

0.0016

-0.0116

0.0017

0.0055

0.0009

0.0008

Slope
Offset

0.9641
0.0137

0.9660
0.0096

0.9672
-0.0034

1.0460
-0.0092

1.0403
-0.0039

0.9563
0.0113

1.0007
0.0006

Test

Calibration

PLS
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ANN
0.9996

Figure 6.1. RMSNV trends of a single independent blend using multiple calibration algorithms on side
sensor data. The solid boxes in the zoomed portion of the figure represent the blend end point as
determined by each algorithm. The end point is defined when the RMSNV over the previous minute is less
than or equal to the test error for the respective calibration. The solid line represents a strictly arbitrary
threshold for RMSNV.

The performance of the CLS algorithm was comparable to that of PLS. This
demonstrates the advantage that CLS based algorithms have over PLS with reduced
sample sets and pure component spectra. Even without spectral shapes in the K̂ matrix
that represent physical effects such as particle size and density, the prediction results
were acceptable.
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Figure 6.2. RMSNV trends of a single independent blend using multiple calibration algorithms on top
sensor data. The solid boxes in the zoomed portion of the figure represent the blend end point as
determined by each algorithm. The end point is defined when the RMSNV over the previous minute is less
than or equal to the test error for the respective calibration. The solid line represents a strictly arbitrary
threshold for RMSNV.

Test and prediction results for CLS were improved by augmenting additional
spectral shapes from other spectrally active factors, but the effects were different for each
component. Calibration performance was improved further by adding the PLS step to the
ACLS calibrations for the ACLS/PLS hybrid algorithm. The PLS step made minor
corrections to the original ACLS predictions to account for errors caused by the
regression vector still containing spectral variation from other components that were not
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represented in the K̂ matrix. These components included spectral baseline effects from
different blend runs, changes in the residual moisture between blends, and changes in the
physical properties of the component powders, most notably the granules.

The

improvements were greater when dealing with the noisier data from the side sensor. It
should be noted that all models showed acceptable prediction performance for blend
homogeneity monitoring, even with as few as 12 and 14 independent samples. Using the
CLS based methods and taking care in calibration optimization, combined with the use of
pure component scans, led to useful calibrations based on a minimal number of samples
(efficient calibration).
6.4.1.1 Side Sensor Analysis
For the side sensor, the starch, MCC, and HPC CLS calibrations were improved
by augmenting the spectral shapes extracted from the differences between blends derived
by a PCA. An additional spectral shape derived from a PCA on different sieve cuts of the
granules was added to the MCC calibration to represent the scattering effects from
particle size differences. The improvements by these ACLS calibrations for both sensors
demonstrate the power of the method. This was particularly noticeable when using small
sample sets. The improvements over PLS were more substantial using the side sensor
data. These data were noisier, which lead to spurious correlations between the X and Y
data that were observed in the PLS predictions. The utility of the CLS based models was
not diminished by these noise effects to the same degree because the pure component
scans forced correlation between the regression vector and appropriate spectral variation.
Error statistics of LSSVM were approximately ten-fold lower than other
algorithms in calibration, but were five times greater from calibration to test results. The
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other algorithms did not show this magnitude of error increase. This was a sign of
overfitting due to the side sensor having a higher noise magnitude, and LSSVM extracted
spurious correlations as useful information.
6.4.1.2 Top Sensor Analysis
The starch and HPC calibrations were improved by augmenting the spectral
shapes that represented the mean difference among the four independent blends that were
included in the calibration set for data from the top sensor. The spectral difference
between independent blends resulted from differences in the baseline of the spectra on a
given day and differences in scattering properties from particles size and bulk density
differences, especially because some blends differed in mass by 200 grams.

These

shapes were derived by concatenating the spectra from these blends into a matrix and
performing PCA on the data. The blends have the same nominal concentrations, but were
clearly separated in score space in the first two principal components. When the loadings
for these two components were added to the K̂ matrix the calibration statistics were
similar or slightly worse because of the removal of pure component signal from the
regression vector. However, the calibrations were more robust, showing better prediction
and test results.
In contrast with the side sensor, LSSVM on the top sensor displayed limited
overfitting because calibration and test error were much closer than on the side sensor.
While still providing lower error statistics, LSSVM was much more sensitive to spectral
noise than most of the other modeling techniques.

6.4.2 Blend End Point Determination
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The performance of the calibration significantly effected the determination of the
blending end point using the RMSNV statistic. The RMSNV profiles resulting from the
predictions on the blend monitored using the side sensor are displayed in Figure 6.1,
while the RMSNV profiles using the top sensor data are displayed in Figure 6.2.
The ending criterion, or RMSNV threshold, should reflect the model’s test
statistics, an empirically derived relationship with future product variability, and/or the
necessary performance of the blend in subsequent unit operations. An arbitrary error
threshold used for all blends is insufficient. The side sensor blend profiles (Figure 6.1)
show that differences in model error can lead to substantial differences in the blend end
point determination using an arbitrary threshold such as 5% (see the solid line in Figure
6.1). The PLS, LSSVM, and ANN algorithms would have stopped the blends before the
blend was homogenous, while the CLS based algorithms would have never stopped the
blends because the error in the models was always greater than the threshold. Figure 6.2
displays the effect an arbitrary threshold had using the top sensor data. All algorithms
would have stopped the blend prematurely because the lower noise of the top sensor
instrument allowed all of the algorithms to reach the 5% threshold quickly.
Without having tablet variability data to train a blend variability model, a more
appropriate ending criterion was the test error for a given model. When a RMSNV point,
which pools the error over the four major components and one minute worth of data
collection, was less than or equal to the test error of the calibration, the blend was
determined to be homogenous. This indicates that the blend had reached a maximum
discernable homogeneity, based on the analytical method employed. Figures 6.1 and 6.2
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demonstrate the blend end point as determined by each algorithm with this criterion by
the solid squares.
6.4.2.1 Side Sensor Performance
The side sensor calibrations demonstrated how increases in the amount of noise
present in the data matrix can affect the performance of the multivariate algorithms. The
presence of significant noise caused all of the algorithms to perform similarly, with all
RMSNV trends correlated at greater than 91.8% (Table 6.3). The small, subtle variations
associated with minor components diffusing throughout the blend were masked and as a
result, the multivariate algorithms were only able to correlate the larger sources of
variation to the reference values. The only major differences between RMSNV profiles
were differences in prediction bias (Figure 6.1), which created offsets in the trends while
the features remained similar.
The CLS algorithm produced the highest error statistics while the nonlinear
methods had the lowest. Both augmenting the CLS algorithm and using the secondary
PLS step improved the error statistics for CLS, but the CLS/PLS hybrid algorithm did a
better job of monitoring the minor blend fluctuations throughout the process. The ACLS
algorithm had the lowest correlations with other algorithms, while PLS, CLS/PLS, and
ACLS/PLS were highly correlated. The PLS algorithm modestly outperformed the other
linear algorithms when comparing overall error.
There was a significant difference in the blend end points as determined by each
algorithm that was the result of differences in prediction bias and the determination of the
ending error threshold. While all algorithms showed similar trends, the valleys or local
minima in the RMSNV trends met the ending threshold at different times because of the
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differences in the test performance and the blend prediction bias. The CLS algorithm
determined that blend homogeneity had been achieved quickly because the test error for
CLS was highest, which defined a higher error threshold.

The PLS and LSSVM

algorithms indicated the ending criterion had been reached quickly because there was a
low prediction bias for this blend.

The ACLS, CLS/PLS, ACLS/PLS, and ANN

algorithms analyzed the blend as requiring longer to reach homogeneity.
Table 6.3. Correlations between RMSNV trends using a single blend and multiple

calibration algorithms for both sensors.
Top Sensor RMSNV Correlations Between Algorithms
PLS

CLS

ACLS

CLS/PLS

ACLS/PLS

LSSVM

ANN

PLS

1.0000

0.8303

0.8851

0.8957

0.8183

0.3556

0.4203

CLS

0.8303

1.0000

0.9838

0.9232

0.9456

0.4336

0.5167

ACLS

0.8851

0.9838

1.0000

0.9446

0.9441

0.3906

0.4650

CLS/PLS

0.8957

0.9232

0.9446

1.0000

0.9540

0.4090

0.4809

ACLS/PLS

0.8183

0.9456

0.9441

0.9540

1.0000

0.2972

0.4026

LSSVM

0.3556

0.4336

0.3906

0.4090

0.2972

1.0000

0.9470

ANN

0.4203

0.5167

0.4650

0.4809

0.4026

0.9470

1.0000

Side Sensor RMSNV Correlations Between Algorithms
PLS

CLS

ACLS

CLS/PLS

ACLS/PLS

LSSVM

ANN

PLS

1.0000

0.9912

0.9183

0.9936

0.9923

0.9294

0.9867

CLS

0.9912

1.0000

0.9352

0.9920

0.9927

0.9383

0.9807

ACLS

0.9183

0.9352

1.0000

0.9280

0.9375

0.9817

0.9406

CLS/PLS

0.9936

0.9920

0.9280

1.0000

0.9990

0.9329

0.9801

ACLS/PLS

0.9923

0.9927

0.9375

0.9990

1.0000

0.9406

0.9820

LSSVM

0.9294

0.9383

0.9817

0.9329

0.9406

1.0000

0.9550

ANN

0.9867

0.9807

0.9406

0.9801

0.9820

0.9550

1.0000

A more rigorous validation procedure that included more than 2 independent
samples at the blend point would have provided a more accurate model performance
metric, which would have allowed the algorithms to determine blend end points over a
narrow time range. Adding a concentration standard deviation statistic over each one
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minute time window as an additional minimum end point criterion would also make the
end points for each algorithm more precise.
6.4.2.2 Top Sensor Performance
The top sensor data (Figure 6.2) show that all of the multivariate algorithms
performed adequately when using data with a lower magnitude of noise and a larger spot
size. Reduced noise resulted in fewer spurious correlations to the reference data, while a
larger spot size reduced the inherent variation observed between measurements. The
linear multivariate algorithms predicted blending trends that were highly correlated
(Table 6.3), while the nonlinear methods showed fewer trends and had lower correlations.
The PLS algorithm did not determine a blend end point, however, due to a prediction bias
for the entire blend run that never allowed the RMSNV statistic to get within 1% of the
test error. All other algorithms established the blend end point within a 75 second range
(20-95 sec.). The short blending times were not surprising for these blends because the
fill ratio of the powder in the blender was less than 50% and the larger spot size resulted
in a larger scale of scrutiny.
The nonlinear methods determined the end point criterion was reached quickly
because the models lacked adequate sensitivity in the concentration range around the
nominal blend end point. The problem with simple, three-level calibrations over the
entire concentration range (0%-100%) is that they traditionally have low prediction
accuracy and sensitivity, with biases in predictions being common. For the nonlinear
methods, the subtle spectral changes associated with small changes in chemical
concentrations in NIR spectra did not produce a proportional response in the predictions
because the calibrations were not trained to recognize these changes appropriately. The
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algorithms recognized samples with a high concentration of a single component as being
very similar to the pure component, and therefore output predictions that were close to
100%.

This resulted in an over-prediction bias for one component and an under-

prediction bias for other components. The same problem was observed near the nominal
concentration point. The nonlinear methods suffered from this problem more severely.
These models no longer showed any trends after the blends had begun to approach the
nominal concentration. Due to the number of parameters that need to be optimized for
the nonlinear methods, reduced sample set calibrations are not appropriate.
Efficient calibration typically is improved by creating a small number of
independent samples around the concentration point of interest.

This allows the

calibration to more accurately predict samples close to this concentration level. The
range of these samples is a function of users’ need. For accurate and precise predictions
of all new samples, the range of concentrations in the calibration set around the point of
interest must encompass all anticipated new sample concentrations. This approach will
result in robust calibrations that are selective, accurate, and precise with a reduced
number of samples. While all of the multivariate algorithms can benefit from additional
samples, the present chapter demonstrates that the ACLS/PLS algorithm’s performance
was satisfactory without requiring additional samples.
All of the linear multivariate algorithms in Figure 6.2 showed a one minute period
of decreasing blend variability after the initial concentration change. The CLS based
algorithms, which used the pure component scans as a significant advantage in the
efficient calibration setting, were most sensitive to the slight concentration changes
around the blend end point and would stop the bed at the more appropriate end point of
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95 seconds. If the blend was stopped before this point, some of the minor excipients
would not have had the opportunity to fully diffuse throughout the blend, resulting in
homogeneity problems that could create problems with the final dosage forms.
The differences among the blend end points determined by the linear algorithms
were strictly the results of prediction biases as proven by the high overall correlations
between these trends (Table 6.3).

As stated previously, a more rigorous validation

process, the inclusion of a prediction standard deviation metric, and the addition of
samples to the calibration set would cause these predicted end points to converge.
This calibration performance study demonstrated the utility of efficient
calibrations while highlighting the importance of understanding the instruments’ noise
characteristics, scale of scrutiny, and resulting capabilities. When using an instrument
with increased noise, reduced sample set calibrations were more appropriate because the
instrument limited the performance of the component predictions. All of the algorithms
presented using the side sensor data performed adequately, and additional expenses used
in model building would be wasted. When an instrument (top sensor) with a higher
signal to noise ratio was used, the calibration process and multivariate algorithm became
more critical. The CLS based algorithms took advantage of pure component scans to
create sensitive models with reduced sample sets. Like all quality by design (QbD)
projects, an adequate risk analysis must be completed prior to performing an
experimental design, so that the user knows the performance level required of the
analytical models that inform the process.

6.4.3 Calibration Transfer Study
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The two best performing algorithms (ACLS/PLS and LSSVM) from the
calibration study were investigated further in a calibration transfer setting. This is an
additional indicator of model robustness. Ease of transfer is an important property for an
NIR model in the pharmaceutical industry. If a new calibration must be created at each
instance that an instrument fails, requires maintenance or a calibration update, or a
different instrument must be utilized, the costs become prohibitive.
For this study, several calibration transfer techniques were compared against
robust calibration designs (calibrations including data from both sensors) to determine
which of the two algorithms were easier to transfer. Transfers were created for predicting
side sensor data using the top sensor calibrations (T-S) and for predicting top sensor data
using side sensor calibrations (S-T). Due to the differences in noise patterns, the S-T
transfers were not successful (data not shown). The failure of the S-T transfer was
anticipated, because a transfer of a calibration created on a poorer instrument to an
instrument of higher quality will inherently be limited by the lower quality instrument.
The T-S transfer results are listed in Table 6.4 and the resulting RMSNV trends
for the independent blend are displayed in Figure 6.3. Table 6.4 shows that most of the
errors incurred by the transfer process were in the Gabapentin predictions. The errors
were mostly the result of a large prediction bias. There were minimal increases in the
prediction variability when transferring the calibrations. This result was confirmed in
Figure 6.3 because the RMSNV profiles resulting from the direct prediction of side
sensor data from the top sensor calibrations showed the same trends as the prediction
results using the side sensor calibration. Only an offset due to a prediction bias was
observed. The results for the transfer of the ACLS/PLS algorithm using PDS 3 and PDS
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5 and for the transfer of the LSSVM algorithm using DS and all PDS parameters showed
low error statistics; however, it is important to note that the low error was due to a lack of
sensitivity, which is visualized in Figure 6.3. Only the PDS 5 error statistics are provided
in Table 6.4. Other iterations of the optical standardization methods provided similar
error statistics.
When data from the side sensor were added to the top sensor calibration set to
create robust calibrations, the blend predictions showed all of the same fluctuations, but
with slight increases in error resulting from an increase in noise in the calibration matrix.
There was very little difference when adding all of the side sensor calibration data, half of
the data, or a quarter of the data. This showed that both the ACLS/PLS and LSSVM
calibrations could be efficiently updated with additional information.
The ideal solution was to simply transfer the original calibration using
mathematical techniques, so a small number of spectra from only the blend concentration
level could be used to train the transfer. The 10 samples having the lowest prediction
residuals from the side sensor calibration set were used to train each method. A simple
bias correction of the predictions was all that was necessary to create transferred RMSNV
trends that were highly correlated with the robust calibration trends.

The optical

standardization methods (DS and PDS) were not as successful for transferring these
calibrations. Due to the differences in instrument noise and band broadening between
instruments, these techniques smoothed away the spectral information containing the
subtle concentration changes that created the blending profiles.
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Table 6.4. Calibration transfer performance for the ACLS/PLS and LSSVM algorithms using several transfer techniques. Calibrations created using top sensor
data are used to predict component concentrations in side sensor data.
Top To Side Sensor Transfer Performance
API
Direct Prediction

Robust (all)

Robust (Quarter)

Bias Correction

PDS 5
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ACLS/PLS

LSSVM

ACLS/PLS

LSSVM

ACLS/PLS

LSSVM

ACLS/PLS

LSSVM

ACLS/PLS

LSSVM

RMSEP

0.25

0.08

0.06

0.02

0.07

0.03

0.06

0.04

0.02

0.01

SEP
Bias

0.06
0.24

0.04
-0.07

0.06
0.01

0.02
-0.01

0.07
0.01
MCC

0.02
0.02

0.06
0.00

0.04
-0.01

0.01
0.02

0.00
0.00

ACLS/PLS

LSSVM

ACLS/PLS

LSSVM

ACLS/PLS

LSSVM

ACLS/PLS

LSSVM

ACLS/PLS

LSSVM

RMSEP

0.05

0.03

0.04

0.01

0.03

0.01

0.03

0.03

0.01

0.00

SEP
Bias

0.03

0.03

0.03

0.01

0.03

0.01

0.03

0.03

0.01

0.00

0.04

0.00

-0.02

0.00

0.01

0.00

0.01

0.01

0.00

ACLS/PLS

LSSVM

ACLS/PLS

LSSVM

-0.01
HPC
ACLS/PLS

LSSVM

ACLS/PLS

LSSVM

ACLS/PLS

LSSVM

RMSEP

0.14

0.03

0.06

0.01

0.06

0.01

0.05

0.04

0.04

0.00

SEP
Bias

0.05
-0.13

0.03
0.01

0.06
0.03

0.01
-0.01

0.06
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Figure 6.3. The RMSNV trends generated by transferring calibrations created using top sensor data to data
collected on the side sensor using several transfer techniques. a.) The transfer prediction results for the
ACLS/PLS calibration. b.) The transfer prediction results for the LSSVM calibration.

The transfer results showed that both the ACLS/PLS and LSSVM calibrations
were robust and easily transferred. The success of the simple bias correction method
demonstrated that both calibrations were correlated strongly to the net analyte signal
(NAS) of each component because new spectral variation encountered by different
instrumental data merely resulted in a prediction bias. All of the relevant (with respect to
the analyte of interest) spectral variation was still recognized by the models.
The LSSVM transfer results were more similar to the original predictions because
the original predictions using LSSVM lacked sensitivity to subtle concentration variation.
The major spectral variations that the LSSVM algorithm was trained to model were
similar between instruments. The ACLS/PLS transfer results showed that the models
retained their original sensitivity to subtle concentration changes, which is an important
property in blend monitoring because it is the trend information that is important. To
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mitigate the problem of a prediction bias, the absolute RMSNV threshold can be scaled to
account for the offsets in blend trends.
These results support the conclusion that sensitive and robust calibrations can be
created efficiently with a limited number of independent samples if pure components are
available and the proper modeling algorithms are used. Classical least-squares based
algorithms were most appropriate for the efficient calibration setting, while nonlinear
algorithms were limited for this application. Modest improvements to the results are
noted with additional calibration samples.

6.5 Conclusion
Sensitivity is the most important model property in blend process monitoring so
that subtle concentration changes caused by the distribution of blend constituents can be
recognized. Depending upon the algorithm, accuracy is also an important feature of a
calibration. Specifically, the RMSNV algorithm requires both sensitivity and accuracy to
achieve an optimum end point calculation. However, the trend information gathered by a
blend monitoring system is most important so that the end point can be determined when
the blend stops changing.
This chapter demonstrates that sensitive and robust multivariate spectral
calibrations can be created from limited sample sets when pure component scans are
available. Classical least-squares based methods produced the most sensitive calibrations
using an efficient calibration strategy. The accuracy of CLS calibrations were further
improved when using the ACLS/PLS algorithm. Nonlinear methods produced low error
statistics based on the samples available in an efficient calibration approach, but lacked
adequate sensitivity without additional samples.
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The chapter also highlighted the need to understand the capabilities of the
instrumentation and the requirements of a given product or system. Efficient calibrations
are ideal for a scenario in which the precision of a calibration is limited by the hardware
(including the sampling system). This study demonstrates that following an efficient
calibration effort, accuracy and precision are improved in diminishing returns through
additional calibration samples.

Efficient calibration offers a means of reducing the

resources required to generate a quantitative calibration. This is particularly important
for the long term success of quantitative spectral analysis in the pharmaceutical industry.
Finally, this chapter demonstrates that the investment incurred for an optimum
control system is process dependent.

In pharmaceutical powder blending, a robust

method for monitoring blend homogeneity is required to reduce the variability between
batches and assure content uniformity in the final dosage forms. This can be developed
using online NIRS, rigorous model development, a rigorous end point criterion, and a
blend-stop communication system. Any additional complexities that are built into the
control system are unnecessary, and do not justify the additional expense.
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Chapter 7: Summary
The pharmaceutical industry has shown significant progress in recent years with
regards to the discovery of new drug molecules, dosage systems, biological targeting
methods, and advanced disease treatments.

Despite these advances, the industry

continues to lag behind comparable industries in terms of manufacturing innovation,
quality production, and industrial efficiency.

In the past, restrictions put on

manufacturers by the FDA and comparable regulatory agencies to “lock in” validated
systems did not enable companies to implement production line improvements. The
regulatory agencies have acknowledged this shortcoming and are currently encouraging
the use of the ICH guidelines that allow flexibility within a validated design space. It is
now the responsibility of pharmaceutical manufactures to design rigorous and efficient
manufacturing systems to meet the standards of current industrial practice while also
realizing a financial return.
In the current QbD paradigm as part of the Critical Path Initiative, the amount of
regulatory flexibility offered to companies is directly proportional to the risk associated
with the given process. The manufacturer must demonstrate that an adequate level of
process understanding has been reached throughout development, and that this
understanding has led to a quantitative description of the relationships between raw
material, process, and product factors, which are then related to clinical performance.
This understanding requires rigorous planning of measurement systems, control systems,
and DOE from initial stages so that the complex relationships between all of the
aforementioned factors can be described clearly.
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This dissertation has demonstrated the importance of rigorous scientific design
and understanding at all levels of process or product development. A system should be
developed to meet the needs of the product or the operation. In chapter 6, a simple
control system that was based on maximizing the information available through multiple
online NIR sensors using a limited number of samples was developed for pharmaceutical
blending. By understanding the information that was available to the pharmaceutical
analysts with no additional effort and comprehending the differences between
multivariate modeling algorithms, a robust and sensitive homogeneity monitoring system
was able to be developed with a minimal investment. This would allow different batches
to be stopped at precisely the same level of homogeneity even when there were
substantial differences between powder properties and blend times. A greater degree of
production quality and process understanding was enabled.
More complex operations require control systems with increased complexity. A
formulation for the delivery of gabapentin is an example of a system with an API that is
sensitive to manufacturing conditions because gabapentin has process induced chemical
instability that is directly related to its physical stability. Complicating matters, the
chemical impurity, gabapentin lactam, has reversed biological activity and is required to
be less than 0.4 mole % in the final dosage form for a two year shelf life. Therefore,
rigorous DOE was necessary to quantify the relationships between unit operations and
gabapentin stability to assure product safety.
A hybrid control system that is the first of its kind was developed in chapter 2 for
the fluid bed drying of a model gabapentin formulation.

Fluid bed processing is a

complex unit operation with a large degree of energy input that requires care during
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development, but offers significant advantages in the process of commercial scale
batches. The hybrid control system combined first principle calculations with empirical
modeling, data management, and online sensing that allowed for strict control of the
drying process. The first principle calculations provided control of the major mechanism
by which the process impacted product quality, while offering substantial economic
benefits by reducing the dimensionality of the DOE and eliminating the need for
preconditioned air systems. The empirical controls allowed the process set points to be
optimized with a limited number of experiments, and the online sensing provided
additional process understanding, immediate feedback, and precise definitions of process
end points between batches. The control system maximized the advantages of traditional
control strategies, while eliminating the major drawbacks, and provided a significant
improvement in production quality with minimal developmental costs.
This dissertation also demonstrated the importance of rigorous statistical analyses
for the calculation of process models, the definitions of design space boundaries, and the
assurance of future product quality. Even with the most extensive DOE and development
efforts, models contain uncertainty that must be accounted for when making decisions
regarding future production. Statistical tolerance calculations can provide the analyst
with information about the probability of meeting specifications in future batches, which
is crucial in making informed decisions.

Without this information, design space

boundaries could be too lenient and lead to an increase number of failed batches.
Due to the care and rigor required during development, a substantial financial
investment is required. For this reason, failure during scale-up or commercialization can
have dire financial consequences for a pharmaceutical company.
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This dissertation

demonstrated that the hybrid control system also offers advantages for scale-up
development with a limited financial investment. The first principle calculations are
directly scalable, and a stochastic approach can be used to do a small magnitude scale-up
that trains all of the transfer functions for scale-up regardless of magnitude.

This

provided substantial material and cost savings.
The benefits of the hybrid control system extended to the spray granulation phase,
where particle agglomeration was controlled using the same EEF calculations and online
measurements. Additionally, this dissertation demonstrated the importance of material
properties in the processing behavior of spray granulation, which necessitates material
factors being included in developmental DOE. Material properties often have strong
interactions with processing factors, which significantly impact final product quality and
necessitate the use of extended ANACOVA modeling. Understanding these relationships
and how they are quantified provides benefits for the production of pharmaceutical
products in a QbD setting, and provides the evidence that is required by regulatory
agencies for allowing flexibility and the constant improvement of production lines.
The use of PAT in QbD development efforts is critical so that process or product
variability can be identified and addressed appropriately. Without measurements that are
implemented at strategic locations, this variability can go undetected, which then
magnifies the variability in final products and reduces product quality.

Online

measurements of the production stream are absolutely necessary for any feedback or
feedforward control to be implemented. Thus, PAT is absolutely necessary for the
development of control systems for continued product improvement, and any
development effort in the QbD paradigm.
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The work demonstrated in this dissertation facilitates the movement of the
pharmaceutical industry toward the desired state, as defined by the FDA’s Critical Path
Initiative and the ICH. It is a demonstration of the next step in manufacturing innovation
so that the pharmaceutical industry can compete in terms of quality and efficiency with
other industries. The rigor that is necessary in the development of control systems
requires extensive work, but the potential rewards are substantial. Continued use of
systems like those described in this dissertation offer great promise to the pharmaceutical
industry.
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